
<html lang="en"     class="pb-page"  data-request-id="db27d819-0866-4b79-9479-0c4666cf3c12"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2011.54.issue-1;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm1013105"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of (7R)-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic Acid (MK-3281), a Potent and Orally Bioavailable Finger-Loop Inhibitor of the Hepatitis C Virus NS5B Polymerase" /></meta><meta name="dc.Creator" content="Frank  Narjes" /></meta><meta name="dc.Creator" content="Benedetta  Crescenzi" /></meta><meta name="dc.Creator" content="Marco  Ferrara" /></meta><meta name="dc.Creator" content="Jörg  Habermann" /></meta><meta name="dc.Creator" content="Stefania  Colarusso" /></meta><meta name="dc.Creator" content="Maria  del Rosario Rico Ferreira" /></meta><meta name="dc.Creator" content="Ian  Stansfield" /></meta><meta name="dc.Creator" content="Angela Claire  Mackay" /></meta><meta name="dc.Creator" content="Immacolata  Conte" /></meta><meta name="dc.Creator" content="Caterina  Ercolani" /></meta><meta name="dc.Creator" content="Simone  Zaramella" /></meta><meta name="dc.Creator" content="Maria-Cecilia  Palumbi" /></meta><meta name="dc.Creator" content="Philip  Meuleman" /></meta><meta name="dc.Creator" content="Geert  Leroux-Roels" /></meta><meta name="dc.Creator" content="Claudio  Giuliano" /></meta><meta name="dc.Creator" content="Fabrizio  Fiore" /></meta><meta name="dc.Creator" content="Stefania  Di Marco" /></meta><meta name="dc.Creator" content="Paola  Baiocco" /></meta><meta name="dc.Creator" content="Uwe  Koch" /></meta><meta name="dc.Creator" content="Giovanni  Migliaccio" /></meta><meta name="dc.Creator" content="Sergio  Altamura" /></meta><meta name="dc.Creator" content="Ralph  Laufer" /></meta><meta name="dc.Creator" content="Raffaele  De Francesco" /></meta><meta name="dc.Creator" content="Michael  Rowley" /></meta><meta name="dc.Description" content="Infections caused by hepatitis C virus (HCV) are a significant world health problem for which novel therapies are in urgent demand. The polymerase of HCV is responsible for the replication of viral..." /></meta><meta name="Description" content="Infections caused by hepatitis C virus (HCV) are a significant world health problem for which novel therapies are in urgent demand. The polymerase of HCV is responsible for the replication of viral..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 8, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm1013105" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm1013105" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm1013105" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm1013105" /></link>
        
    
    

<title>Discovery of (7R)-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic Acid (MK-3281), a Potent and Orally Bioavailable Finger-Loop Inhibitor of the Hepatitis C Virus NS5B Polymerase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm1013105" /></meta><meta property="og:title" content="Discovery of (7R)-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic Acid (MK-3281), a Potent and Orally Bioavailable Finger-Loop Inhibitor of the Hepatitis C Virus NS5B Polymerase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0015.jpeg" /></meta><meta property="og:description" content="Infections caused by hepatitis C virus (HCV) are a significant world health problem for which novel therapies are in urgent demand. The polymerase of HCV is responsible for the replication of viral genome and has been a prime target for drug discovery efforts. Here, we report on the further development of tetracyclic indole inhibitors, binding to an allosteric site on the thumb domain. Structure−activity relationship (SAR) studies around an indolo-benzoxazocine scaffold led to the identification of compound 33 (MK-3281), an inhibitor with good potency in the HCV subgenomic replication assay and attractive molecular properties suitable for a clinical candidate. The compound caused a consistent decrease in viremia in vivo using the chimeric mouse model of HCV infection." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm1013105"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm1013105">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm1013105&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm1013105&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm1013105&amp;href=/doi/10.1021/jm1013105" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 289-301</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm101157q" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm101163m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of (7<i>R</i>)-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylic Acid (MK-3281), a Potent and Orally Bioavailable Finger-Loop Inhibitor of the Hepatitis C Virus NS5B Polymerase<a class="ref internalNav" href="#ac1" aria-label=""></a></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank++Narjes">Frank Narjes</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benedetta++Crescenzi">Benedetta Crescenzi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Ferrara">Marco Ferrara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%B6rg++Habermann">Jörg Habermann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefania++Colarusso">Stefania Colarusso</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria++del+Rosario+Rico+Ferreira">Maria del Rosario Rico Ferreira</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ian++Stansfield">Ian Stansfield</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela+Claire++Mackay">Angela Claire Mackay</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Immacolata++Conte">Immacolata Conte</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Caterina++Ercolani">Caterina Ercolani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simone++Zaramella">Simone Zaramella</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria-Cecilia++Palumbi">Maria-Cecilia Palumbi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip++Meuleman">Philip Meuleman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Geert++Leroux-Roels">Geert Leroux-Roels</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claudio++Giuliano">Claudio Giuliano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrizio++Fiore">Fabrizio Fiore</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefania++Di+Marco">Stefania Di Marco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paola++Baiocco">Paola Baiocco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Uwe++Koch">Uwe Koch</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giovanni++Migliaccio">Giovanni Migliaccio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sergio++Altamura">Sergio Altamura</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ralph++Laufer">Ralph Laufer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raffaele++De+Francesco">Raffaele De Francesco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Rowley">Michael Rowley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">‡</span> <span class="aff-text">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">§</span> <span class="aff-text">Center for Vaccinology, Ghent University and Hospital, De Pintelaan 185, B-9000, Gent, Belgium</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +46 46 337 373. Fax: +46 46 337 119. E-mail: <a href="/cdn-cgi/l/email-protection#ecaa9e8d8287c2a28d9e86899fac8d9f989e8d968982898f8dc28f8381"><span class="__cf_email__" data-cfemail="66201407080d482807140c03152607151214071c03080305074805090b">[email protected]</span></a>. Current address: AstraZeneca R&D Lund, Department of Medicinal Chemistry, 221 87 Lund, Sweden.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm1013105&amp;href=/doi/10.1021%2Fjm1013105" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 289–301</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 8, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 October 2010</li><li><span class="item_label"><b>Published</b> online</span>8 December 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 January 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm1013105" title="DOI URL">https://doi.org/10.1021/jm1013105</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D289%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFrank%2BNarjes%252C%2BBenedetta%2BCrescenzi%252C%2BMarco%2BFerrara%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D1%26contentID%3Djm1013105%26title%3DDiscovery%2Bof%2B%25287R%2529-14-Cyclohexyl-7-%257B%255B2-%2528dimethylamino%2529ethyl%255D%2528methyl%2529%2Bamino%257D-7%252C8-dihydro-6H-indolo%255B1%252C2-e%255D%255B1%252C5%255Dbenzoxazocine-11-carboxylic%2BAcid%2B%2528MK-3281%2529%252C%2Ba%2BPotent%2Band%2BOrally%2BBioavailable%2BFinger-Loop%2BInhibitor%2Bof%2Bthe%2BHepatitis%2BC%2BVirus%2BNS5B%2BPolymerase%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D301%26publicationDate%3DJanuary%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm1013105"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2742</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">50</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm1013105" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of (7R)-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic Acid (MK-3281), a Potent and Orally Bioavailable Finger-Loop Inhibitor of the Hepatitis C Virus NS5B Polymerase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Narjes&quot;},{&quot;first_name&quot;:&quot;Benedetta&quot;,&quot;last_name&quot;:&quot;Crescenzi&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Ferrara&quot;},{&quot;first_name&quot;:&quot;Jörg&quot;,&quot;last_name&quot;:&quot;Habermann&quot;},{&quot;first_name&quot;:&quot;Stefania&quot;,&quot;last_name&quot;:&quot;Colarusso&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;del Rosario Rico Ferreira&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;Stansfield&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Claire Mackay&quot;},{&quot;first_name&quot;:&quot;Immacolata&quot;,&quot;last_name&quot;:&quot;Conte&quot;},{&quot;first_name&quot;:&quot;Caterina&quot;,&quot;last_name&quot;:&quot;Ercolani&quot;},{&quot;first_name&quot;:&quot;Simone&quot;,&quot;last_name&quot;:&quot;Zaramella&quot;},{&quot;first_name&quot;:&quot;Maria-Cecilia&quot;,&quot;last_name&quot;:&quot;Palumbi&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;Meuleman&quot;},{&quot;first_name&quot;:&quot;Geert&quot;,&quot;last_name&quot;:&quot;Leroux-Roels&quot;},{&quot;first_name&quot;:&quot;Claudio&quot;,&quot;last_name&quot;:&quot;Giuliano&quot;},{&quot;first_name&quot;:&quot;Fabrizio&quot;,&quot;last_name&quot;:&quot;Fiore&quot;},{&quot;first_name&quot;:&quot;Stefania&quot;,&quot;last_name&quot;:&quot;Di Marco&quot;},{&quot;first_name&quot;:&quot;Paola&quot;,&quot;last_name&quot;:&quot;Baiocco&quot;},{&quot;first_name&quot;:&quot;Uwe&quot;,&quot;last_name&quot;:&quot;Koch&quot;},{&quot;first_name&quot;:&quot;Giovanni&quot;,&quot;last_name&quot;:&quot;Migliaccio&quot;},{&quot;first_name&quot;:&quot;Sergio&quot;,&quot;last_name&quot;:&quot;Altamura&quot;},{&quot;first_name&quot;:&quot;Ralph&quot;,&quot;last_name&quot;:&quot;Laufer&quot;},{&quot;first_name&quot;:&quot;Raffaele&quot;,&quot;last_name&quot;:&quot;De Francesco&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Rowley&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;289-301&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm1013105&quot;},&quot;abstract&quot;:&quot;Infections caused by hepatitis C virus (HCV) are a significant world health problem for which novel therapies are in urgent demand. The polymerase of HCV is responsible for the replication of viral genome and has been a prime target for drug discovery efforts. Here, we report on the further development of tetracyclic indole inhibitors, binding to an allosteric site on the thumb domain. Structure−activity relationship (SAR) studies around an indolo-benzoxazocine scaffold led to the identification of compound 33 (MK-3281), an inhibitor with good potency in the HCV subgenomic replication assay and attractive molecular properties suitable for a clinical candidate. The compound caused a consistent decrease in viremia in vivo using the chimeric mouse model of HCV infection.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1013105&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1013105" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1013105&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1013105" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1013105&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1013105" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm1013105&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1013105&amp;href=/doi/10.1021/jm1013105" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm1013105" /></input><a href="/doi/pdf/10.1021/jm1013105" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm1013105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm1013105%26sid%3Dliteratum%253Aachs%26pmid%3D21141896%26genre%3Darticle%26aulast%3DNarjes%26date%3D2011%26atitle%3DDiscovery%2Bof%2B%25287R%2529-14-Cyclohexyl-7-%257B%255B2-%2528dimethylamino%2529ethyl%255D%2528methyl%2529%2Bamino%257D-7%252C8-dihydro-6H-indolo%255B1%252C2-e%255D%255B1%252C5%255Dbenzoxazocine-11-carboxylic%2BAcid%2B%2528MK-3281%2529%252C%2Ba%2BPotent%2Band%2BOrally%2BBioavailable%2BFinger-Loop%2BInhibitor%2Bof%2Bthe%2BHepatitis%2BC%2BVirus%2BNS5B%2BPolymerase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D1%26spage%3D289%26epage%3D301%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jmcmar.2011.54.issue-1/production/jmcmar.2011.54.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Infections caused by hepatitis C virus (HCV) are a significant world health problem for which novel therapies are in urgent demand. The polymerase of HCV is responsible for the replication of viral genome and has been a prime target for drug discovery efforts. Here, we report on the further development of tetracyclic indole inhibitors, binding to an allosteric site on the thumb domain. Structure−activity relationship (SAR) studies around an indolo-benzoxazocine scaffold led to the identification of compound <b>33</b> (MK-3281), an inhibitor with good potency in the HCV subgenomic replication assay and attractive molecular properties suitable for a clinical candidate. The compound caused a consistent decrease in viremia in vivo using the chimeric mouse model of HCV infection.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span>†</span> </h4><p class="last">PDB deposition number: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xwy">2xwy</a>.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50842" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50842" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">It has been estimated that more than 170 million people worldwide are infected with the hepatitis C virus (HCV<a class="ref internalNav" href="#fn2" aria-label="a">a</a><div class="NLM_fn" id="fn2">a<p class="last">Abbreviations: 1,2-DCE, 1,2-dichloroethane; DCM, dichloromethane; DIPEA, diisopropylethylamine; DMP, Dess−Martin periodinane; FCS, fetal calf serum; gt, genotype; HATU, <i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyl uronium hexafluorophosphate; HCV, hepatitis C Virus; NHS, normal human serum; SAR, structure−activity relationship; SD, standard deviation; SFC, supercritical fluid chromatography; SOC, standard of care; TBAT, tetrabutylammonium triphenyldifluorosilicate; TFA, trifluoroacetic acid.</p></div>).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Although the infection is typically slow progressing and often asymptomatic, it becomes chronic in a majority of patients and in a significant fraction of these can develop into chronic hepatitis, liver cirrhosis, and eventually hepatocellular carcinoma. Chronic HCV infection has become the leading indication for liver transplants in the developed world<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and is the principal cause of death in HIV coinfected patients.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Although the number of new infections is diminishing, the mortality due to HCV infection is expected to increase in Europe and the USA.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The genetic heterogeneity of the virus, which has been classified into six different genotypes (gt), having as much as 35% nucleotide sequence difference among them, has been a major obstacle for the development of a vaccine.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Currently, the standard of care (SOC) is based upon a combination of subcutaneous pegylated α-interferon and oral ribavirin. It is poorly tolerated and associated with severe flu-like symptoms, depression, and anemia, resulting in poor patient compliance.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Moreover, duration of therapy and response rate are genotype specific. The SOC is efficient in about 80% of patients infected with the gt 2 and 3 of the virus but only in about 50% of patients infected with gt 1, which accounts for approximately 70% of infections in the Western world.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> To improve treatment outcome for chronic hepatitis C infection with respect to efficacy, tolerability, and duration, research in the pharmaceutical industry and in academia has focused on the characterization of viral enzymes as targets for small molecule intervention.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Proof-of-concept in the clinic has been obtained for small molecule inhibitors which target viral proteins such as the NS3/4A protease, the NS5B polymerase, and most recently also NS5A.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14">(10-14)</a> The RNA-dependent RNA polymerase NS5B plays a key role in the life cycle of the virus since it is responsible for the replication of the viral genome.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Classical nucleoside analogues<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> as well as allosteric inhibitors, which were shown to bind to at least four distinct sites on the polymerase, have been described.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Recently, we and other groups reported on the discovery of indole-based inhibitors of NS5B, also called thumb-pocket 1 or finger-loop inhibitors.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> This class of molecules was shown to inhibit the initiation of RNA synthesis by binding to the upper part of the thumb domain, where they interrupt a key interaction between the λ1 loop, which extends from the fingertips, and the thumb domain, impeding a conformational change of the enzyme thought to be important for RNA synthesis.<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21-23)</a> Successive optimization of our indole series, exemplified by <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> led to conformationally constrained indoles, where the ortho position of the C2-aryl group is tethered to the indole nitrogen,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> an approach that was also disclosed recently by a group of scientists at Japan Tobacco.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The tetracyclic benzodiazocine <b>2</b> had good intrinsic and cell-based potency and a superior DMPK profile with respect to <b>1</b>.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Our efforts to improve the potency of this inhibitor class focused on replacement of the indole core and optimization of the tether moiety. Thieno[3,2-<i>b</i>]pyrroles were identified as the only viable replacements for the indole core.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Optimization led to tetracyclic thienopyrrole <b>3</b>, which had similar potency and pharmacokinetic properties with respect to <b>2</b>.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Since we were unable to improve potency of this series further, we turned our attention to the modification of the tether moiety in the indole series, which was more successful. SAR around <b>2</b> and related series had shown that 7- as well as 8-membered rings were equally well tolerated.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> Starting from the tetracyclic benzoazepine <b>4</b>, novel pentacyclic compounds such as <b>5</b> with superior potency in the cell-based assay with respect to our previous compounds were discovered.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> However, different from <b>2</b>, pentacycle <b>5</b> and related compounds lacked oral bioavailability in rodents.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In our search for alternative tetracyclic scaffolds which eventually could combine the potency of <b>5</b> with the good pharmacokinetic properties of <b>2</b>, we also had prepared the simple benzoxazocine <b>6</b>, which showed better cell-based activity compared to tetracyclic benzoazepine <b>4</b> and thus was deemed to provide a better starting point for optimization.<a onclick="showRef(event, 'cit26b'); return false;" href="javascript:void(0);" class="ref cit26b">(26b)</a> In this paper, we describe the synthesis and structure−activity relationship within this class of compounds, leading to the identification of compound <b>33</b>, which combined improved potency with good oral bioavailability in preclinical animal models and which was evaluated in the SCID/<i>Alb-uPA</i> mouse model of HCV infection.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83552" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83552" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Benzoxazocine <b>6</b> was readily prepared from the phenol <b>8</b>, the Suzuki-coupling product obtained from bromide <b>7</b> and the corresponding boronic acid, by double alkylation with dibromopropane (not shown). To obtain a suitable handle for further modification of the tether, ketone <b>11</b> was targeted, but all attempts of alkylating <b>8</b> with dichloroacetone failed (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). As an alternative, <b>8</b> was reacted with (<i>S</i>)-glycidyl nosylate under the influence of cesium fluoride to give (<i>S</i>)-epoxide <b>9a</b>.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Several base-catalyzed conditions, such as sodium hydride in DMF, LHMDS in THF, or cesium carbonate in DMF, induced cyclization to the benzoxazocine alcohol (<i>S</i>)-<b>10a</b>, with the latter giving the highest yield. Reaction of <b>8</b> with (<i>R</i>)-glycidyl nosylate led to epimeric alcohol <b>10b</b>. Oxidation of either alcohol gave ketone <b>11</b>, which was reacted with a variety of amines under reducing conditions to yield the racemic amino acids <b>12</b>−<b>27</b> after hydrolysis of the methyl ester. The compounds exist as mixtures of atropisomers, as was evident from their NMR spectra (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (2-hydroxyphenyl)boronic acid, PdCl<sub>2</sub>[P(Ph)<sub>3</sub>]<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane, 110 °C; (b) (<i>S</i>)-glycidyl 3-nitrobenzenesulfonate, CsF, DMF, RT; (c) Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C; (d) (i) (<i>R</i>)-glycidyl 3-nitrobenzenesulfonate, CsF, DMF, RT, (ii) Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C; (e) DMP, DCM (f) <b>12</b>−<b>20</b>: R<sup>1</sup>R<sup>2</sup>NH, NaBH(OAc)<sub>3</sub>, AcOH, 1,2-DCE, rt; <b>21</b>−<b>27</b>: (i) R<sup>1</sup>NH<sub>2</sub>, NaBH(OAc)<sub>3</sub>, AcOH, 1,2-DCE, (ii) R<sup>2</sup>CHO, NaBH(OAc)<sub>3</sub>; (g) KOH, MeOH/THF (1:1), reflux.</p></p></figure><div class="NLM_p">Yields were satisfactory for primary amines, but secondary amines such as dimethylamine or piperidine gave only low yields, racemic alcohol <b>10</b> being the major product. Better yields were obtained for compounds <b>21</b>−<b>27</b> by using a double reductive amination procedure, where <b>11</b> was first reacted with the primary amine and subsequently with the corresponding aldehyde to introduce the R<sup>2</sup>-substituent.</div><div class="NLM_p">The <i>N</i>-acylated derivatives <b>28</b> and <b>29</b> were obtained as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. For the preparation of compound <b>29</b>, the methyl ester needed to be hydrolyzed prior to amine acylation to avoid cleavage of the tertiary amide bond during the final ester deprotection.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NH<sub>4</sub>OAc or MeNH<sub>2</sub>·HCl NaOAc; NaBH<sub>3</sub>CN, MeOH, RT; (b) <b>28</b>: (i) <i>N</i>,<i>N</i>-dimethylglycine, HATU, DIPEA, DCM, RT, (ii) BBr<sub>3</sub>, DCM; <b>29</b>: (i) KOH, 75 °C; (ii) <i>N</i>,<i>N</i>-dimethylglycine, HATU, DIPEA, DCM, RT.</p></p></figure><div class="NLM_p">Compound <b>21</b> could be separated into the enantiomers <b>33</b> and <b>34</b>. These were also prepared independently from alcohols <b>10a</b> and <b>10b</b>. Tosylate <b>30a</b> was obtained from <b>10a</b>, and reaction with TMS-azide and TBAT as the fluoride source<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) gave azide <b>31a</b> with inversion of configuration in 84% yield and 99.3% enantiomeric excess (ee). This method was superior with respect to yield and enantiomeric purity to reaction of the tosylate with sodium azide in DMF (50% yield, 72% ee) or classical Mitsunobu conditions of alcohol <b>10a</b>, which gave low yields (31% yield, 99.5% ee). The high enantiomeric purity of <b>31a</b> also showed that epoxide <b>9a</b> was obtained by nearly exclusive attack of the phenol on the nosylate moiety of (<i>S</i>)-glycidyl 3-nitrobenzenesulfonate. This excludes a potential racemization at this step via epoxide opening and Payne rearrangement to give the enantiomer of <b>9a</b>.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Reduction of the azide provided the amino ester <b>32a</b>, which was converted to <b>33</b> in three more steps with an enantiomeric excess of 96%, as determined by separation on a chiral column. The same route led from <b>10b</b> to <b>34</b> having the (<i>S</i>)-configuration in 99% enantiomeric excess (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TsCl, pyridine; (b) TMSN<sub>3</sub>, TBAT, THF, 70 °C; (c) H<sub>2</sub>, Pd/C, MeOH; (d) <i>N</i>-Boc-aminoacetaldehyde, HC(OMe)<sub>3</sub>; NaCNBH<sub>3</sub>, HOAc, MeOH; (e) DCM/TFA (1:1); HCHO, NaOAc, NaCNBH<sub>3</sub>, DCM; (f) KOH, dioxane/H<sub>2</sub>O (2:1); (g) separation by SFC.</p></p></figure><div class="NLM_p">Alkylation of alcohol <b>10a</b> with 2-chloro-<i>N</i>,<i>N</i>-dimethylethaneamine yielded, after hydrolysis of the ester, the aminoether <b>35</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Enantiomer <b>36</b> was prepared in the same way starting from the (<i>R</i>)-configurated alcohol <b>10b</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-chloro-<i>N</i>,<i>N</i>-dimethylethanamine, Bu<sub>4</sub>NBr, toluene/30% NaOH, 60 °C.</p></p></figure><div class="NLM_p">Spiroazetidines <b>38</b> and <b>39</b> could be accessed from the reaction of <b>8</b> with 5,5-bis(bromomethyl)-2,2-dimethyl-1,3-dioxane,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> leading to spiroketal <b>37</b>. Hydrolysis, conversion of the alcohols into the corresponding triflates, and reaction with isopropylamine or <i>N</i>,<i>N</i>-dimethylethane-1,2-diamine gave the desired compounds after hydrolysis of the methyl ester (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, DMF, 70 °C; 5,5-bis(bromomethyl)-2,2-dimethyl-1,3-dioxane, 70 °C, 50%; (b) TsOH·H<sub>2</sub>O, MeOH/THF, RT, 89%; (c) Tf<sub>2</sub>O, MeCN, DIPEA, 0 °C, then <i>i</i>PrNH<sub>2</sub> (<b>38</b>) or H<sub>2</sub>N(CH<sub>2</sub>)<sub>2</sub>NMe<sub>2</sub> (<b>39</b>), 70 °C; (d) KOH, dioxane, 75 °C.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Optimization of Replicon Activity</h3><div class="NLM_p">Compounds were assayed in a polymerase enzyme inhibition assay (IC<sub>50</sub>) on the HCV genotype 1b NS5B (ΔC21) polymerase.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The cellular activity (EC<sub>50</sub>) was determined in the replicon system expressing genotype 1b in a Huh-7 hepatoma cell line in the presence of 10% fetal calf serum (FCS) or 50% normal human serum (NHS) for compounds with replicon EC<sub>50</sub>s < 1 μM in 10% FCS.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Introduction of a basic amine onto the indole carboxylic acids had usually proven the method of choice to gain cell-based potency for this series of compounds.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> This was also the case for benzoxazocine <b>6</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Methyl amine <b>12</b> was already 2-fold more active in the replicon assay in 10% FCS compared to <b>6</b>. Introduction of another methyl group increased cellular activity even further (<b>13</b>, EC<sub>50</sub> 570 nM), although intrinsic potency of <b>12</b> and <b>13</b> did not change much with respect to <b>6</b>. Introduction of an ethane-1,2-diamine gave <b>14</b>, which displayed similar levels of cell-based activity with respect to <b>13</b>. Methylation of the distal amine yielded <b>15</b>, with a 3-fold improvement in EC<sub>50</sub>. Elongation of the distance between the two amines, as in <b>16</b>, or incorporating the outer amine into a piperidine ring as in <b>17</b>, led to a slight loss in cell-based potency with respect to <b>15</b>. Testing compounds <b>13</b>−<b>17</b> in high serum conditions resulted in a moderate 4−5-fold shift in replicon potency.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Enzymatic and Cell-Based Activity of Compounds <b>6</b> and <b>12</b>−<b>16</b></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0007.gif" alt="" id="fx1" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0008.gif" alt="" id="fx2" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Values are the mean ± SD of at least three independent measurements. Values without SD are the average of at two independent measurements.</p></div></div></div><div class="NLM_p">Compound <b>15</b> had the same level of potency when compared to <b>2</b> and was characterized further with respect to metabolic stability and rodent PK. The compound demonstrated an encouraging PK profile in Sprague−Dawley rats after single intravenous and oral doses. Following intravenous dosing, plasma clearance and half-lives were significantly improved with respect to <b>2</b>, consistent with the increased metabolic stability of <b>15</b> in rat liver microsomes (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). After an oral dose of 3 mg/kg of <b>15</b>, bioavailability was determined to be 20%, slightly lower than that for <b>1</b> (31%). Elevated concentrations of <b>15</b> were found in rat liver tissue 6 h after oral dosing, corresponding to a liver tissue to plasma concentration ratio of 21 at this point in time (16 for compound <b>1</b>). The stability in dog and human liver microsome preparations was similar to rat, with the low intrinsic clearance rates observed in all three species.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacokinetic Profile for Compounds <b>2</b> and <b>15</b> Following Single Dose Administration to Rats<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> and Their Stability in Liver Microsome Preparations</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" colspan="3" align="char" char=".">iv, 3 mg/kg</th><th class="colsep0 rowsep0" colspan="4" align="char" char=".">po, 3 mg/kg</th><th class="colsep0 rowsep0" align="left"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">compd</th><th class="colsep0 rowsep0" align="char" char=".">Cl (mL/min/kg)</th><th class="colsep0 rowsep0" align="char" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="char" char=".">Vd (L/kg)</th><th class="colsep0 rowsep0" align="left" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="char" char=".">AUC (μM·h)</th><th class="colsep0 rowsep0" align="char" char="."><i>F</i> (%)</th><th class="colsep0 rowsep0" align="char" char=".">rat [liver] 6 h (μM)</th><th class="colsep0 rowsep0" align="left">Cl<sub>int</sub> r, d, h (μL/min/mg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">61</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">0.64</td><td class="colsep0 rowsep0" align="left">100, 26, 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="left">7, 7, 5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Compounds <b>2</b> and <b>15</b> were dosed as their respective TFA salts to Sprague−Dawley rat, <i>n</i> = 3 (DMSO/PEG400/water 20%/60%/20%); po (PEG400).</p></div></div></div><div class="NLM_p">Encouraged by these results, we undertook further SAR around the ethane-diamine side chain of <b>15</b> and key results are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. A distal basic amine was required for cell-based activity. Methylether <b>18</b> lost an order of magnitude in activity compared to <b>15</b>, and amide <b>19</b> was 4-fold less potent. In both cases, the loss in intrinsic potency was only about 2-fold. Conversely, the conversion of the inner amine to an amide as in <b>28</b> was tolerated and cell-based activity was further improved by methylation of the nitrogen, leading to tertiary amide <b>29</b> (EC<sub>50</sub> 73 nM). Removal of the amide oxygen gave the fully methylated bis-amine <b>21</b>, which was equipotent to <b>29</b> in the standard replicon conditions. Compounds <b>21</b> and <b>29</b> were the first examples displaying an EC<sub>50</sub> < 100 nM in the tetracyclic indole series. In the presence of 50% NHS, compound <b>29</b> showed a nearly 10-fold shift in potency, whereas <b>21</b> shifted only 4-fold under high serum conditions, reflecting the higher binding to human plasma protein of <b>29</b> (0.5% free) versus <b>21</b> (2.7% free). With respect to replicon potency under low and high serum conditions, the methyl substitution on the two amines proved to be optimal, although several analogues with modifications on the distal amine such compounds <b>22</b>−<b>25</b> displayed similar replicon potency under standard replicon conditions. For the most potent of these analogues, <i>N</i>-methylpiperazine <b>25</b> (EC<sub>50</sub> 66 nM), a low free fraction in the presence of human plasma proteins (1.1% free), led to a 9-fold shift in the replicon assay. Exchanging the methyl group on the inner amine for an ethyl- and isopropyl group as in compounds <b>26</b> and <b>27</b> resulted in a 2-fold loss in cell-based activity and a more pronounced shift (7-fold) under high serum conditions.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Enzymatic and Cell-Based Activity of Compounds <b>18</b>−<b>29</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0010.gif" alt="" id="_i8" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0009.gif" alt="" id="fx3" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Values are the mean ± SD of at least three independent measurements. Values without SD are the average of at two independent measurements.</p></div></div></div><div class="NLM_p">To investigate the impact of the stereochemistry on the tether, compound <b>21</b> was separated into the enantiomers <b>33</b> and <b>34</b>. The activity resided mostly in the (<i>R</i>)-configurated compound <b>33</b>, which was 4-fold more potent intrinsically with respect to the (<i>S</i>)-enantiomer <b>34</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Moreover, <b>33</b> was about 10-fold more potent than <b>34</b> in the cell-based assay, with an EC<sub>50</sub> of 38 nM and a moderate 3-fold shift under high serum conditions. The absolute configuration of <b>33</b> was established also by synthesis from <b>10a</b> and later confirmed by an X-ray structure of <b>33</b> bound to NS5B (vide infra).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 4. <img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0012.gif" alt="" id="_i9" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0011.gif" alt="" id="_i10" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Values are the mean ± SD of at least three independent measurements. Values without SD are the average of at two independent measurements.</p></div></div></div><div class="NLM_p">Further SAR around the side chain established that the inner methylamine group could be replaced with oxygen, giving compounds <b>35</b> and <b>36</b>. The more active epimer <b>35</b> was 2-fold less potent in the replicon assay with respect to <b>33</b>, and the EC<sub>50</sub> shifted 6-fold under high serum conditions. Different from what had been observed for bis-amines <b>33</b> and <b>34</b>, the activity in the resulting amino ethers <b>35</b> and <b>36</b> resided mostly in (<i>S</i>)-enantiomer <b>35</b>, having the opposite configuration at position 7 of the tether. We also briefly investigated the possibility to eliminate the stereogenic center at this position by introduction of a spirocycle. Geminal disubstitution was tolerated, as spiro-azetidines <b>38</b> and <b>39</b> show. Monoamine <b>38</b> had similar potency levels with respect to monoamine <b>13</b> (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), and bisamine <b>39</b> showed slightly improved intrinsic potency with respect to <b>33</b> but was 2-fold less active in the replicon assay, with a 5−6-fold shift in the presence of 50% NHS.</div><div class="NLM_p">On the basis of its potency in cell-based assay, compound <b>33</b> was characterized further.</div><div class="NLM_p last">Against a panel of chimeric replicons containing different NS5B genotypes, <b>33</b> was an equally potent inhibitor of gt 1a (EC<sub>50</sub> = 28 nM), 1b BK (EC<sub>50</sub> = 9 nM), and 3a (EC<sub>50</sub> = 37 nM) replicons, whereas it resulted 2 orders of magnitude less active on 2a (EC<sub>50</sub> = 2018 nM) and 2b (EC<sub>50</sub> = 1833 nM) replicons.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The lower sensitivity of the finger-loop inhibitors against HCV genotype 2b is due to differences in the amino acid composition of the binding pocket, resulting in a different shape between the two genotypes.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Crystal Structure of <b>33</b> Bound to NS5B</h3><div class="NLM_p">Compound <b>33</b> was successfully soaked into crystals of a NS5B ΔC<sub>55</sub> genotype 1b construct (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). As had been previously observed with the related indole and thienopyrrole inhibitors, the tetracyclic compound binds in the allosteric pocket in the thumb domain, which in the apoenzyme is occupied by a short α-helix protruding from the finger domain and displays the same binding mode.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The cyclohexyl ring is tightly bound in a lipophilic pocket, and the indole scaffold itself is accommodated mainly in a lipophilic environment with its carboxylate forming a salt bridge to Arg503. The dihedral angle between the C2-phenyl ring and the indole in the complex structure is 46°, as predicted form our docking studies. The amine containing side chain is pointing out into solvent, preferring an orientation which brings the basic amine into proximity of the indole caboxylate. The structure confirms the (<i>R</i>)-configuration on the 7-position of the benzoxazocine ring. In this configuration, the 2-(dimethylamino)ethyl]-(methyl)amino moiety occupies the pseudoequatorial position on the benzoxazocine-ring, which is calculated to be 13 kJ/mol lower in energy with respect to the corresponding pseudoaxial conformation which would be required for binding of the (<i>S</i>)-configurated epimer <b>34</b>.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of HCV ΔC<sub>55</sub> NS5B polymerase from genotype 1b in complex with compound <b>33</b><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (2.53 Å resolution, compound is in stick representation in green, with nitrogen in blue and oxygen in red). The lipophilic protein surface is in white and light gray, except for Arg503, shown in stick representation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In the enantiomorphic pseudoequatorial conformation of the <i>S</i>-epimer, the ring would adopt an orientation incompatible with binding because it clashes with the enzyme surface. This might be the reason for the difference in activity for the enantiomers. In the oxygen-linked series, the more active isomer, compound <b>35</b>, has the side chain in the pseudoaxial position. We hypothesize that the pseudoaxial arrangement is favored by a gauche effect between the exocyclic O-atom and the endocyclic nitrogen and oxygen atoms. Sterically the ether O-atom is less disfavoring for the pseudoaxial arrangement than the sterically more demanding N-Me group.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Animal Pharmacokinetics and Safety Assessment</h3><div class="NLM_p">The pharmacokinetic profile of compound <b>33</b> was evaluated in rats, dogs, and rhesus monkeys (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The compound displayed moderate plasma clearance in rats, dogs, and rhesus monkeys, with 22, 7, and 7 mL/min/kg, respectively. The volumes of distribution were 3.7 in rats, 2.6 in dogs, and 2.2 L/kg in monkeys. Terminal half-lives were 3.4 h in rats, 6.1 h in dogs, and 5.7 h in monkeys. The oral bioavailability of the amorphous bis-HCl salt was 49% in rats, 78% in dogs, and 35% in monkeys. After an oral dose of 3 mg/kg to rat, liver concentrations 6 h after dosing of <b>33</b> were determined to be 0.42 ± 0.16 μM, which corresponds to a liver tissue to plasma concentration ratio of 5. The levels are 3-fold lower than those observed for compound <b>15</b> at the same dose, but they are 4-fold higher than the EC<sub>50</sub> in 50% NHS, which compares favorably with compounds <b>2</b> and <b>15</b>, where this ratio is about 1 and 2, respectively.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Profile of Compound <b>33</b> Following Single Dose Administration<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char="±">Cl (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="±">Vd<sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="±"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="±"><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="±">AUC<sub>po</sub> (μM·h)</th><th class="colsep0 rowsep0" align="center" char="±"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char="±">22 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">3.7 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">3.4 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">2.4 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">49 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char="±">7 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">2.6 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">6.1 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±">1.0</td><td class="colsep0 rowsep0" align="char" char="±">8.6</td><td class="colsep0 rowsep0" align="char" char="±">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rhesus</td><td class="colsep0 rowsep0" align="char" char="±">7 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">2.2 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">5.7 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">7.4 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">35 ± 12</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Compound <b>33</b> was dosed as the bis-HCl salt; rat, dog, and rhesus <i>n</i> = 3 (except dog po <i>n</i> = 2); iv 3, 1, and 2 mg/kg (DMSO/PEG400/water 20%/60%/20%); po 3, 2, and 4 mg/kg (PEG400 rat and dog, PEG400/water 70%/30% rhesus).</p></div></div></div><div class="NLM_p">Compound <b>33</b> displayed relatively high binding to rat (97%), dog (97.3%), monkey (92.6%), and human (96.9%) plasma proteins. NADPH-dependent metabolism was observed in liver microsomes, with low intrinsic clearance in dog, human, and rat, 3, 7, and 7 μL/min/mg, respectively. In liver microsomes supplemented with UDPGA, <b>33</b> exhibited very low turnover in all species, < 4 μL/min/mg.</div><div class="NLM_p">The compound did not inhibit CYP3A4, CYP2D6, or CYP2C9 at concentrations up to 50 μM and was not a time-dependent inhibitor of human CYP3A4. In the PXR transactivation assay, <b>33</b> showed no potential for inducing CYP3A4.</div><div class="NLM_p last">In the PanLabs screen, only 2 off-target activities were seen for matrix metalloprotease 12 (IC<sub>50</sub> = 8.3 μM) and protein kinase Cα (IC<sub>50</sub> = 59 μM). Selectivity versus inhibition of NS5B is >1000-fold. The human DNA polymerases α, β, and γ were not inhibited at concentrations up to 50 μM.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Viral Response in HCV-Infected Chimeric Mice</h3><div class="NLM_p">The in vivo efficacy of <b>33</b> was demonstrated preclinically in a humanized mouse model for the study of viral hepatitis. T- and B-cell deficient mice carrying a tandem array of murine urokinase-type plasminogen activator transgenes under the control of the mouse albumin promoter (Alb/uPA<sup>+/+</sup>-SCID) suffer from a severe liver disease and consequently are excellent recipients for primary human hepatocyte transplantation. Several weeks after transplantation, the liver of these mice can harbor up to 90% of well-organized, functional, and healthy human hepatocytes.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> They can then be inoculated with infectious HCV particles of different origins and genotypes and support durable replication of the virus at levels equivalent to those seen in infected humans.<a onclick="showRef(event, 'cit31a ref40'); return false;" href="javascript:void(0);" class="ref cit31a ref40">(31a, 40)</a> This animal model has been validated with IFN-α, non-nucleoside inhibitors of the polymerase such as HCV-796 and pyrano-indole-based inhibitors, protease inhibitors such as BILN-2061, and entry inhibitors like anti-CD81 antibodies.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p">In preparation of the experiment, SCID mice (<i>n</i> = 3) were dosed by intraperitoneal injection for five consecutive days twice daily with 50 mg/kg of compound <b>33</b>. The compound was well tolerated, and no gross changes in body or organ weight were observed. Twelve hours after administration of the last dose, plasma levels of compound were 3.6 μM. The same dose of 50 mg/kg of <b>33</b> was then administered by intraperitoneal injection to three humanized uPA<sup>+/+</sup>-SCID mice infected with HCV of genotype 1b twice daily over the course of 4 days. Treatment caused a consistent decrease in the viremia in the three animals A−C (A, −2.84 log<sub>10</sub>; B, −3.94 log<sub>10</sub>; C, −2.60 log<sub>10</sub>), with a mean decrease of HCV plasma RNA levels of 3.13 ± 0.7 log<sub>10</sub>. The mean plasma trough concentration of <b>33</b> 12 h after administration of the last dose was similar in all three animals, 2.6 ± 0.2 μM. Viral titers rebounded after treatment withdrawal as measured on day 21 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Three mice were also dosed only with the vehicle (30% PEG400 + 70% water) for four days, and no decrease in viremia was observed (range 0−0.3 log<sub>10</sub>).</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0014.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Antiviral response induced by treatment with compound <b>33</b> of humanized uPA<sup>+/+</sup>-SCID mice (A, B, C) infected with HCV of genotype 1b. LOQ: lower limit of detection of HCV RNA (= 315 IU/mL). Vehicle = PEG400/water 30%/70%.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">At a 5-fold lower dose of 10 mg/kg, the mean C<sub>12 h</sub> of <b>33</b> was determined to be 0.67 ± 0.2 μM, and also at this dose an antiviral effect with a mean drop in HCV RNA of 1.4 ± 0.25 log<sub>10</sub> was observed (data not shown).</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52216" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52216" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, a novel second-generation series of tetracyclic allosteric finger-loop inhibitors of the HCV NS5B polymerase was identified. Exploration of the SAR around the amine side-chain on the benzoxazocine tether of compound <b>6</b> led to the identification of compound <b>33</b>, designated as MK-3281,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> which combined excellent cell-based potency with good pharmacokinetic properties in preclinical species. The compound was efficacious in the chimeric mouse model of HCV infection, where at a twice daily dose of 10 mg/kg and 50 mg/kg bid a consistent drop in viremia of 1.4 log<sub>10</sub> and 3.1 log<sub>10</sub>, respectively, was observed. On the basis of this promising profile, the compound was further characterized for efficacy in HCV-infected chimpanzee and advanced into phase I clinical trials.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84047" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84047" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry</h3><div class="NLM_p last">Solvents and reagents were obtained from commercial suppliers and were used without further purification. Organic extracts were dried over sodium sulfate and were concentrated (after filtration of the drying agent) on rotary evaporators operating under reduced pressure. Flash chromatography purifications were performed on Merck silica gel (200−400 mesh) as the stationary phase or on commercial flash chromatography systems (Biotage Corporation and Jones Flashmaster) utilizing prepacked columns. Petroleum ether (PE) refers to the fraction boiling between 40 and 60 °C. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded at 300 K (if not stated otherwise) in the indicated solvent on Bruker AMX spectrometers operating at the reported frequencies. Chemical shifts (δ) for signals corresponding to nonexchangeable protons (and exchangeable protons where visible) are recorded in parts per million (ppm) relative to tetramethylsilane or to the residual solvent peak. Signals are tabulated in the order: multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; b, broad, and combinations thereof); coupling constant(s) in hertz; number of protons. HPLC-MS data were obtained on an Acquity Waters UPLC operating in negative (ES<sup>−</sup>) or positive (ES<sup>+</sup>) ionization mode, and results are reported as the ratio of mass over charge (<i>m</i>/<i>z</i>) for the parent ion only. High resolving power accurate mass measurement electrospray (ES) mass spectral data were acquired by use of a Bruker Daltonics apex-Qe Fourier transform ion cyclotron resonance mass spetrometer (FT-ICR MS). External calibration was accomplished with oligomers of polypropylene. The purity of the final compounds was determined by analytical RP-HPLC with a Waters Alliance separation module 2695, using acetonitrile/water gradients (both modified with 0.1% TFA). Peaks were detected with a Waters 996 PDA detector using the Maxplot option (210−400 nM) contained in the PDA program. Method A: Waters Sunfire C18 column (2.1 mm × 50 mm, 3.5 μm), flow rate 0.5 mL/min; gradient 10% acetonitrile, 0.5 min isocratic, linear to 100% acetonitrile over 6 min, then isocratic. Method B: Waters Sunfire C18 column (4.6 mm × 150 mm, 5 μM), flow 1.0 mL/min; gradient 70% acetonitrile, 1 min isocratic, then linear to 70% acetonitrile over 10 min, then linear to 100% acetonitrile over 5 min and then isocratic. All compounds described in this article showed purities higher than 95% in both analytical methods, except for compound <b>14</b> (method A 99%, method B 91%) and <b>27</b> (method A 96.9%, method B 90.5%). A table with purity data and retention times can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Preparative scale HPLC separations were carried out on a Waters 2525 pump, equipped with a 2487 dual absorbance detector or on a mass-triggered automated Waters MassLynx purification system. Compounds were eluted with linear gradients of water and MeCN with water containing 0.1% TFA. Supercritical fluid chromatography (SFC) was performed on a Berger system equipped with a Berger ALS 719.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Methyl 3-Cyclohexyl-2-{2-[(2<i>S</i>)-oxiran-2-ylmethoxy]phenyl}-1<i>H</i>-indole-6-carboxylate (<b>9a</b>)</h3><div class="NLM_p last">To a solution of <b>8</b> (6.0 g, 17 mmol) in DMF (200 mL) were added cesium fluoride (7.74 g, 51 mmol) and (<i>S</i>)-glycidyl 3-nitrobenzenesulfonate (5.79 g, 22 mmol). The resulting mixture was stirred at RT overnight and then diluted with EtOAc and washed with water and brine. The crude product was purified by trituation with Et<sub>2</sub>O to afford <b>9a</b> as a colorless foam (5.11 g, 74%); [α]<sub>D</sub><sup>20</sup> = +22° (<i>c</i> = 0.5, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.14−1.40 (m, 3H), 1.62−1.80 (m, 5H), 1.81−1.96 (m, 2H), 2.58−2.68 (m, 1H), 2.59 (dd, <i>J</i> = 2.5, 5.0 Hz, 1H), 2.76 (t, <i>J</i> = 5.0 Hz, 1H), 3.19−3.25 (m, 1H), 3.85 (s, 3H), 3.91 (dd, <i>J</i> = 6.2, 11.6 Hz, 1H), 4.33 (dd, <i>J</i> = 2.7, 11.6 Hz, 1H), 7.11 (t, <i>J</i> = 7.4 Hz, 1H), 7.20 (d, <i>J</i> = 8.3 Hz, 1H), 7.32 (dd, <i>J</i> = 1.6, 7.4 Hz, 1H), 7.44 (dt, <i>J</i> = 1.6, 8.3 Hz, 1H), 7.58 (dd, <i>J</i> = 1.3, 8.4 Hz, 1H), 7.79 (d, <i>J</i> = 8.4 Hz, 1H), 7.98 (d, <i>J</i> = 1.2 Hz, 1H), 11.28 (s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 26.3, 27.07, 27.1, 33.0, 33.1, 36.6, 44.6, 50.3, 51.8, 68.4, 113.2, 113.5, 119.5, 120.0, 120.2, 121.7, 122.1, 122.9, 130.4, 129.6, 131.7, 133.8, 135.4, 156.2, 168.3. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 406.5 (M + H)<sup>+</sup>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Methyl (7<i>S</i>)-14-Cyclohexyl-7-hydroxy-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylate (<b>10a</b>)<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></h3><div class="NLM_p last">A solution of <b>9a</b> (4.36 g, 10.7 mmol) in dioxane (220 mL) was treated with Cs<sub>2</sub>CO<sub>3</sub> (7.0 g, 21.5 mmol), and the resulting suspension heated to reflux for 48 h. The reaction was cooled to RT, diluted with EtOAc, and washed with water and brine. The crude product was purified by flash chromatography on silica gel (DCM/MeOH 98:2) to afford <b>10a</b> as a colorless powder (2.38 g, 55%); [α]<sub>D</sub><sup>20</sup> = −28° (<i>c</i> = 0.5, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 2 diastereomers, 2:1*) δ 1.02−1.40 (m, 3H), 1.48−1.59 (m, 1H), 1.60−1.78 (m, 2H), 1.79−1.90 (m, 1H), 1.90−2.06 (m, 3H), 2.60−2.78 (m, 1H), 3.63 (dd, <i>J</i> = 10.6, 14.7 Hz, 1H), 3.68 (dd, <i>J</i> = 8.2, 12.0 Hz, 1H), 3.77* (d, <i>J</i> = 12.7 Hz, 1H), 3.80−3.83 (m, 1H), 3.86*, 3.89 (s, 3H), 3.90−4.06* (m, 3 H), 4.32 (dd, <i>J</i> = 4.4, 12.0 Hz, 1H), 4.40 (dd, <i>J</i> = 1.0, 14.7 Hz, 1H), 4.58* (dd, <i>J</i> = 1.3, 12.7 Hz, 1H), 5.24*, 5.66 (d, <i>J</i> = 3.0*, 4.8 Hz, 1H, OH), 7.15−7.33 (m, 3H), 7.47*, 7.52 (dt, <i>J</i> = 1.7*, 8.4*, 1.9, 8.5 Hz, 1H), 7.61*, 7.68 (d, <i>J</i> = 8.4*, 8.5 Hz, 1H), 7.84*, 7.89 (d, <i>J</i> = 8.4*, 8.5 Hz, 1H), 8.20, 8.22* (s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 26.2, 26.9, 27.0, 33.0, 33.1, 33.3*, 33.4*, 36.6, 46.2, 46.5*, 51.9, 68.1*, 68.4, 72.7*, 78.5, 111.3*, 112.9, 119.4*, 119.9, 120.0*, 120.03, 120.3*, 120.4, 121.0, 122.3, 123.0*, 123.3*, 123.7, 130.1*, 130.4, 130.7*, 131.0, 132.2, 133.2*, 135.8, 136.9*, 137.4*, 138.0, 158.6*, 159.0, 168.2. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 406.6 (M + H)<sup>+</sup>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Methyl 14-Cyclohexyl-7-oxo-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylate (<b>11</b>)</h3><div class="NLM_p last">A solution of <b>10a</b> (3.59 g, 8.85 mmol) in DCM (85 mL) was treated with Dess−Martin periodinane (4.5 g, 10.6 mmol), and the mixture was stirred for 1 h at RT. At this point, another 0.45 g of DMP (1.06 mmol) were added and the reaction left overnight. The reaction mixture was diluted with EtOAc and washed with an aqueous solution of a 1:1 mixture containing sodium thiosulfate and sodium hydrogen carbonate (both saturated solutions) and then with water and brine. Drying over Na<sub>2</sub>SO<sub>4</sub>, filtration, and concentration in vacuo gave crude <b>11</b> (3.4 g, 95%), which was used without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.30−1.48 (m, 3H), 1.71−1.85 (m, 3H), 1.86−2.03 (m, 4H), 2.73−2.89 (m, 1H), 3.95 (s, 3H), 4.46 (d, <i>J</i> = 16.7 Hz, 1H), 4.62 (d, <i>J</i> = 17.2 Hz, 1H), 4.74 (d, <i>J</i> = 17.2 Hz, 1H), 4.84 (d, <i>J</i> = 16.7 Hz, 1H), 7.30 (d, <i>J</i> = 8.1 Hz, 1H), 7.34 (dt, <i>J</i> = 0.9, 7.6 Hz, 1H), 7.43 (dd, <i>J</i> = 0.8, 7.6 Hz, 1H), 7.53 (dt, <i>J</i> = 1.8, 8.1 Hz, 1H), 7.82 (dd, <i>J</i> = 1.2, 8.6 Hz, 1H), 7.87 (d, <i>J</i> = 8.6 Hz, 1H), 8.07 (s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 26.2, 26.9, 27.0, 33.3, 33.5, 36.6, 52.0, 53.7, 77.8, 111.4, 120.5, 120.7, 121.1, 121.4, 121.6, 123.8, 125.0, 130.5, 131.3, 131.5, 136.3, 137.0, 157.4, 167.9, 202.6. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 404.5 (M + H)<sup>+</sup>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure for the Reductive Amination of Ketone <b>11</b> and Ester Hydrolysis: 14-Cyclohexyl-7-(methylamino)-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylic Acid (<b>12</b>)</h3><div class="NLM_p last">To a suspension of <b>11</b> (40 mg, 0.1 mmol) in 1,2-dichloroethane (2 mL) was added acetic acid (0.008 mL, 0.15 mmol) and methylamine (0.14 mL, 1 M in THF). After stirring for 15 min at RT, sodium triacetoxyborohydride (32 mg, 0.15 mmol) was added in one portion. The resulting mixture was stirred at RT for 2 h. Sodium hydroxide was added (2 mL, 1N) and after stirring for 5 min the mixture was taken into EtOAc. The phases were separated, and the organic phase was washed with water and brine. The crude methyl ester was used without further purification. The ester was dissolved in a mixture of THF and methanol (2 mL, 1:1 v/v) and treated with 1 N KOH (1 mL). The resulting solution was heated to 60 °C for 4 h. After cooling to RT, the reaction mixture was brought to pH 2 by the dropwise addition of hydrochloric acid (1 N) and then diluted with MeCN and purified by RP-HPLC to afford <b>12</b> as its TFA salt (31 mg, 58%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.07−1.28 (m, 1H), 1.30−1.46 (m, 2H), 1.56 (bd, <i>J</i> = 11.9 Hz, 1H), 1.65−1.79 (m, 2H), 1.80−2.09, m, 4H), 2.61−2.80 (m, 1H), 2.77 (s, 3H), 3.57−3.71 (m, 1H), 3.91 (bt, <i>J</i> = 12.8 Hz, 1H), 4.08−4.27 (m, 2H), 4.85 (d, <i>J</i> = 14.4 Hz, 1H), 7.22−7.35 (m, 3H), 7.53 (dt, <i>J</i> = 2.1, 7.9 Hz, 1H), 7.72 (d, <i>J</i> = 8.6 Hz, 1H), 7.91 (d, <i>J</i> = 8.6 Hz, 1H), 8.30 (s, 1H), 8.94 (bs, 1H), 12.68 (bs, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, 320 K) δ 25.6, 26.6, 30.8, 32.6, 36.4, 41.3, 55.4, 67.8, 11.9, 119.1, 119.3, 120.1, 120.3, 121.3, 123.1, 124.2, 129.7, 131.1, 132.7, 135.4, 136.7, 157.9, 168.2. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 405.3 (M + H)<sup>+</sup>. HRMS (M + H)<sup>+</sup> calcd for C<sub>25</sub>H<sub>29</sub>N<sub>2</sub>O<sub>3</sub> 405.2178; found 405.218.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 14-Cyclohexyl-7-{[2-(dimethylamino)ethyl]amino}-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylic Acid (<b>15</b>)</h3><div class="NLM_p last">Compound <b>15</b> was prepared following the procedure for the synthesis of <b>12</b> from <b>11</b> (100 mg, 0.25 mmol) and <i>N</i>,<i>N</i>-dimethylethane-1,2-diamine (0.033 mL, 0.30 mmol). HPLC analysis of the crude methyl ester (120 mg, quantitative) indicated a ratio of ester to racemic alcohol <b>10</b> of about 9:1; MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 476 (M + H)<sup>+</sup>. Hydrolysis and purification by RP-HPLC afforded <b>15</b> as its bis-TFA salt (109 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 2 atropisomers 7:1*) δ 1.09−1.22 (m, 1H), 1.25−1.46 (m, 2H), 1.50−1.58 (m, 1H), 1.65−1.78 (m, 2H), 1.82−1.88 (m, 1H), 1.89−2.07 (m, 3H), 2.64−2.75 (m, 1H), 2.79*, 2.82 (s, 6H), 2.98−3.10 (m, 1H), 3.10−3.90 (m, 5H, together with water peak and probably the three exchangeable protons), 3.96−4.02 (m, 1H), 4.18, 4.32* (dd, <i>J</i> = 3.0, 12.6 Hz, 1H), 4.74, 4.84* (d, <i>J</i> = 11.9 Hz, 1H), 7.22−7.28 (m, 2H), 7.30 (dd, <i>J</i> = 1.9, 7.9 Hz, 1H), 7.52 (dt, <i>J</i> = 1.9, 8.5 Hz, 1H), 7.64*, 7.70 (dd, <i>J</i> = 1.0, 8.4 Hz, 1H), 7.86*, 7.99 (d, <i>J</i> = 8.5*, 8.4 Hz, 1H), 8.22, 8.35* (s, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>, 320 K, only data for the major atropisomer shown) δ 25.6, 26.7, 32.7, 36.4, 40.4, 42.9, 43.3, 54.4, 55.5, 70.3, 111.6, 118.9, 119.8, 120.06, 120.08, 121.3, 122.9, 124.0, 129.6, 131.1, 132.6, 135.4, 136.9, 158.3, 168.2. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 462.3 (M + H)<sup>+</sup>. HRMS (M + H)<sup>+</sup> calcd for C<sub>28</sub>H<sub>36</sub>N<sub>3</sub>O<sub>3</sub> 462.2757; found 462.2766.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl)amino}-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylic Acid (<b>21</b>)</h3><div class="NLM_p last">To a solution of crude methyl ester of compound <b>15</b> (100 mg, 0.21 mmol) in DCM (2 mL) were added aq formaldehyde (37%, 0.050 mL, 0.63 mmol) and acetic acid (0.018 mL, 0.32 mmol), followed after 5 min by solid sodium cyanoborohydride (20 mg, 0.32 mmol). After stirring at RT for 2 h, sodium hydroxide (4 mL, 1 N) was added and the resulting suspension stirred for another 5 min before being taken into EtOAc and washed with water and brine. Drying over sodium sulfate and concentration in vacuo gave the crude ester, which was used without any further purification. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 490 (M + H)<sup>+</sup>. The ester was dissolved in a mixture of dioxane/water (2 mL, 2:1, v/v), and aq potassium hydroxide (1 mL, 1N) was added. The mixture was stirred at 70 °C for 6 h and then brought to pH 2 by the dropwise addition of hydrochloric acid (1 N) and then diluted with MeCN. After purification by RP-HPLC, <b>21</b> was obtained as its bis-TFA salt (66 mg, 45%). For proton and carbon spectra, see compound <b>33</b>. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 476.5 (M + H)<sup>+</sup>. HRMS (M + H)<sup>+</sup> calcd for C<sub>29</sub>H<sub>38</sub>N<sub>3</sub>O<sub>3</sub> 476.2913; found 476.2924.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 14-Cyclohexyl-7-[(<i>N</i>,<i>N</i>-dimethylglycyl)(methyl)amino]-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylic Acid (<b>29</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (23 mg, 0.044 mmol) in DCM (0.5 mL) was added <i>N</i>,<i>N</i>-diisopropylethylamine (0.015 mL, 0.088 mmol), followed by a solution of <i>N</i>,<i>N</i>-dimethylglycine (18 mg, 0.18 mmol), HATU (67 mg, 0.18 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (38 μL, 0.22 mmol) in dichloromethane (1 mL). The reaction mixture was concentrated in vacuo after 2 h and dissolved in acetonitrile (1 mL). Potassium hydroxide (1 N, 0.31 mL, 0.310 mmol) was added, and the mixture was stirred at 45 °C for three days to destroy the mixed anhydride. The reaction mixture was concentrated in vacuo, dissolved in DMSO, and purified by RP-HPLC to afford <b>29</b> as its TFA salt (16 mg, 58%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, two atropisomers 1:1) δ 1.09−1.44 (m, 3H), 1.47−1.59 (m, 1H), 1.63−2.03 (m, 6H), 2.26 (s, 1.5 H), 2.62−2.94 (m, 7H), 2.97 (s, 1.5 H), 3.81 (d, <i>J</i> = 17.0, 0.5H), 3.90 (d, <i>J</i> = 15.4, 0.5H), 4.13 (d, <i>J</i> = 17.0, 0.5H), 4.15−4.39 (m, 3.5H), 4.46 (dd, <i>J</i> = 14.0, 4.3, 0.5H), 4.56 (d, <i>J</i> = 14.6, 0.5H), 4.62−4.72 (m, 1H), 7.31−7.39 (m, 3H), 7.54−7.63 (m, 1H), 7.65−7.70 (m, 1H), 7.76 (bs, 0.5H), 7.87−7.92 (m, 1H), 8.10 (bs, 0.5H), 9.50−9.79 (bm, 1H), 12.51−12.82 (bs, 1H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) 27.3, 28.2, 31.3, 34.5, 34.7, 38.3, 44.2, 45.2, 54.3, 59.6, 78.1, 111.9, 121.1, 121.6, 123.8, 125.9, 127.1, 131.6, 132.7, 132.8, 138.3, 138.4, 161.2, 166.6, 171.2. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 490.4 (M + H)<sup>+</sup>. HRMS (M + H)<sup>+</sup> calcd for C<sub>29</sub>H<sub>35</sub>N<sub>3</sub>O<sub>4</sub> 490.2706; found 490.2717.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Methyl (7<i>S</i>)-14-Cyclohexyl-7-{[(4-methylphenyl)sulfonyl]oxy}-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylate (<b>30a</b>)</h3><div class="NLM_p last">To a solution of <b>10a</b> (325 mg, 0.802 mmol) in pyridine (10 mL), tosyl chloride (229 mg, 1.203 mmol) was added and the reaction was stirred at room temperature overnight. The reaction mixture was diluted with EtOAc and washed with hydrochloric acid (1 N), sodium hydrogen carbonate (saturated solution), and brine. The crude product was purified by flash chromatography on silica gel (PE/EtOAc 9:1) to afford <b>30a</b> as a pale-yellow oil (423 mg, 94%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 2 atropisomers 7:3) δ 1.29−1.44 (m, 3H), 1.58−1.68 (m, 1H) 1.69−1.81 (m, 2H), 1.82−2.09 (m, 4H), 2.43*(s, 3H*), 2.46 (s, 3H), 2.68−2.80 (m, 1H), 3.92 (dd, <i>J</i> = 6.6, 12.8, 1H), 3.97* (s, 3H*), 4.01 (s, 3H), 4.03−4.17 (m, 2H), 4.26* (dd, <i>J</i> = 6.5, 12.8, 1H*), 4.51−4.66 (m, 2H), 4.73* (dd, <i>J</i> = 2.4, 16.0, 1H*), 4.98−5.55* (bs, 1H*), 7.05−7.28 (m, 3H, partially overlapped with CHCl<sub>3</sub> peak), 7.31* (d, <i>J</i> = 8.1, 2H*), 7.39 (d, <i>J</i> = 8.1, 2H), 7.37−7.47 (m, 1H), 7.75* (d, <i>J</i> = 8.3, 1H*), 7.79−7.87 (m, 2H + 1H*), 7.90 (d, <i>J</i> = 8.3, 2H), 8.18 (s, 1H), 8.21* (s, 1H*). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 560 (M + H)<sup>+</sup>.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Methyl (7<i>R</i>)-7-Azido-14-cyclohexyl-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylate (<b>31a</b>)</h3><div class="NLM_p last">To a solution of <b>30a</b> (423 mg, 0.757 mmol) in anhyd THF (12 mL), azidotrimethylsilane (0.26 mL, 2.06 mmol) and tetrabutylammonium triphenyldifluorosilicate (1.140 g, 2.112 mmol) were added at RT. The reaction was stirred for 20 h at 65 °C, and then more azidotrimethylsilane (0.26 mL, 2.06 mmol) and tetrabutylammonium triphenyldifluorosilicate (1.140 g, 2.112 mmol) were added. The mixture was stirred at 65 °C for another 36 h. The volatiles were evaporated in vacuo, and the residue was dissolved in EtOAc and washed with hydrochloric acid (1 N), sodium hydrogen carbonate (saturated solution) and brine. The crude product was purified by flash chromatography on silica gel (PE/EtOAc 95:5) to afford azide <b>31a</b> as white foam (210 mg, 62%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, atropisomers 6:4*) δ 1.14−1.31 (m, 1H), 1.32−1.45 (m, 2H), 1.62−1.72(m, 1H), 1.73−1.83 (m, 2H), 1.84−2.13 (m, 4H), 2.69−2.84 (m, 1H), 3.58−3.66* (m, 1H*), 3.67−3.76 (m, 1H), 3.93−4.03 (m, 2H), 3.99 (s, 3H), 4.06* (d, <i>J</i> = 11.8, 1H*), 4.19−4.27 (m, 1H), 4.58 (dd, <i>J</i> = 3.9, 15.1, 1H), 4.63* (dd, <i>J</i> = 3.5, 12.9, 1H*), 4.71* (dd, <i>J</i> = 4.6, 15.6, 1H*), 7.13−7.32 (m, 3H), 7.40−7.50 (m, 1H), 7.75−7.84 (m,1H), 7.89 (d, <i>J</i> = 8.6,1H), 8.13 (s, 1H), 8.29* (s, 1H*). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 431 (M + H)<sup>+</sup>. SFC chromatography indicated an ee of 99.3% (Chiracel OJ-H 250 μm × 1.0, 5 μm; <i>T</i><sub>col</sub> 35 °C, <i>P</i><sub>col</sub> 100 bar, flow 9.99 mL/min, modifier MeOH, 0.2% diethylamine (A); gradient 0−1 min 20% A, 1−6.7 min to 60% A, then another 2 min isocratic.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Methyl (7<i>R</i>)-7-Amino-14-cyclohexyl-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylate (<b>32a</b>)</h3><div class="NLM_p last">A solution of <b>31a</b> (210 mg, 0.520 mmol) in methanol (10 mL) containing Pd/C (10%, w/w, 30 mg) was stirred under hydrogen at atmospheric pressure for 4 h. The catalyst was filtered off, and the solution was concentrated to dryness under reduced pressure to afford <b>32a</b> (192 mg, 92%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 2 atropisomers 6:4*) δ 1.14−1.30 (m,1H), 1.31−1.52 (m, 2H), 1.58−1.70 (m, 1H), 1.71−1.86 (m, 2H), 1.87−2.26 (m, 4H), 2.68−2.89 (m, 1H), 3.44* (s, 3H*), 3.68−3.84 (bs, 4H), 3.85−4.02* (bs, 1H*), 4.03−4.25 (m, 3H + 1H*), 4.31* (dd, <i>J</i> = 2.9, 13.6, 1H*), 4.89 (t, <i>J</i> = 12.9, 1H + 1H*), 5.02* (dd, <i>J</i> = 3.8, 16.3, 1H*), 7.00−7.12 (m, 1H + 2H*), 7.19 (dd, <i>J</i> = 1.4, 7.6, 1H), 7.22−7.31 (m, 2H, partialy overlapped with CHCl<sub>3</sub> peak), 7.34* (t, <i>J</i> = 7.5, 1H*), 7.43* (d, <i>J</i> = 8.6, 1H*), 7.47−7.55* (m, 1H*), 7.70−7.78 (m, 1H), 7.85 (d, <i>J</i> = 8.6, 1H), 8.08 (s, 1H), 8.27* (s, 1H*). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 405 (M + H)<sup>+</sup>; [α]<sub>D</sub><sup>20</sup> = +46.4 (<i>c</i> = 1.0, CHCl<sub>3</sub>).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (7<i>R</i>)-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl)amino}-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylic Acid (<b>33</b>)</h3><div class="NLM_p last">To a solution of <b>32a</b> (868 mg, 2.146 mmol) in anhyd trimethyl orthoformate (6 mL) was added <i>tert</i>-butyl <i>N</i>-(2-oxoethyl)carbamate (359 mg, 2.25 mmol), and the mixture was stirred at room temperature overnight. The solution was concentrated to dryness under reduced pressure and the crude dissolved in dry methanol (9 mL). The resulting solution was treated with acetic acid (0.37 mL, 6.44 mmol) and sodium cyanoborohydride (202 mg, 3.22 mmol). The mixture was stirred at room temperature for 1 h. Sodium hydroxide (2 mL, 1 N) was added, and after stirring for 5 min the mixture was taken into EtOAc and washed with water and brine. The crude product was purified by flash chromatography on silica gel (1:4 EtOAc + 0.1% triethylamine/petroleum ether + 0.1%triethylamine; then 6/4) to afford methyl (7<i>R</i>)-7-({2-[(<i>tert</i>-butoxycarbonyl)amino]ethyl}amino)-14-cyclohexyl-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylate as colorless foam (524 mg, 46%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.05−1.50 (m, 12H), 1.51−1.62 (m, 1H), 1.64−1.78 (m, 2H), 1.79−1.88 (m, 1H), 1.89−2.07 (m, 3H), 2.73−2.77 (m, 1H), 3.08−3.40 (m, 5H), 3.65−3.84 (m, 1H), 3.89 (s, 3H), 3.84−4.03 (m, 1H), 4.11−4.29 (m, 2H), 4.91 (dd, <i>J</i> = 3.0, 14.8, 1H), 7.02−7.12 (bt, 1H), 7.15−7.36 (m, 3H), 7.48−7.58 (m, 1H), 7.72 (dd, <i>J</i> = 1.1, 8.3, 1H), 7.93 (d, <i>J</i> = 8.6, 1H), 8.33 (s, 1H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 548 (M + H)<sup>+</sup>. This compound (524 mg, 0.956 mmol) was dissolved in a mixture of dichloromethane/trifluoroacetic acid (3:1, v/v, 8 mL), and the mixture was stirred at room temperature. The solution was concentrated to dryness under reduced pressure. The residue was dissolved in dichloromethane and sodium acetate (470 mg, 5.736 mmol), and 40% aq solution of formaldehyde (0.46 mL, 5.74 mmol) and sodium cyanoborohydride (356 mg, 5.74 mmol) were added. After stirring at RT for 1 H, sodium hydroxide (2 mL, 1 N) was added, and after stirring for 5 min, the mixture was taken into EtOAc and washed with brine. Drying over sodium sulfate and concentration in vacuo gave methyl (7<i>R</i>)-14-cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl)amino}-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylate, which was used without any further purification. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 490 (M + H)<sup>+</sup>. To a solution of the crude product (280 mg, 0.572 mmol) in dioxane (12 mL) 1N KOH (3 mL, 1N in water) was added and the mixture was stirred at 80 °C for 2 h. Evaporation of the volatiles gave a residue, which was purified by RP-HPLC (column Waters Symmetry prep. C18, 7 μm, 19 mm × 300 mm). Fractions containing the pure compound were combined and freeze-dried to afford the bis-TFA salt of <b>33</b> as a white powder (123 mg, 45% over two steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 2 atropisomers 94:6*) δ 1.09−1.25 (m, 1H), 1.26−1.43 (m, 2H), 1.54 (d, <i>J</i> = 12.2, 1H), 1.62−1.78 (m, 2H), 1.79−2.06 (m, 4H), 2.39 (s, 3H), 2.61*(s, 6H*), 2.65−2.77 (m, 1H), 2.85 (s, 6H), 2.94 (dt, <i>J</i> = 5.5, 13.6, 1H), 3.04−3.15 (m, 2H), 3.18 (dt, <i>J</i> = 5.6, 13.0, 1H), 3.23−3.34 (m, 1H), 3.74−3.80* (m, 1H* partially overlapped with the signal at 3.85 ppm), 3.85 (dd, <i>J</i> = 10.2, 14.4, 1 H), 4.07 (dd, <i>J</i> = 9.0, 12.1, 1H), 4.11−4.17* (m, 1H* partially overlapped with the signal at 4.07 ppm), 4.31 (dd, <i>J</i> = 4.3, 12.1, 1H), 4.64 (d, <i>J</i> = 14.4, 1H), 4.75* (d, <i>J</i> = 13.1, 1H*), 4.79−4.87* (m, 1H*), 7.24−7.37 (m, 3H), 7.50−7.59 (m, 1H), 7.63−7.66* (m, 1H* partially overlapped with the signal at 7.69), 7.69 (dd, <i>J</i> = 0.8, 8.3, 1H), 7.82−7.85* (m, 1H* partially overlapped with dd at 7.87 ppm), 7.87 (d, <i>J</i> = 8.3, 1H), 8.15, 8.32* (s, 1H). <sup>13</sup>C NMR (100 MHz; DMSO-<i>d</i><sub>6</sub>, 320 K, only data for the major atropisomer reported) δ 25.7, 26.4, 30.3, 32.4, 36.1, 37.5, 42.0, 47.6, 50.2, 61.1, 73.2, 111.7, 119.1, 119.3, 119.9, 120.1, 121.4, 123.2, 123.9, 129.4, 131.1, 132.4, 135.2, 136.4, 157.5, 168.4. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 476 (M + H)<sup>+</sup>. HRMS (M + H)<sup>+</sup> calcd for C<sub>29</sub>H<sub>38</sub>N<sub>3</sub>O<sub>3</sub> 476.2913; found 476.2922. Chromatography on Chiralpak AD column gave an ee of 96% (250 mm × 4.6 mm, 5 μm; flow 1.0 mL/min, isocratic 70:30; eluent A 0.2% TFA/<i>n</i>-hexane; eluent B 0.2% TFA in EtOH (containing 3% MeOH); 300 nm; <i>R</i><sub>t</sub> 5.37 min. [α]<sub>D</sub><sup>20</sup> = +36.8 (<i>c</i> = 0.5, CHCl<sub>3</sub>).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (7<i>S</i>)-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl)amino}-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylic Acid (<b>34</b>)</h3><div class="NLM_p last">The compound was obtained as described for its enantiomer <b>33</b> starting from alcohol <b>10b</b>. HRMS (M + H)<sup>+</sup> calcd for C<sub>29</sub>H<sub>38</sub>N<sub>3</sub>O<sub>3</sub> 476.2913; found 476.2918. Chromatography on Chiralpak AD column (conditions see compound <b>33</b>) gave an ee of 99%; RT 14.55 min. [α]<sub>D</sub><sup>20</sup> = −40 (<i>c</i> = 0.1, CHCl<sub>3</sub>).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (7<i>S</i>)-14-Cyclohexyl-7-[2-(dimethylamino)ethoxy]-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylic Acid (<b>35</b>)</h3><div class="NLM_p last">To a suspension of <b>10a</b> (49 mg, 0.12 mmol) in toluene (2.4 mL) was added 30% w/w aq NaOH (0.16 mL, 1.20 mmol), followed by tetrabutylammonium bromide (10 mg, 0.03 mmol). After stirring for 30 min, 2-chloro-<i>N</i>,<i>N</i>-dimethylethanaminium chloride (35 mg, 0.24 mmol) was added and the reaction mixture was stirred at 60 °C for 16 h. More 2-chloro-<i>N</i>,<i>N</i>-dimethylethanaminium chloride (17 mg, 0.12 mmol) was added, and the reaction mixture was stirred at 80 °C for a further 4 h. The reaction mixture was concentration in vacuo, dissolved in DMSO, and purified by RP-HPLC to afford the TFA salt of <b>35</b> as a white powder (33 mg, 47%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, two atropisomers 1:1) δ 1.08−1.23 (m, 1H), 1.24−1.44 (m, 2H), 1.49−1.61 (m, 1H), 1.64−1.77 (m, 2H), 1.80−1.88 (m, 1H), 1.89−2.07 (m, 3H), 2.56 (s, 1.5 H), 2.63−2.73 (m, 1H), 2.78 (s, 1.5H), 3.07 (m, 1H), 3.27 (m, 1H), 3.68 (dd, <i>J</i> = 10.7, 14.5, 0.5H), 3.75−3.97 (m, 3H), 3.98−4.14 (m, 1.5H), 4.24 (dd, <i>J</i> = 4.2, 13.2, 0.5H), 4.77 (dd, <i>J</i> = 2.7, 14.6, 0.5H), 4.93 (dd, <i>J</i> = 3.1, 15.6, 0.5H), 7.16−7.34 (m, 3H), 7.49 (d, <i>J</i> = 6.8, 0.5H), 7.50 (d, <i>J</i> = 6.8, 0.5H), 7.62 (d, <i>J</i> = 8.1, 0.5H), 7.69 (d, <i>J</i> = 8.3, 0.5H), 7.82 (d, <i>J</i> = 8.6, 0.5H), 7.89 (d, <i>J</i> = 8.3, 0.5H), 8.20 (s, 0.5H), 8.21 (s, 0.5H). <sup>13</sup>C NMR (150 MHz, CD<sub>3</sub>OD, 300 K, only signals for major atropisomer reported) δ 26.9, 27.8, 34.1, 38.0, 43.3, 44.6, 57.8, 63.9, 72.8, 78.0, 113.9, 120.0, 120.4, 120.8, 122.5, 123.9, 124.0, 124.5, 130.9, 131.9, 133.4, 138.3, 159.6, 171.4. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 463 (M + H)<sup>+</sup>. HRMS (M + H)<sup>+</sup> calcd for C<sub>28</sub>H<sub>35</sub>N<sub>2</sub>O<sub>4</sub> 463.2597; found 463.2591; [α]<sub>D</sub><sup>20</sup> = −41.2 (<i>c</i> = 0.31, CH<sub>3</sub>OH).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Methyl 14′-Cyclohexyl-2,2-dimethylspiro[1,3-dioxane-5,7′-indolo[1,2-<i>e</i>][1,5]benzoxazocine]-11-carboxylate (<b>37</b>)</h3><div class="NLM_p last">NaH (151 mg, 6.30 mmol, 60% dispersion in mineral oil) was added to a degassed solution of <b>8</b> (440 mg, 1.26 mmol) in DMF (10 mL). The suspension was allowed to stir at RT for 20 min, and the resulting solution was placed in an oil bath preheated at 70 °C. A degassed solution of 5,5-bis(bromomethyl)-2,2-dimethyl-1,3-dioxane (0.57 g, 1.89 mmol), prepared as described in ref <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">34</a> in dry DMF (6 mL), was added and the mixture was stirred for at 70 °C for 1 h. Additional electrophile (0.57 g, 1.89 mmol) was added in the same way, and stirring was continued at 70 °C for another 3 h. After cooling to RT, the reaction was quenched with an aq satd NH<sub>4</sub>Cl, acidified with 1N HCl and extracted with Et<sub>2</sub>O. The crude material was purified by chromatography (PE/EtOAc 5:1) to afford the <b>37</b> (50%) as the first fraction (second fraction: recovered <b>8</b>, 44%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.21−1.38 (m, 3H), 1.45 (s, 3H), 1.66 (s, 3H), 1.68−2.11 (m, 7H), 2.72−2.80 (m, 1H), 3.49 (d, <i>J</i> = 12.3 Hz, 1H), 3.59 (d, <i>J</i> = 11.8 Hz, 1H), 3.69 (d, <i>J</i> = 12.3 Hz, 1H), 3.72 (d, <i>J</i> = 15.3 Hz, 1H), 3.77 (d, <i>J</i> = 12.5 Hz, 1H), 3.83 (d, <i>J</i> = 11.8 Hz, 1H), 3.93 (s, 3H), 4.15 (d, <i>J</i> = 12.5 Hz, 1H), 4.79 (d, <i>J</i> = 15.3 Hz, 1H), 7.13−7.17 (m, 2H), 7.23 (dd, <i>J</i> = 7.8, 1.7 Hz, 1H), 7.41 (bt, <i>J</i> = 7.8 Hz, 1H), 7.74 (dd, <i>J</i> = 8.5, 1.3 Hz, 1H), 7.84 (d, <i>J</i> = 8.5 Hz, 1H), 8.44 (s, 1H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 490 (M + H)<sup>+</sup>.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 14′-Cyclohexyl-1-[2-(dimethylamino)ethyl]spiro[azetidine-3,7′-indolo[1,2-<i>e</i>][1,5]benzoxazocine]-11′-carboxylic Acid (<b>39</b>)</h3><div class="NLM_p last">To a suspension of <b>37</b> (135 mg, 0.28 mmol) in a mixture of MeOH and THF (1:2, v/v, 12 mL) was added TsOH·H<sub>2</sub>O (6 mg, 0.03 mmol), and the solution was stirred at RT for 3 h. Filtration over a pad of neutral alumina using EtOAc as eluent afforded, after evaporation of the solvent, methyl 14-cyclohexyl-7,7-bis(hydroxymethyl)-7,8-dihydro-6<i>H</i>-indolo[1,2-<i>e</i>][1,5]benzoxazocine-11-carboxylate (110 mg, 89%). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 450.4 (M + H)<sup>+</sup>. Triflic anhydride (220 mg, 0.78 mmol) was added at 0 °C to a solution of the diol (100 mg, 0.22 mmol) in anhyd MeCN (4 mL). DIPEA (0.16 mL, 0.89 mmol) was then added, and the mixture was stirred at 0 °C for 15 min. Another 0.16 mL of DIPEA were added, followed by <i>N</i>,<i>N</i>-dimethylethane-1,2-diamine (0.049 mL, 0.445 mmol). The mixture was stirred at 70 °C for 2 h. After removal of the solvent, EtOAc was added, and the organic phase was washed with water and brine. After drying and evaporation, the residue was dissolved in dioxane (2 mL) and 1N KOH (1 mL) was added. After heating to 75 °C for 2 h, the reaction was cooled to 0 °C, acidified with 1N HCl, and purified by RP-HPLC to afford the bis-TFA salt of <b>39</b> as a colorless powder (50 mg, 25%). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 1.18−1.27 (m, 1H), 1.43 (bt, <i>J</i> = 9.9 Hz, 2H), 1.67 (bd, <i>J</i> = 12.6 Hz, 1H), 1.74−1.85 (m, 2H), 1.86−2.22 (m, 4H), 2.67−2.81 (m, 1H), 2.81 (s, 6H), 3.27 (t, <i>J =</i> 6.0 Hz, 2H), 3.46 (t, <i>J =</i> 6.0 Hz, 2H), 3.57 (d, <i>J</i> = 9.8 Hz, 1H), 3.88 (d, <i>J</i> = 9.5 Hz, 1H), 3.99 (d, <i>J</i> = 9.8 Hz, 1H), 4.03 (d, <i>J</i> = 9.5 Hz, 1H), 4.08 (d, <i>J</i> = 15.4 Hz, 1H), 4.23 (d, <i>J</i> = 12.7 Hz, 1H), 4.42 (d, <i>J</i> = 12.7 Hz, 1H), 5.10 (d, <i>J</i> = 15.4 Hz, 1H), 7.28−7.33 (m, 3H), 7.52 (dt, <i>J</i> = 1.8, 7.6 Hz, 1H), 7.81 (d, <i>J</i> = 8.5 Hz, 1H), 7.92 (d, <i>J</i> = 8.5 Hz, 1H), 8.53 (s, 1H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD) δ 27.6, 28.45, 28.50, 34.2, 34.6, 38.6, 41.5, 46.0, 48.6, 53.6, 60.5, 62.2, 77.0, 113.5, 121.4, 121.6, 121.9, 122.0, 122.9, 124.4, 125.1, 132.1, 138.4, 139.1, 132.6, 134.5, 160.1, 171.6. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 488.5 (M + H)<sup>+</sup>. HRMS (M + H)<sup>+</sup> calcd for C<sub>30</sub>H<sub>38</sub>N<sub>3</sub>O<sub>3</sub> 488.2913; found 488.2916.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34"><a href="/doi/suppl/10.1021/jm1013105">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures and spectroscopic data for compounds <b>6</b>, <b>8</b>, <b>10b</b>, <b>13</b>, <b>14</b>, <b>16</b>−<b>20</b>, <b>22</b>−<b>28</b>, <b>36</b>, and <b>38</b>; table with purity data and retention times for all tested compounds; enzyme and cell-based assay protocols; soaking experiments and X-ray data collection. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm1013105/suppl_file/jm1013105_si_001.pdf">jm1013105_si_001.pdf (120.14 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm1013105" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12507" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12507" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Narjes</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1e586c7f707530507f6c747b6d5e7f6d6a6c7f647b707b7d7f307d7173"><span class="__cf_email__" data-cfemail="3f794d5e515411715e4d555a4c7f5e4c4b4d5e455a515a5c5e115c5052">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benedetta Crescenzi</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Ferrara</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jörg Habermann</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefania Colarusso</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria del Rosario Rico Ferreira</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian Stansfield</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Center for Vaccinology, Ghent University and Hospital, De Pintelaan 185, B-9000, Gent, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Claire Mackay</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Immacolata Conte</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caterina Ercolani</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simone Zaramella</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria-Cecilia Palumbi</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip Meuleman</span> - <span class="hlFld-Affiliation affiliation">Center for Vaccinology, Ghent University and Hospital, De Pintelaan 185, B-9000, Gent, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Geert Leroux-Roels</span> - <span class="hlFld-Affiliation affiliation">Center for Vaccinology, Ghent University and Hospital, De Pintelaan 185, B-9000, Gent, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudio Giuliano</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrizio Fiore</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefania Di Marco</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paola Baiocco</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Uwe Koch</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giovanni Migliaccio</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sergio Altamura</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ralph Laufer</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raffaele De Francesco</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Rowley</span> - <span class="hlFld-Affiliation affiliation">Istituto Di Ricerche Di Biologia Molecolare, P. Angeletti SpA (Merck Research Laboratories, Rome), Via Pontina Km 30,600, I-00040 Pomezia, Italy</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23083" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23083" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Silvia Pesci and Renzo Bazzo for NMR experiments and Francesca Naimo, Anna Alfieri, and Fabio Bonelli for analytical chemistry support. We are indebted to Nadia Gennari, Monica Bisbocci, Sergio Serafini, and Mauro Cerretani for the inhibition data on the NS5B enzyme and the replicon, to Giacomo Paonessa and Linda Bartholomew for the chimeric replicon data, and to Annalisa Di Marco for CYP inhibition data. We are grateful to Lieven Verhoye and Petra Premereur for excellent technical assistance with the chimeric mouse experiment. The work was funded in part by a concerted action grant from UGent (no. 01G00507) and by the Belgian state via the Interuniversity Attraction Poles Program (P6/36-HEPRO). P.M. is a postdoctoral fellow supported by The Research Foundation—Flanders (FWO-Vlaanderen). This work was supported in part by a grant from the MIUR.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32145" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32145" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 44 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>Hepatitis C; <span class="NLM_series">Fact Sheet No. 164</span>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_month">October</span><span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>available from <a href="http://www.who.int/mediacentre/factsheets/fs164/en/index.html" class="extLink">http://www.who.int/mediacentre/factsheets/fs164/en/index.html</a>].</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hepatitis+C%3B+Fact+Sheet+No.+164%3B+World+Health+Organization%3A+Geneva%2C+October+2000%3B+available+from+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs164%2Fen%2Findex.html%5D."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatitis%2520C%26pub%3DWorld%2520Health%2520Organization%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cohen, J.</span><span> </span><span class="NLM_article-title">The scientific challenge of Hepatitis C</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=26-30&author=J.+Cohen&title=The+scientific+challenge+of+Hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DJ.%26atitle%3DThe%2520scientific%2520challenge%2520of%2520Hepatitis%2520C%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D26%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lauer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, B. D.</span><span> </span><span class="NLM_article-title">Hepatitis C virus infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">345</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1056%2FNEJM200107053450107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=11439948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A280%3ADC%252BD3MzosFGrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2001&pages=41-52&author=G.+M.+Lauerauthor=B.+D.+Walker&title=Hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C virus infection</span></div><div class="casAuthors">Lauer G M; Walker B D</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-52</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRy0bRRzrSTmLesJRIHUP1ofW6udTcc2eZVadGRRWP5Drntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MzosFGrug%253D%253D&md5=668267468c81fe82d22e1679fbe4af41</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1056%2FNEJM200107053450107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200107053450107%26sid%3Dliteratum%253Aachs%26aulast%3DLauer%26aufirst%3DG.%2BM.%26aulast%3DWalker%26aufirst%3DB.%2BD.%26atitle%3DHepatitis%2520C%2520virus%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D345%26spage%3D41%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Brown, R. S.</span><span> </span><span class="NLM_article-title">Hepatitis C and liver transplantation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=973-978&author=R.+S.+Brown&title=Hepatitis+C+and+liver+transplantation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BS.%26atitle%3DHepatitis%2520C%2520and%2520liver%2520transplantation%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D973%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Salmon-Ceron, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewden, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morlat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bévilacqua, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jougla, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Héripret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costagliola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chêne, G.</span><span> </span><span class="NLM_article-title">Liver disease as a major cause of death among HIV infected patients: role of hepatitis B and C virus and alcohol</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1016%2Fj.jhep.2005.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=15973779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktVGmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2005&pages=799-805&author=D.+Salmon-Ceronauthor=C.+Lewdenauthor=P.+Morlatauthor=S.+B%C3%A9vilacquaauthor=E.+Jouglaauthor=F.+Bonnetauthor=L.+H%C3%A9ripretauthor=D.+Costagliolaauthor=T.+Mayauthor=G.+Ch%C3%AAne&title=Liver+disease+as+a+major+cause+of+death+among+HIV+infected+patients%3A+role+of+hepatitis+B+and+C+virus+and+alcohol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol</span></div><div class="casAuthors">Salmon-Ceron, Dominique; Lewden, Charlotte; Morlat, Philippe; Bevilacqua, Sibylle; Jougla, Eric; Bonnet, Fabrice; Heripret, Laurence; Costagliola, Dominique; May, Thierry; Chene, Genevieve</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">799-805</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We analyzed the characteristics of HIV-infected patients who died from liver disease, focusing on hepatitis virus co-infection.  One-hundred and eighty-five French hospital departments involved in HIV/AIDS management prospectively notified all deaths occurring in 2000.  Patients whose hepatitis C (HCV) and hepatitis B (HBV) serostatus was known were classified as being infected by HCV alone, HBV alone (HBsAg pos.), both HCV and HBV, or neither HCV nor HBV.  Among 822 HIV infected patients, 29% were infected by HCV alone, 8% by HBV alone, and 4% by both HCV and HBV.  The most frequent causes of death were liver disease (31% of cases) and AIDS (29%) among HIV-HCV co-infected patients, and AIDS (38%) and liver disease (22%) among HIV-HBV co-infected patients.  Liver disease was a more frequent cause of death among patients co-infected by both HCV and HBV (44% of cases).  Hepatocellular carcinoma was present in 15% of patients who died from liver disease, and was assocd. with HBV co-infection.  Nearly half the patients who died from liver disease had more than 200 CD4/mm3.  Liver disease is now a leading cause of death among HIV-HCV co-infected patients and is becoming an important cause of death among HIV-HBV co-infected patients.  The risk of death from liver disease is highest in patients co-infected by both HCV and HBV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxiRIxXPw237Vg90H21EOLACvtfcHk0lhF4AaOTy8kNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktVGmtrk%253D&md5=dcedbbba9e185f1783e680b6da3fa4ce</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2005.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2005.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DSalmon-Ceron%26aufirst%3DD.%26aulast%3DLewden%26aufirst%3DC.%26aulast%3DMorlat%26aufirst%3DP.%26aulast%3DB%25C3%25A9vilacqua%26aufirst%3DS.%26aulast%3DJougla%26aufirst%3DE.%26aulast%3DBonnet%26aufirst%3DF.%26aulast%3DH%25C3%25A9ripret%26aufirst%3DL.%26aulast%3DCostagliola%26aufirst%3DD.%26aulast%3DMay%26aufirst%3DT.%26aulast%3DCh%25C3%25AAne%26aufirst%3DG.%26atitle%3DLiver%2520disease%2520as%2520a%2520major%2520cause%2520of%2520death%2520among%2520HIV%2520infected%2520patients%253A%2520role%2520of%2520hepatitis%2520B%2520and%2520C%2520virus%2520and%2520alcohol%26jtitle%3DJ.%2520Hepatol.%26date%3D2005%26volume%3D42%26spage%3D799%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Deuffic-Burban, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poynard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J. B.</span><span> </span><span class="NLM_article-title">Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States</span> <span class="citation_source-journal">J. Virol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1111%2Fj.1365-2893.2006.00785.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=17244250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FksFShtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=107-115&author=S.+Deuffic-Burbanauthor=T.+Poynardauthor=M.+S.+Sulkowskiauthor=J.+B.+Wong&title=Estimating+the+future+health+burden+of+chronic+hepatitis+C+and+human+immunodeficiency+virus+infections+in+the+United+States"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States</span></div><div class="casAuthors">Deuffic-Burban S; Poynard T; Sulkowski M S; Wong J B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of viral hepatitis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-15</span>
        ISSN:<span class="NLM_cas:issn">1352-0504</span>.
    </div><div class="casAbstract">The aim of this work was to estimate the future disease burden of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections in the United States until the year 2030.  Two back-calculation models of the HIV and the HCV epidemic were developed.  They were based on US epidemiological data regarding prevalence, age and gender of incident cases, AIDS, hepatocellular carcinoma (HCC) mortality and general population mortality from the Centers for Disease Control and WHO.  Based on the HCV back-calculation model, HCV incidence peaked in 1984 at 350,000 new infections and then fell to about 77,000 in 1998.  Based on the HIV back-calculation model, HIV incidence reached its maximum in 1989 at 142,000 new infections and then declined to 79,000 in 1998.  Mortality related to HCV (death from liver failure or HCC) rose from about 3,700 in 1998 and is expected to peak at about 13,000 in 2030.  Predicted HCV mortality would fall only if increased access to or more effective antiviral therapy occurs.  For comparison, observed HIV-related mortality was 14,400 in 1998 and projected to be 4,200 for 2030.  With the availability of effective highly active antiretroviral therapy for HIV infection, mortality from HIV appears to have declined substantially, whereas HCV-related deaths as a result of pre-1999 infections will likely continue to increase over the next 25 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPlShw69z_4nqj_yg7twvpfW6udTcc2eYxP-x-YFjNqrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FksFShtA%253D%253D&md5=fcc55db23dcfc935b7de5ccebe641df3</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2893.2006.00785.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2893.2006.00785.x%26sid%3Dliteratum%253Aachs%26aulast%3DDeuffic-Burban%26aufirst%3DS.%26aulast%3DPoynard%26aufirst%3DT.%26aulast%3DSulkowski%26aufirst%3DM.%2BS.%26aulast%3DWong%26aufirst%3DJ.%2BB.%26atitle%3DEstimating%2520the%2520future%2520health%2520burden%2520of%2520chronic%2520hepatitis%2520C%2520and%2520human%2520immunodeficiency%2520virus%2520infections%2520in%2520the%2520United%2520States%26jtitle%3DJ.%2520Virol.%2520Hepatol.%26date%3D2007%26volume%3D14%26spage%3D107%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallet, V. O.</span><span> </span><span class="NLM_article-title">Improving Anti-Hepatitis C Virus Therapy</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1517%2F14712598.6.9.923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=16918259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot12isbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=923-933&author=S.+Polauthor=V.+O.+Mallet&title=Improving+Anti-Hepatitis+C+Virus+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Improving anti-hepatitis C virus therapy</span></div><div class="casAuthors">Pol, Stanislas; Mallet, Vincent O.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">923-933</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The estd. prevalence of hepatitis C virus (HCV) infection is 2%, representing 123 million infected individuals worldwide.  HCV infection burdens public health in relation to hepatic (cirrhosis and its complications in 20% of patients) and extrahepatic (vasculitis) complications, and lessens quality of life.  Major progress has been made in the last two decades for the diagnosis and treatment of HCV, including more appropriate screening strategies for HCV infection (improved sensitivity of serol. and virol. tests); a better evaluation of the impact of chronic HCV infection on the liver (semi-quant. scoring systems of necro-inflammation and fibrosis on liver biopsy, non-invasive evaluation of fibrosis with biochem. markers and elastometry); and improved therapeutic regimens.  This progress provides a better definition of who to treat (clin. impact or significant fibrosis); how to treat; tailoring therapies for doses and durations of the pegylated interferon plus ribavirin combination according to virol. (mainly genotype and early viral kinetics, but also baseline viral load) and hosts factors (fibrosis, immune status, wt.); and how to monitor efficacy and tolerance of therapy.  The progress has now resulted in a 50% rate of complete HCV eradication, ranging 45 - 90% according to the genotype and esp. in those patients with early viral response.  New therapies, specifically HCV protease or polymerase inhibitors, in combination with pegylated interferon, or more potent and less toxic new formulations of interferons or ribavirin, will increase these encouraging results in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhZqk5PT8mg7Vg90H21EOLACvtfcHk0lhF4AaOTy8kNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot12isbw%253D&md5=f2ccc4c6c2eb131607f6cd3c4f2cde7e</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1517%2F14712598.6.9.923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.6.9.923%26sid%3Dliteratum%253Aachs%26aulast%3DPol%26aufirst%3DS.%26aulast%3DMallet%26aufirst%3DV.%2BO.%26atitle%3DImproving%2520Anti-Hepatitis%2520C%2520Virus%2520Therapy%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2006%26volume%3D6%26spage%3D923%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Houghton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrigani, S.</span><span> </span><span class="NLM_article-title">Prospects for a vaccine against the hepatitis C virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=961-966&author=M.+Houghtonauthor=S.+Abrigani&title=Prospects+for+a+vaccine+against+the+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoughton%26aufirst%3DM.%26aulast%3DAbrigani%26aufirst%3DS.%26atitle%3DProspects%2520for%2520a%2520vaccine%2520against%2520the%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D961%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Heathcote, A. J.</span><span> </span><span class="NLM_article-title">Antiviral therapy: chronic hepatitis C</span> <span class="citation_source-journal">J. Viral Hepatitis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1111%2Fj.1365-2893.2007.00921.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=17958648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A280%3ADC%252BD2snosVKkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=82-88&issue=Suppl.+1&author=A.+J.+Heathcote&title=Antiviral+therapy%3A+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Antiviral therapy: chronic hepatitis C</span></div><div class="casAuthors">Heathcote E Jenny</div><div class="citationInfo"><span class="NLM_cas:title">Journal of viral hepatitis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14 Suppl 1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">82-8</span>
        ISSN:<span class="NLM_cas:issn">1352-0504</span>.
    </div><div class="casAbstract">The combination of pegylated interferon (IFN) with ribavirin is the standard of care for chronic hepatitis C.  Response rates range from 50 to 90% for genotype 1 and 2/3 which also differ in the duration of treatment (48 vs 24 weeks, respectively).  Therapy if given with weight-based dosing may be shortened from 24 to 12, 14 or 16 weeks (genotypes 2 and 3), and from 48 to 24 weeks (genotype 1) in case of hepatitis C virus (HCV) clearance at week 4, without reducing sustained virologic response (SVR).  Conversely, prolonging treatment for 72 weeks in those with only a decrease of viral load at week 4, i.e. "slow responders" increases SVR rates by preventing relapse.  In spite of such progress, over half of patients are relapsers or nonresponders.  If the previous treatment was suboptimal, retreatment with higher doses or longer duration may be beneficial unless an individual was a 'null responder' previously.  New promising anti-HCV molecules (antiproteases and antipolymerases), some with potent antiviral activity, are in phase II trials but appear to require the addition of IFN and ribavirin to maintain viral suppression.  Other immunomodulatory agents such as new IFN or therapeutic vaccines and alternatives to ribavirin are also under development.  Future regimens should improve efficacy and provide shorter and better-tolerated combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRN6ybVoFnOvhKDYG3bNImrfW6udTcc2eaf3Vb2iQCTr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snosVKkuw%253D%253D&md5=2567502b861d090343fda18d3b217a60</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2893.2007.00921.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2893.2007.00921.x%26sid%3Dliteratum%253Aachs%26aulast%3DHeathcote%26aufirst%3DA.%2BJ.%26atitle%3DAntiviral%2520therapy%253A%2520chronic%2520hepatitis%2520C%26jtitle%3DJ.%2520Viral%2520Hepatitis%26date%3D2007%26volume%3D14%26issue%3DSuppl.%25201%26spage%3D82%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hoofnagle, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeff, L. B.</span><span> </span><span class="NLM_article-title">Peginterferon and ribavirin for chronic hepatitis C</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1056%2FNEJMct061675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=17151366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12nt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=2444-2451&author=J.+H.+Hoofnagleauthor=L.+B.+Seeff&title=Peginterferon+and+ribavirin+for+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon and ribavirin for chronic hepatitis C</span></div><div class="casAuthors">Hoofnagle, Jay H.; Seeff, Leonard B.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2444-2451</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  A 44-yr-old woman with chronic hepatitis C has intermittent fatigue and persistent elevations in serum alanine aminotransferase levels.  She has had hepatitis C for 10 years.  The diagnosis was made after she attempted to donate blood and was found to have antibodies against the hepatitis C virus (HCV).  On questioning, she reports having used illicit injection drugs in her early 20s.  The phys. examn. is normal except for obesity.  The results of lab. tests show an alanine aminotransferase level of 86 U per L (normal value, <42); the alk. phosphatase level, direct and total bilirubin levels, albumin level, prothrombin time, and complete blood count are normal.  The serum HCV RNA level is 3.5 million IU per mL (genotype 1), and a liver biopsy specimen shows bridging fibrosis.  The patient is evaluated by a hepatologist, who recommends treatment with pegylated interferon and ribavirin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEoSFaZ9BVhbVg90H21EOLACvtfcHk0lgCRQiA63nnHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12nt7%252FK&md5=fc356db5608b52c75cd96a652f8c2d4a</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1056%2FNEJMct061675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMct061675%26sid%3Dliteratum%253Aachs%26aulast%3DHoofnagle%26aufirst%3DJ.%2BH.%26aulast%3DSeeff%26aufirst%3DL.%2BB.%26atitle%3DPeginterferon%2520and%2520ribavirin%2520for%2520chronic%2520hepatitis%2520C%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D2444%26epage%3D2451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Fried, M. W.</span><span> </span><span class="NLM_article-title">Side effects of therapy of hepatitis C and their management</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">S237</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=S237-244&author=M.+W.+Fried&title=Side+effects+of+therapy+of+hepatitis+C+and+their+management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFried%26aufirst%3DM.%2BW.%26atitle%3DSide%2520effects%2520of%2520therapy%2520of%2520hepatitis%2520C%2520and%2520their%2520management%26jtitle%3DHepatology%26date%3D2002%26volume%3D36%26spage%3DS237%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockstroh, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.; F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoulim, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">The way forward in HCV treatment—finding the right path</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=991-1000&author=M.+P.+Mannsauthor=G.+R.+Fosterauthor=J.+K.+Rockstrohauthor=S.%3B+F.+Zeuzemauthor=F.+Zoulimauthor=M.+Houghton&title=The+way+forward+in+HCV+treatment%E2%80%94finding+the+right+path"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DFoster%26aufirst%3DG.%2BR.%26aulast%3DRockstroh%26aufirst%3DJ.%2BK.%26aulast%3DZeuzem%26aufirst%3DS.%253B%2BF.%26aulast%3DZoulim%26aufirst%3DF.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DThe%2520way%2520forward%2520in%2520HCV%2520treatment%25E2%2580%2594finding%2520the%2520right%2520path%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D991%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="note"><p class="first last">For recent review see:</p></div><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gordon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. A.</span><span> </span><span class="NLM_article-title">Control of hepatitis C: a medicinal chemistry perspective</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0400101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1-20&author=C.+P.+Gordonauthor=P.+A.+Keller&title=Control+of+hepatitis+C%3A+a+medicinal+chemistry+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm0400101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0400101%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DC.%2BP.%26aulast%3DKeller%26aufirst%3DP.%2BA.%26atitle%3DControl%2520of%2520hepatitis%2520C%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span> </span><span class="NLM_article-title">Challenges and successes in developing new therapies for hepatitis C</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">463</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2005&pages=953-959&author=R.+De+Francescoauthor=G.+Migliaccio&title=Challenges+and+successes+in+developing+new+therapies+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMigliaccio%26aufirst%3DG.%26atitle%3DChallenges%2520and%2520successes%2520in%2520developing%2520new%2520therapies%2520for%2520hepatitis%2520C%26jtitle%3DNature%26date%3D2005%26volume%3D463%26spage%3D953%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kronenberger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span> </span><span class="NLM_article-title">Future treatment options for HCV: double, triple, what is the optimal combination?</span> <span class="citation_source-journal">Best Practi. Res. Clin. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1123</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1016%2Fj.bpg.2008.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=19187871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=1123-1136&author=B.+Kronenbergerauthor=S.+Zeuzem&title=Future+treatment+options+for+HCV%3A+double%2C+triple%2C+what+is+the+optimal+combination%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Future treatment options for HCV: Double, triple, what is the optimal combination?</span></div><div class="casAuthors">Kronenberger, Bernd; Zeuzem, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Best Practice & Research, Clinical Gastroenterology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1123-1136</span>CODEN:
                <span class="NLM_cas:coden">BPRCB6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Specifically targeted antiviral therapy against hepatitis virus (STAT-C) stands for a new era in the treatment of patients with chronic hepatitis C.  Results from recent trials with protease and polymerase inhibitors indicate that therapy with a single HCV specific compd. will not be sufficient to eradicate hepatitis C virus infection and that combination therapy will be necessary to improve sustained virol. response rates.  The search for the optimal combination of STAT-C compds. with peginterferon alfa with or without ribavirin is currently under investigation in several clin. trials.  Overall the current studies indicate that peginterferon alfa and ribavirin remain the backbone of antiviral therapy of chronic hepatitis C even in the era of STAT-C.  Nevertheless, it can be anticipated that combination of STAT-C compds. with non-overlapping resistance profiles could improve response to antiviral therapy.  Promising combinations are protease inhibitors plus nucleoside analog and non-nucleoside analog polymerase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrejE167j7rsrVg90H21EOLACvtfcHk0liIkBTPh1_AgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOitbw%253D&md5=89fe78486134b8f9eb688a4c7523eaed</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1016%2Fj.bpg.2008.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpg.2008.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DKronenberger%26aufirst%3DB.%26aulast%3DZeuzem%26aufirst%3DS.%26atitle%3DFuture%2520treatment%2520options%2520for%2520HCV%253A%2520double%252C%2520triple%252C%2520what%2520is%2520the%2520optimal%2520combination%253F%26jtitle%3DBest%2520Practi.%2520Res.%2520Clin.%2520Gastroenterol.%26date%3D2008%26volume%3D22%26spage%3D1123%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Schmitz, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, S.-L.</span><span> </span><span class="NLM_article-title">NS5A—from obscurity to new target for HCV therapy</span> <span class="citation_source-journal">Recent Pat. Anti-Infect. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.2174%2F157489108784746597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1Kjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=77-92&author=U.+Schmitzauthor=S.-L.+Tan&title=NS5A%E2%80%94from+obscurity+to+new+target+for+HCV+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">NS5A - from obscurity to new target for HCV therapy</span></div><div class="casAuthors">Schmitz, Uli; Tan, Seng-Lai</div><div class="citationInfo"><span class="NLM_cas:title">Recent Patents on Anti-Infective Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">77-92</span>CODEN:
                <span class="NLM_cas:coden">RPADCX</span>;
        ISSN:<span class="NLM_cas:issn">1574-891X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The hepatitis C virus (HCV) non-structural 5A (NS5A) protein is essential for viral RNA replication and may play a role in subverting host intracellular signaling pathways.  Although no intrinsic enzymic activity has been ascribed to NS5A, this proline-rich hydrophilic phosphoprotein is likely to exert its functions by interacting with viral and cellular factors.  Recent studies using the HCV replicon cell culture system as a model for HCV RNA replication as well as for high-throughput screening of pharmacol. inhibitors have revealed blockade of NS5A as a promising therapeutic strategy for the treatment of HCV.  This review will summarize our progress in understanding the role of NS5A in HCV RNA replication and will introduce the most recent patents on inhibitors of NS5A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEYaqZrcncjbVg90H21EOLACvtfcHk0liIkBTPh1_AgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1Kjs70%253D&md5=29d24e11907fe2c10f5649426b864a87</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.2174%2F157489108784746597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157489108784746597%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitz%26aufirst%3DU.%26aulast%3DTan%26aufirst%3DS.-L.%26atitle%3DNS5A%25E2%2580%2594from%2520obscurity%2520to%2520new%2520target%2520for%2520HCV%2520therapy%26jtitle%3DRecent%2520Pat.%2520Anti-Infect.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26spage%3D77%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Holler, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkinson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryde, D. C.</span><span> </span><span class="NLM_article-title">Targeting the non-structural proteins of hepatitis C virus: beyond hepatitis C virus protease and polymerase</span> <span class="citation_source-journal">Expert Opin. Drug Discovery.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=293-314&author=T.+P.+Hollerauthor=T.+Parkinsonauthor=D.+C.+Pryde&title=Targeting+the+non-structural+proteins+of+hepatitis+C+virus%3A+beyond+hepatitis+C+virus+protease+and+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoller%26aufirst%3DT.%2BP.%26aulast%3DParkinson%26aufirst%3DT.%26aulast%3DPryde%26aufirst%3DD.%2BC.%26atitle%3DTargeting%2520the%2520non-structural%2520proteins%2520of%2520hepatitis%2520C%2520virus%253A%2520beyond%2520hepatitis%2520C%2520virus%2520protease%2520and%2520polymerase%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery.%26date%3D2009%26volume%3D4%26spage%3D293%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">A review of HCV protease inhibitors</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=821-837&author=K.+X.+Chenauthor=F.+G.+Njoroge&title=A+review+of+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DA%2520review%2520of%2520HCV%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D821%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Macrocyclic inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Expert Opin. Ther. Patents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1277</span><span class="NLM_x">–</span> <span class="NLM_lpage">1303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1517%2F13543770903044994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=19563268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWitL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1277-1303&author=S.+Venkatramanauthor=F.+G.+Njoroge&title=Macrocyclic+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of HCV NS3 protease</span></div><div class="casAuthors">Venkatraman, Srikanth; Njoroge, F. George</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1277-1303</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  HCV NS3 is a serine protease that plays a pivotal role in catalyzing the cleavage of the single polyprotein encoded by HCV after infection of hepatocytes.  Anal. of the X-ray crystal structure of the enzyme reveals a shallow catalytic site located on the surface of the protein, which has made development of inhibitors a formidable task.  Attempts to discover leads by a traditional approach of screening of compd. libraries have proved futile and, therefore, researchers have adopted a structure-based drug design.  Anal. of the X-ray structure of NS3 protease reveals close proximity of S1-S3 and S2-S4 pockets.  Various novel approaches have been used to design preorganized, depeptidized macrocyclic inhibitors linking the P2-P4 groups and P1-P3 residues.  The article summarizes efforts by various groups to develop inhibitors that bind to the active site and inhibit viral replication.  Review of recent patents and scientific literature.  Macrocyclization has proved to be an effective tool for depeptidization of peptidic inhibitors with improved binding and pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodbzHliWVL17Vg90H21EOLACvtfcHk0liIkBTPh1_AgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWitL%252FI&md5=4081e78be8e92b762d50501ca8fcb97c</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1517%2F13543770903044994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903044994%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2009%26volume%3D19%26spage%3D1277%26epage%3D1303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective and orally bioavailable inhibitor in hepatitis C virus NS3−4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.+P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective+and+orally+bioavailable+inhibitor+in+hepatitis+C+virus+NS3%E2%88%924A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.%2BP.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520inhibitor%2520in%2520hepatitis%2520C%2520virus%2520NS3%25E2%2588%25924A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Malcolm, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheyas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease,suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1013-1020&author=B.+A.+Malcolmauthor=R.+Liuauthor=F.+Lahserauthor=S.+Agrawalauthor=B.+Belangerauthor=N.+Butkiewiczauthor=R.+Chaseauthor=F.+Gheyasauthor=A.+Hartauthor=D.+Heskauthor=P.+Ingravalloauthor=C.+Jiangauthor=R.+Kongauthor=J.+Luauthor=J.+Pichardoauthor=A.+Prongayauthor=A.+Skeltonauthor=X.+Tongauthor=S.+Venkatramanauthor=E.+Xiaauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=SCH+503034%2C+a+mechanism-based+inhibitor+of+hepatitis+C+virus+NS3+protease%2Csuppresses+polyprotein+maturation+and+enhances+the+antiviral+activity+of+alpha+interferon+in+replicon+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalcolm%26aufirst%3DB.%2BA.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DBelanger%26aufirst%3DB.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DGheyas%26aufirst%3DF.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DSkelton%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DSCH%2520503034%252C%2520a%2520mechanism-based%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%252Csuppresses%2520polyprotein%2520maturation%2520and%2520enhances%2520the%2520antiviral%2520activity%2520of%2520alpha%2520interferon%2520in%2520replicon%2520cells%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1013%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">MK-7009, a potent and selective Inhibitor of hepatitis C virus NS3/4A protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=305-311&author=N.+J.+Livertonauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=D.+J.+Grahamauthor=D.+Hazudaauthor=M.+K.+Hollowayauthor=S.+W.+Ludmererauthor=J.+A.+McCauleyauthor=C.+J.+McIntyreauthor=D.+B.+Olsenauthor=M.+T.+Ruddauthor=M.+Stahlhutauthor=J.+P.+Vacca&title=MK-7009%2C+a+potent+and+selective+Inhibitor+of+hepatitis+C+virus+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMK-7009%252C%2520a%2520potent%2520and%2520selective%2520Inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D305%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Flisiak, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parfieniuk, A.</span><span> </span><span class="NLM_article-title">Investigational drugs for hepatitis C</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=63-75&author=R.+Flisiakauthor=A.+Parfieniuk&title=Investigational+drugs+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlisiak%26aufirst%3DR.%26aulast%3DParfieniuk%26aufirst%3DA.%26atitle%3DInvestigational%2520drugs%2520for%2520hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D63%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Legrand-Abravanel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izopet, J.</span><span> </span><span class="NLM_article-title">New NS5B polymerase inhibitors for Hepatitis C</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=963-975&author=F.+Legrand-Abravanelauthor=F.+Nicotauthor=J.+Izopet&title=New+NS5B+polymerase+inhibitors+for+Hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLegrand-Abravanel%26aufirst%3DF.%26aulast%3DNicot%26aufirst%3DF.%26aulast%3DIzopet%26aufirst%3DJ.%26atitle%3DNew%2520NS5B%2520polymerase%2520inhibitors%2520for%2520Hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D963%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Brown, N. A.</span><span> </span><span class="NLM_article-title">Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=709-725&author=N.+A.+Brown&title=Progress+towards+improving+antiviral+therapy+for+hepatitis+C+with+hepatitis+C+virus+polymerase+inhibitors.+Part+I%3A+Nucleoside+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DN.%2BA.%26atitle%3DProgress%2520towards%2520improving%2520antiviral%2520therapy%2520for%2520hepatitis%2520C%2520with%2520hepatitis%2520C%2520virus%2520polymerase%2520inhibitors.%2520Part%2520I%253A%2520Nucleoside%2520analogues%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26spage%3D709%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1517%2F13543770802672598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=145-164&author=P.+L.+Beaulieu&title=Recent+advances+in+the+development+of+NS5B+polymerase+inhibitors+for+the+treatment+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-164</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  170 To 200 million people worldwide are believed to suffer from chronic hepatitis C virus (HCV) infection, a blood-born disease that targets the liver and progresses to organ cirrhosis and primary cancer in a significant proportion of patients.  The currently available treatment has limited efficacy and suffers from restricting side effects.  HCV infection is the principal cause of liver transplant in industrialized nations and between 8000 and 10,000 deaths result annually from the disease in the United States alone.  Virus-specific, more efficacious, and better-tolerated anti-HCV therapies are thus required to address the unmet medical need.  Objective: To review progress achieved since 2005 in the development of HCV NS5B polymerase inhibitors as potential therapy for the treatment of HCV infection with a primary focus on available patent and medical literature.  Results/conclusion: Several classes of small-mol. inhibitors of HCV NS5B have progressed into clin. development and demonstrated efficacy in reducing viral load in infected patients.  The results so far provide an encouraging foundation for the development of novel, more tolerable therapies and addressing emergence of resistance through combination of antiviral agents with complementary mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo8VVFJs4oSbVg90H21EOLACvtfcHk0lhdhtJtn9Zrmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D&md5=64b78562e2b4e3e8a166fdabf14f7efe</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1517%2F13543770802672598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770802672598%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520NS5B%2520polymerase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D145%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Recent Progress in the Development of Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1302</span><span class="NLM_x">–</span> <span class="NLM_lpage">1329</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.2174%2F156802607781212211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=17627559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1302-1329&author=U.+Kochauthor=F.+Narjes&title=Recent+Progress+in+the+Development+of+Inhibitors+of+the+Hepatitis+C+Virus+RNA-Dependent+RNA+Polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of inhibitors of the hepatitis C virus RNA-dependent RNA polymerase</span></div><div class="casAuthors">Koch, Uwe; Narjes, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1302-1329</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The global prevalence of hepatitis C virus (HCV) infection and the serious consequences assocd. with the chronic state of the disease have become a worldwide health problem.  A combination therapy comprising Interferon-alpha and Ribavirin represents the current std. treatment for chronic HCV infection, although it has demonstrated limited success and causes serious side effects.  Promising alternative approaches toward the control of HCV infection include the development of small mol. inhibitors of viral enzymes interfering with the essential steps in the life cycle of the virus.  In this review we will focus on inhibitors of the HCV-encoded NS5B RNA-dependent RNA polymerase (NS5B RdRp) which is essential for viral replication and has been recognized as a prime target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiFy9xnAKP5rVg90H21EOLACvtfcHk0lgkIXeVUAP3tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvI&md5=02ed6506840e322371e043ce557a31d4</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.2174%2F156802607781212211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607781212211%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Development%2520of%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520RNA-Dependent%2520RNA%2520Polymerase%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1302%26epage%3D1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNair, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, S.</span><span> </span><span class="NLM_article-title">Recent progress in the development of selected hepatitis C virus NS34A protease and NS5B polymerase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1016%2Fj.coph.2008.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=18835365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlaqsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=522-531&author=A.+D.+Kwongauthor=L.+McNairauthor=I.+Jacobsenauthor=S.+George&title=Recent+progress+in+the+development+of+selected+hepatitis+C+virus+NS34A+protease+and+NS5B+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of selected hepatitis C virus NS3·4A protease and NS5B polymerase inhibitors</span></div><div class="casAuthors">Kwong, Ann D.; McNair, Lindsay; Jacobson, Ira; George, Shelley</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">522-531</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Chronic hepatitis C virus (HCV) infection is a pressing medical problem worldwide.  Current therapy with pegylated interferon plus ribavirin (Peg-IFN/RBV) is assocd. with a poor risk benefit profile, a long treatment duration (48 wk) and inadequate success rate (∼40-50%) of SVR (sustained viral response) in patients infected with genotype 1 HCV.  This review is focused on recent clin. trial results with specifically targeted antiviral therapy for HCV (STAT-C) protease and polymerase inhibitors.  In the past decade, anti-HCV drug discovery has focused first on targeting host factors required for viral replication and second on multiple HCV antiviral agents.  Owing to the large no. of HCV inhibitors currently in pre-clin. and clin. development today, we have focused on the most advanced compds. in the HCV polymerase and HCV protease inhibitor classes.  Within each class, compds. will be used to illustrate some of the properties assocd. with inhibitors that bind to the active site of HCV polymerase, the active site of HCV protease (macrocyclic and linear ketoamide inhibitors) and allosteric polymerase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb0B_J-gyRGLVg90H21EOLACvtfcHk0lgkIXeVUAP3tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlaqsLrE&md5=0787600cc6e2a2c28c1240470bf6bf22</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DMcNair%26aufirst%3DL.%26aulast%3DJacobsen%26aufirst%3DI.%26aulast%3DGeorge%26aufirst%3DS.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520selected%2520hepatitis%2520C%2520virus%2520NS34A%2520protease%2520and%2520NS5B%2520polymerase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D522%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettles, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano-Wu, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, D. R.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1038%2Fnature08960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=20410884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=96-100&author=M.+Gaoauthor=R.+E.+Nettlesauthor=M.+Belemaauthor=L.+B.+Snyderauthor=V.+N.+Nguyenauthor=R.+A.+Fridellauthor=M.+H.+Serrano-Wuauthor=D.+R.+Langleyauthor=J.-H.+Sunauthor=D.+R.+O%E2%80%99Boyleauthor=J.+A.+Lemmauthor=C.+Wangauthor=J.+O.+Knipeauthor=C.+Chienauthor=R.+J.+Colonnoauthor=D.+M.+Graselaauthor=N.+A.+Meanwellauthor=L.+G.+Hamann&title=Chemical+genetics+strategy+identifies+an+HCV+NS5A+inhibitor+with+a+potent+clinical+effect"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span></div><div class="casAuthors">Gao, Min; Nettles, Richard E.; Belema, Makonen; Snyder, Lawrence B.; Nguyen, Van N.; Fridell, Robert A.; Serrano-Wu, Michael H.; Langley, David R.; Sun, Jin-Hua; O'Boyle, Donald R., II; Lemm, Julie A.; Wang, Chunfu; Knipe, Jay O.; Chien, Caly; Colonno, Richard J.; Grasela, Dennis M.; Meanwell, Nicholas A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7294</span>),
    <span class="NLM_cas:pages">96-100</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The worldwide prevalence of chronic hepatitis C virus (HCV) infection is estd. to be approaching 200 million people.  Current therapy relies upon a combination of pegylated interferon-α and ribavirin, a poorly tolerated regimen typically assocd. with less than 50% sustained virol. response rate in those infected with genotype 1 virus.  The development of direct-acting antiviral agents to treat HCV has focused predominantly on inhibitors of the viral enzymes NS3 protease and the RNA-dependent RNA polymerase NS5B.  Here we describe the profile of BMS-790052, a small mol. inhibitor of the HCV NS5A protein that exhibits picomolar half-max. effective concns. (EC50) towards replicons expressing a broad range of HCV genotypes and the JFH-1 genotype 2a infectious virus in cell culture.  In a phase I clin. trial in patients chronically infected with HCV, administration of a single 100-mg dose of BMS-790052 was assocd. with a 3.3 log10 redn. in mean viral load measured 24 h post-dose that was sustained for an addnl. 120 h in two patients infected with genotype 1b virus.  Genotypic anal. of samples taken at baseline, 24 and 144 h post-dose revealed that the major HCV variants obsd. had substitutions at amino-acid positions identified using the in vitro replicon system.  These results provide the first clin. validation of an inhibitor of HCV NS5A, a protein with no known enzymic function, as an approach to the suppression of virus replication that offers potential as part of a therapeutic regimen based on combinations of HCV inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAY7Lig0xT9LVg90H21EOLACvtfcHk0lgkIXeVUAP3tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D&md5=620427e987f2bccd153270cde2ef5027</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature08960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08960%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DM.%26aulast%3DNettles%26aufirst%3DR.%2BE.%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.-H.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DChemical%2520genetics%2520strategy%2520identifies%2520an%2520HCV%2520NS5A%2520inhibitor%2520with%2520a%2520potent%2520clinical%2520effect%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D96%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">O’Farrell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trowbridge, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jager, J.</span><span> </span><span class="NLM_article-title">Substrate Complexes of Hepatitis C Virus RNA Polymerase (HC-J4): Structural Evidence for Nucleotide Import and De Novo Initiation</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1035</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2003&pages=1025-1035&author=D.+O%E2%80%99Farrellauthor=R.+Trowbridgeauthor=D.+Rowlandsauthor=J.+Jager&title=Substrate+Complexes+of+Hepatitis+C+Virus+RNA+Polymerase+%28HC-J4%29%3A+Structural+Evidence+for+Nucleotide+Import+and+De+Novo+Initiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Farrell%26aufirst%3DD.%26aulast%3DTrowbridge%26aufirst%3DR.%26aulast%3DRowlands%26aufirst%3DD.%26aulast%3DJager%26aufirst%3DJ.%26atitle%3DSubstrate%2520Complexes%2520of%2520Hepatitis%2520C%2520Virus%2520RNA%2520Polymerase%2520%2528HC-J4%2529%253A%2520Structural%2520Evidence%2520for%2520Nucleotide%2520Import%2520and%2520De%2520Novo%2520Initiation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D326%26spage%3D1025%26epage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Butcher, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimes, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makeyev, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, D. I. A</span><span> </span><span class="NLM_article-title">Mechanism for Initiating RNA-Dependent RNA Polymerization</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">410</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2001&pages=235-240&author=S.+J.+Butcherauthor=J.+M.+Grimesauthor=E.+V.+Makeyevauthor=D.+H.+Bamfordauthor=D.+I.+A+Stuart&title=Mechanism+for+Initiating+RNA-Dependent+RNA+Polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DButcher%26aufirst%3DS.%2BJ.%26aulast%3DGrimes%26aufirst%3DJ.%2BM.%26aulast%3DMakeyev%26aufirst%3DE.%2BV.%26aulast%3DBamford%26aufirst%3DD.%2BH.%26aulast%3DStuart%26aufirst%3DD.%2BI.%2BA%26atitle%3DMechanism%2520for%2520Initiating%2520RNA-Dependent%2520RNA%2520Polymerization%26jtitle%3DNature%26date%3D2001%26volume%3D410%26spage%3D235%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racela, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigat, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span> </span><span class="NLM_article-title">De Novo Initiation of RNA Synthesis by the RNA-Dependent RNA Polymerase (NS5B) of Hepatitis C Virus</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">851</span><span class="NLM_x">–</span> <span class="NLM_lpage">863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1128%2FJVI.74.2.851-863.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=10623748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1CksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=851-863&author=G.+Luoauthor=R.+K.+Hamatakeauthor=D.+M.+Mathisauthor=J.+Racelaauthor=K.+L.+Rigatauthor=J.+Lemmauthor=R.+J.+Colonno&title=De+Novo+Initiation+of+RNA+Synthesis+by+the+RNA-Dependent+RNA+Polymerase+%28NS5B%29+of+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15c</span><div class="casTitle"><span class="NLM_cas:atitle">De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus</span></div><div class="casAuthors">Luo, Guangxiang; Hamatake, Robert K.; Mathis, Danielle M.; Racela, Jason; Rigat, Karen L.; Lemm, Julie; Colonno, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">851-863</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) NS5B protein possesses an RNA-dependent RNA polymerase (RdRp) activity, a major function responsible for replication of the viral RNA genome.  To further characterize the RdRp activity, NS5B proteins were expressed from recombinant baculoviruses, purified to near homogeneity, and examd. for their ability to synthesize RNA in vitro.  As a result, a highly active NS5B RdRp (1b-42), which contains an 18-amino acid C-terminal truncation resulting from a newly created stop codon, was identified among a no. of independent isolates.  The RdRp activity of the truncated NS5B is comparable to the activity of the full-length protein and is 20 times higher in the presence of Mn2+ than in the presence of Mg2+.  When a 384-nucleotide RNA was used as the template, two major RNA products were synthesized by 1b-42.  One is a complementary RNA identical in size to the input RNA template (monomer), while the other is a hairpin dimer RNA synthesized by a "copy-back" mechanism.  Substantial evidence derived from several expts. demonstrated that the RNA monomer was synthesized through de novo initiation by NS5B rather than by a terminal transferase activity.  Synthesis of the RNA monomer requires all four ribonucleotides.  The RNA monomer product was verified to be the result of de novo RNA synthesis, as two expected RNA products were generated from monomer RNA by RNase H digestion.  In addn., modification of the RNA template by the addn. of the chain terminator cordycepin at the 3' end did not affect synthesis of the RNA monomer but eliminated synthesis of the self-priming hairpin dimer RNA.  Moreover, synthesis of RNA on poly(C) and poly(U) homopolymer templates by 1b-42 NS5B did not require the oligonucleotide primer at high concns. (≥50 μM) of GTP and ATP, further supporting a de novo initiation mechanism.  These findings suggest that HCV NS5B is able to initiate RNA synthesis de novo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx7U3Pxol3JrVg90H21EOLACvtfcHk0liLK8lPbPhKCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1CksA%253D%253D&md5=59e871a13b1211af1a6ef6f48479f0cc</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1128%2FJVI.74.2.851-863.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.74.2.851-863.2000%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DHamatake%26aufirst%3DR.%2BK.%26aulast%3DMathis%26aufirst%3DD.%2BM.%26aulast%3DRacela%26aufirst%3DJ.%26aulast%3DRigat%26aufirst%3DK.%2BL.%26aulast%3DLemm%26aufirst%3DJ.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26atitle%3DDe%2520Novo%2520Initiation%2520of%2520RNA%2520Synthesis%2520by%2520the%2520RNA-Dependent%2520RNA%2520Polymerase%2520%2528NS5B%2529%2520of%2520Hepatitis%2520C%2520Virus%26jtitle%3DJ.%2520Virol.%26date%3D2000%26volume%3D74%26spage%3D851%26epage%3D863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Bressanelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Incitti, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, F. A.</span><span> </span><span class="NLM_article-title">Crystal Structure of the RNA-Dependent RNA Polymerase of Hepatitis C Virus</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">13034</span><span class="NLM_x">–</span> <span class="NLM_lpage">13039</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1073%2Fpnas.96.23.13034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=10557268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADyaK1MXns1Gmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=13034-13039&author=S.+Bressanelliauthor=L.+Tomeiauthor=A.+Rousselauthor=I.+Incittiauthor=R.+L.+Vitaleauthor=M.+Mathieuauthor=R.+De+Francescoauthor=F.+A.+Rey&title=Crystal+Structure+of+the+RNA-Dependent+RNA+Polymerase+of+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15dR"><div class="casContent"><span class="casTitleNuber">15d</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span></div><div class="casAuthors">Bressanelli, Stephane; Tomei, Licia; Roussel, Alain; Incitti, Ilario; Vitale, Rosa Letizia; Mathieu, Magali; De Francesco, Raffaele; Rey, Felix A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">13034-13039</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The crystal structure of the RNA-dependent RNA polymerase (RNA replicase) (I) of hepatitis C virus, a major human pathogen, is reported to 2.8 Å resoln.  I is a key target for developing specific antiviral therapy.  The structure of the catalytic domain contained 531 residues folded in the characteristic fingers, palm, and thumb subdomains.  The fingers subdomain contained a region, the "fingertips," that shared the same fold with reverse transcriptases.  Superposition to the available structures of the latter showed that residues from the palm and fingertips were structurally equiv.  In addn., it showed that hepatitis C virus I was crystd. in a closed fingers conformation, similar to HIV-1 reverse transcriptase in ternary complex with DNA and dTTP.  This superposition revealed the majority of the amino acid residues of the hepatitis C virus enzyme that are likely to be implicated in binding to the replicating RNA mol. and to the incoming NTP.  It also suggested a rearrangement of the thumb domain as well as a possible concerted movement of thumb and fingertips during translocation of the RNA template-primer in successive polymn. rounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoMMlZvielKLVg90H21EOLACvtfcHk0liLK8lPbPhKCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXns1Gmsrk%253D&md5=2ba97997c8a8e24c0db560260fb5ea9a</span></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.23.13034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.23.13034%26sid%3Dliteratum%253Aachs%26aulast%3DBressanelli%26aufirst%3DS.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DRoussel%26aufirst%3DA.%26aulast%3DIncitti%26aufirst%3DI.%26aulast%3DVitale%26aufirst%3DR.%2BL.%26aulast%3DMathieu%26aufirst%3DM.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DRey%26aufirst%3DF.%2BA.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520RNA-Dependent%2520RNA%2520Polymerase%2520of%2520Hepatitis%2520C%2520Virus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D13034%26epage%3D13039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span> </span><span class="NLM_article-title">Nucleoside Analog Inhibitors of Hepatitis C Virus Replication</span> <span class="citation_source-journal">Infect. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.2174%2F187152606776056698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=16787301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=17-29&author=S.+S.+Carrollauthor=D.+B.+Olsen&title=Nucleoside+Analog+Inhibitors+of+Hepatitis+C+Virus+Replication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside analog inhibitors of hepatitis C virus replication</span></div><div class="casAuthors">Carroll, S. S.; Olsen, D. B.</div><div class="citationInfo"><span class="NLM_cas:title">Infectious Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-29</span>CODEN:
                <span class="NLM_cas:coden">IDDTAD</span>;
        ISSN:<span class="NLM_cas:issn">1871-5265</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Of the 30 compds. currently marketed in the United States for treatment of viral infections, 15 are nucleoside analogs, demonstrating the utility of this class of compd. as a source of antiviral drugs.  The success of nucleoside analogs in treating other viral infections provides a compelling rationale for the significant effort that is currently being devoted to the discovery and development of nucleoside analogs to treat infection by hepatitis C virus (HCV) that may lead to improvements in response rates compared to currently available therapies.  Several different approaches were adopted to identify promising analogs, including the use of surrogate viruses in cell culture assays, screening in the cell-based bicistronic HCV replicon assay, and screening nucleoside triphosphates for the ability to inhibit the activity of the HCV RNA-dependent RNA polymerase in vitro.  Several classes of ribonucleoside analogs with modifications of the ribose inhibit HCV replication.  Nucleoside analogs incorporating a 2'-C-Me modification are potent inhibitors in the replicon assay in the absence of cytotoxicity, and appear to exert their inhibition by acting as functional chain terminators of RNA synthesis.  NM283, a prodrug of 2'-C-methylcytidine, has entered clin. trials and demonstrated viral load redns. in subjects infected with genotype 1 HCV, a genotype known to be difficult to treat effectively with currently approved therapies.  Overall, results to date offer encouragement that improved therapies to treat HCV infection including newly developed nucleoside analogs may become available within the next few years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVhFYWU3S1hbVg90H21EOLACvtfcHk0liLK8lPbPhKCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7Y%253D&md5=27a3f74bc6da7bfd4ce02a1266511f5c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F187152606776056698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152606776056698%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26atitle%3DNucleoside%2520Analog%2520Inhibitors%2520of%2520Hepatitis%2520C%2520Virus%2520Replication%26jtitle%3DInfect.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2006%26volume%3D6%26spage%3D17%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tramontano, E.</span><span> </span><span class="NLM_article-title">The exploding field of the HCV polymerase non-nucleoside inhibitors: summary of a first generation compounds</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1298</span><span class="NLM_x">–</span> <span class="NLM_lpage">1310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1298-1310&author=E.+Tramontano&title=The+exploding+field+of+the+HCV+polymerase+non-nucleoside+inhibitors%3A+summary+of+a+first+generation+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTramontano%26aufirst%3DE.%26atitle%3DThe%2520exploding%2520field%2520of%2520the%2520HCV%2520polymerase%2520non-nucleoside%2520inhibitors%253A%2520summary%2520of%2520a%2520first%2520generation%2520compounds%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1298%26epage%3D1310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infection</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=17668364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKgsbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=614-634&author=P.+L.+Beaulieu&title=Non-nucleoside+inhibitors+of+the+HCV+NS5B+polymerase%3A+progress+in+the+discovery+and+development+of+novel+agents+for+the+treatment+of+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (Thomson Scientific)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">614-634</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">1472-4472</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  The severe health conditions assocd. with chronic HCV infection remain a global concern.  Small-mol. drugs that specifically target essential virally encoded enzymes have not yet progressed to market, and the current std. of care continues to rely on a combination of pegylated IFN with ribavirin.  This therapy has serious side effects and a significant proportion of patients infected with HCV genotype 1 (the major genotype in industrialized countries) have an unsatisfactory outcome with this therapy.  Major advances have been realized in the development of specific non-nucleoside inhibitors of the viral NS5B RNA-dependent RNA polymerase.  This well-characterized replicative enzyme is a highly drugable target that, in addn. to its active site, features at least three known allosteric binding pockets that regulate RNA synthesis and are suitable for inhibitor design.  Clin. proof-of-concept for allosteric non-nucleoside HCV polymerase inhibitors has been reported and several compds. have progressed into preclin. studies.  It is likely that in the future NS5B inhibitors will form an integral part of more effective anti-HCV therapies, combining the use of small-mol. antiviral drugs with or without the assistance of immune modulators such as IFNs in order to minimize the emergence of resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTl5U1TLVJ57Vg90H21EOLACvtfcHk0lghHcfjerqOHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKgsbvK&md5=347a7983497b1b50bba61a455783f302</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DNon-nucleoside%2520inhibitors%2520of%2520the%2520HCV%2520NS5B%2520polymerase%253A%2520progress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520novel%2520agents%2520for%2520the%2520treatment%2520of%2520HCV%2520infection%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D8%26spage%3D614%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Allosteric inhibition of the hepatitis C virus NS5B RNA dependent RNA polymerase</span> <span class="citation_source-journal">Infect. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.2174%2F187152606776056724" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=16787302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=31-41&author=U.+Kochauthor=F.+Narjes&title=Allosteric+inhibition+of+the+hepatitis+C+virus+NS5B+RNA+dependent+RNA+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibition of the hepatitis C virus NS5B RNA dependent RNA polymerase</span></div><div class="casAuthors">Koch, Uwe; Narjes, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Infectious Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-41</span>CODEN:
                <span class="NLM_cas:coden">IDDTAD</span>;
        ISSN:<span class="NLM_cas:issn">1871-5265</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The human and monetary costs of chronic hepatitis C and the complications arising from this disease emphasize the urgency to find a treatment for Hepatitis C Virus (HCV) infected patients.  The current std. of treatment for patients chronically infected with HCV is combination therapy with pegylated interferon plus ribavirin.  Recently, viral enzymes have become the target of efforts to develop small mol. inhibitors interfering with the essential steps in the life cycle of the virus.  Amongst these enzymes the HCV-encoded NS5B RNA-dependent RNA polymerase (NS5B RdRp) is essential for viral replication and has been recognized as a prime target for therapeutic intervention.  Several distinct classes of inhibitors of NS5B RdRp have been disclosed in the literature, including active site inhibitors such as nucleosides and pyrophosphate mimetics, as well as nonnucleoside inhibitors.  The latter, based on the success of allosteric inhibitors in the treatment of HIV infection, have been developed into compds. which show activity in the subgenomic cell-culture assay of HCV replication.  This review provides an account of the recent developments in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbJzS0wn4zMLVg90H21EOLACvtfcHk0lghHcfjerqOHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7c%253D&md5=d299870b484180aa4f9e179cb96eabe2</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.2174%2F187152606776056724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152606776056724%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DAllosteric%2520inhibition%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA%2520dependent%2520RNA%2520polymerase%26jtitle%3DInfect.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2006%26volume%3D6%26spage%3D31%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Condon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPorte, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span> </span><span class="NLM_article-title">Allosteric inhibitors of hepatitis C NS5B RNA-dependent RNA polymerase</span> <span class="citation_source-journal">Curr. Med. Chem.: Anti-Infect. Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.2174%2F1568012053506972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1Gjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=99-110&author=S.+M.+Condonauthor=M.+G.+LaPorteauthor=T.+Herbertz&title=Allosteric+inhibitors+of+hepatitis+C+NS5B+RNA-dependent+RNA+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibitors of hepatitis C NS5B RNA-dependent RNA polymerase</span></div><div class="casAuthors">Condon, Stephen M.; LaPorte, Matthew G.; Herbertz, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Infective Agents</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-110</span>CODEN:
                <span class="NLM_cas:coden">CMCAFL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0126</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Infection with HCV is a global concern.  Ests. from the WHO suggest that over 170 million people are infected worldwide with over 2.7 million people infected in the US.  Current therapies including interferon (IFN-α) and ribavirin are ineffective against many HCV genotypes and a sustained viral response is difficult to achieve in many HCV patients.  Inconvenient dosing regimens and overall toxicity conspire to make these current therapies inadequate.  Although the recent development of pegylated interferons have shown signs of improved genotype applicability and reduced toxicity, it is believed that alternative therapies will be needed to battle this disease on a global scale.  The incidence of HIV/HCV co-infection is a growing trend and the authors' ability to effectively treat these patients is anticipated to be a significant medical challenge.  For HIV-1, the successful development of nucleotide- and non-nucleotide-based reverse transcriptase inhibitors (NNRTIs) as well as HIV protease inhibitors (PIs) has afforded patients a variety of treatment options.  Although 5-times more prevalent than HIV-1 infection, the development of target-directed HCV treatments was less successful.  Like HIV, the 2 HCV targets receiving the most attention are the protease (NS3-4A) and the polymerase (NS5B).  Recently, the discovery of several classes of allosteric HCV NS5B inhibitors were reported in the patent and scientific literature and many have made their way into clin. trials.  This review will describe the nature of these novel inhibitors while drawing comparisons and contrasts to the structural biol., development, and clin. utility of HIV NNRTIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Vem_5eUtRLVg90H21EOLACvtfcHk0lghHcfjerqOHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1Gjtr0%253D&md5=fda8f3199c59c9f5fee4639d6f214ec5</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.2174%2F1568012053506972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568012053506972%26sid%3Dliteratum%253Aachs%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DLaPorte%26aufirst%3DM.%2BG.%26aulast%3DHerbertz%26aufirst%3DT.%26atitle%3DAllosteric%2520inhibitors%2520of%2520hepatitis%2520C%2520NS5B%2520RNA-dependent%2520RNA%2520polymerase%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Anti-Infect.%2520Agents%26date%3D2005%26volume%3D4%26spage%3D99%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avolio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Filippo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Development and Preliminary Optimization of Indole-<i>N</i>-Acetamide Inhibitors of Hepatitis C Virus NS5B Polymerase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1314</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049122i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1314-1317&author=S.+Harperauthor=B.+Paciniauthor=S.+Avolioauthor=M.+Di+Filippoauthor=G.+Migliaccioauthor=R.+Lauferauthor=R.+De+Francescoauthor=M.+Rowleyauthor=F.+Narjes&title=Development+and+Preliminary+Optimization+of+Indole-N-Acetamide+Inhibitors+of+Hepatitis+C+Virus+NS5B+Polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fjm049122i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049122i%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DPacini%26aufirst%3DB.%26aulast%3DAvolio%26aufirst%3DS.%26aulast%3DDi%2BFilippo%26aufirst%3DM.%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DDevelopment%2520and%2520Preliminary%2520Optimization%2520of%2520Indole-N-Acetamide%2520Inhibitors%2520of%2520Hepatitis%2520C%2520Virus%2520NS5B%2520Polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1314%26epage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Finger loop inhibitors of the HCV NS5B polymerase: discovery and prospects for new HCV therapy</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=618-626&author=P.+L.+Beaulieu&title=Finger+loop+inhibitors+of+the+HCV+NS5B+polymerase%3A+discovery+and+prospects+for+new+HCV+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DFinger%2520loop%2520inhibitors%2520of%2520the%2520HCV%2520NS5B%2520polymerase%253A%2520discovery%2520and%2520prospects%2520for%2520new%2520HCV%2520therapy%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D618%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valois, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Non-Nucleoside Benzimidazole-Based Allosteric Inhibitors of the Hepatitis C Virus NS5B Polymerase: Inhibition of Subgenomic Hepatitis C Virus RNA Replicons in Huh-7 Cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6884</span><span class="NLM_x">–</span> <span class="NLM_lpage">6892</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040134d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6884-6892&author=P.+L.+Beaulieuauthor=Y.+Bousquetauthor=J.+Gauthierauthor=J.+Gillardauthor=M.+Marquisauthor=G.+McKercherauthor=C.+Pellerinauthor=S.+Valoisauthor=G.+Kukolj&title=Non-Nucleoside+Benzimidazole-Based+Allosteric+Inhibitors+of+the+Hepatitis+C+Virus+NS5B+Polymerase%3A+Inhibition+of+Subgenomic+Hepatitis+C+Virus+RNA+Replicons+in+Huh-7+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1021%2Fjm040134d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040134d%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DBousquet%26aufirst%3DY.%26aulast%3DGauthier%26aufirst%3DJ.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DMarquis%26aufirst%3DM.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DPellerin%26aufirst%3DC.%26aulast%3DValois%26aufirst%3DS.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DNon-Nucleoside%2520Benzimidazole-Based%2520Allosteric%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS5B%2520Polymerase%253A%2520Inhibition%2520of%2520Subgenomic%2520Hepatitis%2520C%2520Virus%2520RNA%2520Replicons%2520in%2520Huh-7%2520Cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6884%26epage%3D6892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Plante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Non-Nucleoside Inhibitors of the Hepatitis C Virus NS5B Polymerase: Discovery and Preliminary SAR of Benzimidazole Derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=119-124&author=P.+L.+Beaulieuauthor=M.+Bosauthor=Y.+Bousquetauthor=G.+Fazalauthor=J.+Gauthierauthor=J.+Gillardauthor=S.+Gouletauthor=S.+La+Planteauthor=M.-A.+Poupartauthor=S.+Lefebvreauthor=G.+McKercherauthor=C.+Pellerinauthor=V.+Austelauthor=G.+Kukolj&title=Non-Nucleoside+Inhibitors+of+the+Hepatitis+C+Virus+NS5B+Polymerase%3A+Discovery+and+Preliminary+SAR+of+Benzimidazole+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DBos%26aufirst%3DM.%26aulast%3DBousquet%26aufirst%3DY.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGauthier%26aufirst%3DJ.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DLa%2BPlante%26aufirst%3DS.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DPellerin%26aufirst%3DC.%26aulast%3DAustel%26aufirst%3DV.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DNon-Nucleoside%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS5B%2520Polymerase%253A%2520Discovery%2520and%2520Preliminary%2520SAR%2520of%2520Benzimidazole%2520Derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D119%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Plante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thauvette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Specific Inhibitors of HCV Polymerase Identified Using an NS5B with Lower Affinity for Template/Primer Substrate</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=422-431&author=G.+McKercherauthor=P.+L.+Beaulieuauthor=D.+Lamarreauthor=S.+La+Planteauthor=S.+Lefebvreauthor=C.+Pellerinauthor=L.+Thauvetteauthor=G.+Kukolj&title=Specific+Inhibitors+of+HCV+Polymerase+Identified+Using+an+NS5B+with+Lower+Affinity+for+Template%2FPrimer+Substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DLa%2BPlante%26aufirst%3DS.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DPellerin%26aufirst%3DC.%26aulast%3DThauvette%26aufirst%3DL.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DSpecific%2520Inhibitors%2520of%2520HCV%2520Polymerase%2520Identified%2520Using%2520an%2520NS5B%2520with%2520Lower%2520Affinity%2520for%2520Template%252FPrimer%2520Substrate%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2004%26volume%3D32%26spage%3D422%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bykowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansereau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duceppe, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hache, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakalian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagace, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thauvette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: from benzimidazole to indole scaffolds</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4987</span><span class="NLM_x">–</span> <span class="NLM_lpage">4993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4987-4993&author=P.+L.+Beaulieuauthor=J.+Gillardauthor=D.+Bykowskiauthor=C.+Brochuauthor=N.+Dansereauauthor=J.-S.+Duceppeauthor=B.+Hacheauthor=A.+Jakalianauthor=L.+Lagaceauthor=S.+LaPlanteauthor=G.+McKercherauthor=E.+Moreauauthor=S.+Perreaultauthor=T.+Stammersauthor=L.+Thauvetteauthor=J.+Warringtonauthor=G.+Kukolj&title=Improved+replicon+cellular+activity+of+non-nucleoside+allosteric+inhibitors+of+HCV+NS5B+polymerase%3A+from+benzimidazole+to+indole+scaffolds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DBykowski%26aufirst%3DD.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DDansereau%26aufirst%3DN.%26aulast%3DDuceppe%26aufirst%3DJ.-S.%26aulast%3DHache%26aufirst%3DB.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DLagace%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DMoreau%26aufirst%3DE.%26aulast%3DPerreault%26aufirst%3DS.%26aulast%3DStammers%26aufirst%3DT.%26aulast%3DThauvette%26aufirst%3DL.%26aulast%3DWarrington%26aufirst%3DJ.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DImproved%2520replicon%2520cellular%2520activity%2520of%2520non-nucleoside%2520allosteric%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%253A%2520from%2520benzimidazole%2520to%2520indole%2520scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4987%26epage%3D4993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansereau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Plante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thauvette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Benzimidazole thumb pocket I finger-loop inhibitors of HCV NS5B polymerase: Improved drug-like properties through C-2 SAR in three sub-series</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1825</span><span class="NLM_x">–</span> <span class="NLM_lpage">1829</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1825-1829&author=P.+L.+Beaulieuauthor=N.+Dansereauauthor=J.+Duanauthor=M.+Garneauauthor=J.+Gillardauthor=G.+McKercherauthor=S.+La+Planteauthor=L.+Lagaceeauthor=L.+Thauvetteauthor=G.+Kukolj&title=Benzimidazole+thumb+pocket+I+finger-loop+inhibitors+of+HCV+NS5B+polymerase%3A+Improved+drug-like+properties+through+C-2+SAR+in+three+sub-series"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DDansereau%26aufirst%3DN.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DLa%2BPlante%26aufirst%3DS.%26aulast%3DLagacee%26aufirst%3DL.%26aulast%3DThauvette%26aufirst%3DL.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DBenzimidazole%2520thumb%2520pocket%2520I%2520finger-loop%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%253A%2520Improved%2520drug-like%2520properties%2520through%2520C-2%2520SAR%2520in%2520three%2520sub-series%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1825%26epage%3D1829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ishida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirashima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, H.</span><span> </span><span class="NLM_article-title">Benzimidazole inhibitors of Hepatitis C virus NS5B polymerase: Identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1859</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1016%2Fj.bmcl.2006.01.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=16455252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVyrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1859-1863&author=T.+Ishidaauthor=T.+Suzukiauthor=S.+Hirashimaauthor=K.+Mizutaniauthor=A.+Yoshidaauthor=I.+Andoauthor=S.+Ikedaauthor=T.+Adachiauthor=H.+Hashimoto&title=Benzimidazole+inhibitors+of+Hepatitis+C+virus+NS5B+polymerase%3A+Identification+of+2-%5B%284-diarylmethoxy%29phenyl%5D-benzimidazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Benzimidazole inhibitors of hepatitis C virus NS5B polymerase: Identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole</span></div><div class="casAuthors">Ishida, Tomio; Suzuki, Takayoshi; Hirashima, Shintaro; Mizutani, Kenji; Yoshida, Atsuhito; Ando, Izuru; Ikeda, Satoru; Adachi, Tsuyoshi; Hashimoto, Hiromasa</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1859-1863</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 1-cycloalkyl-2-phenyl-1H-benzimidazole-5-carboxylic acid derivs. was synthesized and evaluated for inhibitory activity against hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase.  A SAR study led to identify the 2-[(4-diarylmethoxy)phenyl]benzimidazoles as potent inhibitors.  They inhibit subgenomic HCV RNA replication in the replicon cells at low micromolar concns. (EC50 ≥ 1.1 μM).  They are selective against DNA polymerases (IC50 > 10 μM) and exhibit low cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpafYllvKcYs7Vg90H21EOLACvtfcHk0ljRR_-0cSVEgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVyrur4%253D&md5=0ae4f62a4f946596fafea62b1d543d13</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.01.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.01.032%26sid%3Dliteratum%253Aachs%26aulast%3DIshida%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DHirashima%26aufirst%3DS.%26aulast%3DMizutani%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DA.%26aulast%3DAndo%26aufirst%3DI.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DH.%26atitle%3DBenzimidazole%2520inhibitors%2520of%2520Hepatitis%2520C%2520virus%2520NS5B%2520polymerase%253A%2520Identification%2520of%25202-%255B%25284-diarylmethoxy%2529phenyl%255D-benzimidazole%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1859%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hirashima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noji, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, H.</span><span> </span><span class="NLM_article-title">Benzimidazole derivatives bearing substituted biphenyls as hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors: structure−activity relationship studies and identification of a potent and highly selective inhibitor JTK-109</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4721</span><span class="NLM_x">–</span> <span class="NLM_lpage">4736</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060269e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4721-4736&author=S.+Hirashimaauthor=T.+Suzukiauthor=T.+Ishidaauthor=S.+Nojiauthor=S.+Yataauthor=I.+Andoauthor=M.+Komatsuauthor=S.+Ikedaauthor=H.+Hashimoto&title=Benzimidazole+derivatives+bearing+substituted+biphenyls+as+hepatitis+C+virus+NS5B+RNA-dependent+RNA+polymerase+inhibitors%3A+structure%E2%88%92activity+relationship+studies+and+identification+of+a+potent+and+highly+selective+inhibitor+JTK-109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fjm060269e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060269e%26sid%3Dliteratum%253Aachs%26aulast%3DHirashima%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DIshida%26aufirst%3DT.%26aulast%3DNoji%26aufirst%3DS.%26aulast%3DYata%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DI.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DH.%26atitle%3DBenzimidazole%2520derivatives%2520bearing%2520substituted%2520biphenyls%2520as%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA-dependent%2520RNA%2520polymerase%2520inhibitors%253A%2520structure%25E2%2588%2592activity%2520relationship%2520studies%2520and%2520identification%2520of%2520a%2520potent%2520and%2520highly%2520selective%2520inhibitor%2520JTK-109%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4721%26epage%3D4736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartholomew, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biroccio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccacci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gennari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisbocci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Incitti, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsatti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stansfield, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span> </span><span class="NLM_article-title">Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">13225</span><span class="NLM_x">–</span> <span class="NLM_lpage">13231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1128%2FJVI.77.24.13225-13231.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=14645579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslSmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2003&pages=13225-13231&author=L.+Tomeiauthor=S.+Altamuraauthor=L.+Bartholomewauthor=A.+Biroccioauthor=A.+Ceccacciauthor=L.+Paciniauthor=F.+Narjesauthor=N.+Gennariauthor=M.+Bisbocciauthor=I.+Incittiauthor=L.+Orsattiauthor=S.+Harperauthor=I.+Stansfieldauthor=M.+Rowleyauthor=R.+De+Francescoauthor=G.+Migliaccio&title=Mechanism+of+action+and+antiviral+activity+of+benzimidazole-based+allosteric+inhibitors+of+the+hepatitis+C+virus+RNA-dependent+RNA+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase</span></div><div class="casAuthors">Tomei, Licia; Altamura, Sergio; Bartholomew, Linda; Biroccio, Antonino; Ceccacci, Alessandra; Pacini, Laura; Narjes, Frank; Gennari, Nadia; Bisbocci, Monica; Incitti, Ilario; Orsatti, Laura; Harper, Steven; Stansfield, Ian; Rowley, Michael; De Francesco, Raffaele; Migliaccio, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">13225-13231</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The RNA-dependent RNA polymerase of hepatitis C virus (HCV) is the catalytic subunit of the viral RNA amplification machinery and is an appealing target for the development of new therapeutic agents against HCV infection.  Nonnucleoside inhibitors based on a benzimidazole scaffold have been recently reported.  Compds. of this class are efficient inhibitors of HCV RNA replication in cell culture, thus providing attractive candidates for further development.  Here we report the detailed anal. of the mechanism of action of selected benzimidazole inhibitors.  Kinetic data and binding expts. indicated that these compds. act as allosteric inhibitors that block the activity of the polymerase prior to the elongation step.  Escape mutations that confer resistance to these compds. map to proline 495, a residue located on the surface of the polymerase thumb domain and away from the active site.  Substitution of this residue is sufficient to make the HCV enzyme and replicons resistant to the inhibitors.  Interestingly, proline 495 lies in a recently identified noncatalytic GTP-binding site, thus validating it as a potential allosteric site that can be targeted by small-mol. inhibitors of HCV polymerase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLeqFmAyaoXrVg90H21EOLACvtfcHk0ljRR_-0cSVEgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslSmsrY%253D&md5=05154e4c748a15ecdb96bc5fa2a4f6cb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1128%2FJVI.77.24.13225-13231.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.77.24.13225-13231.2003%26sid%3Dliteratum%253Aachs%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DBartholomew%26aufirst%3DL.%26aulast%3DBiroccio%26aufirst%3DA.%26aulast%3DCeccacci%26aufirst%3DA.%26aulast%3DPacini%26aufirst%3DL.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DGennari%26aufirst%3DN.%26aulast%3DBisbocci%26aufirst%3DM.%26aulast%3DIncitti%26aufirst%3DI.%26aulast%3DOrsatti%26aufirst%3DL.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DStansfield%26aufirst%3DI.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMigliaccio%26aufirst%3DG.%26atitle%3DMechanism%2520of%2520action%2520and%2520antiviral%2520activity%2520of%2520benzimidazole-based%2520allosteric%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520RNA-dependent%2520RNA%2520polymerase%26jtitle%3DJ.%2520Virol.%26date%3D2003%26volume%3D77%26spage%3D13225%26epage%3D13231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Di Marco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carfi, A.</span><span> </span><span class="NLM_article-title">Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">29765</span><span class="NLM_x">–</span> <span class="NLM_lpage">29770</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1074%2Fjbc.M505423200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=15955819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD2MXns1Sltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=29765-29770&author=S.+Di+Marcoauthor=C.+Volpariauthor=L.+Tomeiauthor=S.+Altamuraauthor=S.+Harperauthor=F.+Narjesauthor=U.+Kochauthor=M.+Rowleyauthor=R.+De+Francescoauthor=G.+Migliaccioauthor=A.+Carfi&title=Interdomain+communication+in+hepatitis+C+virus+polymerase+abolished+by+small+molecule+inhibitors+bound+to+a+novel+allosteric+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small Molecule Inhibitors Bound to a Novel Allosteric Site</span></div><div class="casAuthors">Di Marco, Stefania; Volpari, Cinzia; Tomei, Licia; Altamura, Sergio; Harper, Steven; Narjes, Frank; Koch, Uwe; Rowley, Michael; De Francesco, Raffaele; Migliaccio, Giovanni; Carfi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">29765-29770</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase is required for replication of the viral genome and is a key target for therapeutic intervention against HCV.  We have detd. the crystal structures of the HCV polymerase complexed with two indole-based allosteric inhibitors at 2.3- and 2.4-Å resoln.  The structures show that these inhibitors bind to a site on the surface of the thumb domain.  A cyclohexyl and Ph ring substituents, bridged by an indole moiety, fill two closely spaced pockets, whereas a carboxylate substituent forms a salt bridge with an exposed arginine side chain.  Interestingly, in the apoenzyme, the inhibitor binding site is occupied by a small α-helix at the tip of the N-terminal loop that connects the fingers and thumb domains.  Thus, these mols. inhibit the enzyme by preventing formation of intramol. contacts between these two domains and consequently precluding their coordinated movements during RNA synthesis.  Our structures identify a novel mechanism by which a new class of allosteric inhibitors inhibits the HCV polymerase and open the way to the development of novel antiviral agents against this clin. relevant human pathogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWHS1-2Y1C8LVg90H21EOLACvtfcHk0lhnNvMejMGIeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXns1Sltr0%253D&md5=1192532b3624ec0032d9dff24c19a704</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M505423200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M505423200%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMarco%26aufirst%3DS.%26aulast%3DVolpari%26aufirst%3DC.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DCarfi%26aufirst%3DA.%26atitle%3DInterdomain%2520communication%2520in%2520hepatitis%2520C%2520virus%2520polymerase%2520abolished%2520by%2520small%2520molecule%2520inhibitors%2520bound%2520to%2520a%2520novel%2520allosteric%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D29765%26epage%3D29770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGibbon, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thauvette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">39260</span><span class="NLM_x">–</span> <span class="NLM_lpage">39267</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=39260-39267&author=G.+Kukoljauthor=G.+A.+McGibbonauthor=G.+McKercherauthor=M.+Marquisauthor=S.+Lefebvreauthor=L.+Thauvetteauthor=J.+Gauthierauthor=S.+Gouletauthor=M.-A.+Poupartauthor=P.+L.+Beaulieu&title=Binding+site+characterization+and+resistance+to+a+class+of+non-nucleoside+inhibitors+of+the+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DMcGibbon%26aufirst%3DG.%2BA.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DMarquis%26aufirst%3DM.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DThauvette%26aufirst%3DL.%26aulast%3DGauthier%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DBinding%2520site%2520characterization%2520and%2520resistance%2520to%2520a%2520class%2520of%2520non-nucleoside%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D39260%26epage%3D39267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avolio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Filippo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paonessa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carfi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padron, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-<i>N</i>-acetamide allosteric inhibitors of the viral NS5B polymerase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4547</span><span class="NLM_x">–</span> <span class="NLM_lpage">4557</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050056%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4547-4557&author=S.+Harperauthor=S.+Avolioauthor=B.+Paciniauthor=M.+Di+Filippoauthor=S.+Altamuraauthor=L.+Tomeiauthor=G.+Paonessaauthor=S.+Di+Marcoauthor=A.+Carfiauthor=C.+Giulianoauthor=J.+Padronauthor=F.+Bonelliauthor=G.+Migliaccioauthor=R.+De+Francescoauthor=R.+Lauferauthor=M.+Rowleyauthor=F.+Narjes&title=Potent+inhibitors+of+subgenomic+hepatitis+C+virus+RNA+replication+through+optimization+of+indole-N-acetamide+allosteric+inhibitors+of+the+viral+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm050056%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050056%252B%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DAvolio%26aufirst%3DS.%26aulast%3DPacini%26aufirst%3DB.%26aulast%3DDi%2BFilippo%26aufirst%3DM.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DPaonessa%26aufirst%3DG.%26aulast%3DDi%2BMarco%26aufirst%3DS.%26aulast%3DCarfi%26aufirst%3DA.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DPadron%26aufirst%3DJ.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DPotent%2520inhibitors%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNA%2520replication%2520through%2520optimization%2520of%2520indole-N-acetamide%2520allosteric%2520inhibitors%2520of%2520the%2520viral%2520NS5B%2520polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4547%26epage%3D4557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Stansfield, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercolani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conte, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=627-632&author=I.+Stansfieldauthor=C.+Ercolaniauthor=A.+Mackayauthor=I.+Conteauthor=M.+Pompeiauthor=U.+Kochauthor=C.+Giulianoauthor=M.+Rowleyauthor=F.+Narjes&title=Tetracyclic+indole+inhibitors+of+hepatitis+C+virus+NS5B-polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStansfield%26aufirst%3DI.%26aulast%3DErcolani%26aufirst%3DC.%26aulast%3DMackay%26aufirst%3DA.%26aulast%3DConte%26aufirst%3DI.%26aulast%3DPompei%26aufirst%3DM.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DTetracyclic%2520indole%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS5B-polymerase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D627%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ikegashira, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirashima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noji, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruha, J.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, H.</span><span> </span><span class="NLM_article-title">Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6950</span><span class="NLM_x">–</span> <span class="NLM_lpage">6953</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0610245" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKrs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6950-6953&author=K.+Ikegashiraauthor=T.+Okaauthor=S.+Hirashimaauthor=S.+Nojiauthor=H.+Yamanakaauthor=Y.+Haraauthor=T.+Adachiauthor=J.-I.+Tsuruhaauthor=S.+Doiauthor=Y.+Haseauthor=T.+Noguchiauthor=I.+Andoauthor=N.+Oguraauthor=S.+Ikedaauthor=H.+Hashimoto&title=Discovery+of+conformationally+constrained+tetracyclic+compounds+as+potent+hepatitis+C+virus+NS5B+RNA+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors</span></div><div class="casAuthors">Ikegashira, Kazutaka; Oka, Takahiro; Hirashima, Shintaro; Noji, Satoru; Yamanaka, Hiroshi; Hara, Yoshinori; Adachi, Tsuyoshi; Tsuruha, Jun-Ichiro; Doi, Satoki; Hase, Yasunori; Noguchi, Toru; Ando, Izuru; Ogura, Naoki; Ikeda, Satoru; Hashimoto, Hiromasa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6950-6953</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report a new series of hepatitis C virus NS5B RNA polymerase inhibitors contg. a conformationally constrained tetracyclic scaffold.  SAR studies led to the identification of 6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indoles (I and II) bearing a basic pendent group with high biochem. and cellular potencies.  These compds. displayed a very small shift in cellular potency when the replicon assay was performed in the presence of human serum albumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF0S142h4FZLVg90H21EOLACvtfcHk0lhnNvMejMGIeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKrs7rF&md5=18234c5535779cf60484899c6e63770f</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fjm0610245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0610245%26sid%3Dliteratum%253Aachs%26aulast%3DIkegashira%26aufirst%3DK.%26aulast%3DOka%26aufirst%3DT.%26aulast%3DHirashima%26aufirst%3DS.%26aulast%3DNoji%26aufirst%3DS.%26aulast%3DYamanaka%26aufirst%3DH.%26aulast%3DHara%26aufirst%3DY.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DTsuruha%26aufirst%3DJ.-I.%26aulast%3DDoi%26aufirst%3DS.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DNoguchi%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DI.%26aulast%3DOgura%26aufirst%3DN.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520conformationally%2520constrained%2520tetracyclic%2520compounds%2520as%2520potent%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA%2520polymerase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6950%26epage%3D6953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">Similar results were reported by Japan Tobacca (ref <a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">26a</a>).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Similar+results+were+reported+by+Japan+Tobacca+%28ref+26a%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padron Velazquez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Paz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcucci, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span> </span><span class="NLM_article-title">Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase</span> <span class="citation_source-journal">Xenobiotics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1054</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1080%2F00498250500356548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=16393860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlGhurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=1035-1054&author=C.+Giulianoauthor=F.+Fioreauthor=A.+Di+Marcoauthor=J.+Padron+Velazquezauthor=A.+Bishopauthor=F.+Bonelliauthor=O.+Gonzalez-Pazauthor=I.+Marcucciauthor=S.+Harperauthor=F.+Narjesauthor=B.+Paciniauthor=E.+Monteagudoauthor=G.+Migliaccioauthor=M.+Rowleyauthor=R.+Laufer&title=Preclinical+pharmacokinetics+and+metabolism+of+a+potent+non-nucleoside+inhibitor+of+the+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase</span></div><div class="casAuthors">Giuliano, C.; Fiore, F.; Di Marco, A.; Padron Velazquez, J.; Bishop, A.; Bonelli, F.; Gonzalez-paz, O.; Marcucci, I.; Harper, S.; Narjes, F.; Pacini, B.; Monteagudo, E.; Migliaccio, G.; Rowley, M.; Laufer, R.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10/11</span>),
    <span class="NLM_cas:pages">1035-1054</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The disposition of compd. A, a potent inhibitor of the hepatitis C virus (HCV) NS5B polymerase, was characterized in animals in support of its selection for further development.  Compd. A exhibited marked species differences in pharmacokinetics.  Plasma clearance was 44 mL min-1 kg-1 in rats, 9 mL min-1 kg-1 in dogs and 16 mL min-1 kg-1 in rhesus monkeys.  Oral bioavailability was low in rats (10%) but significantly higher in dogs (52%) and monkeys (26%).  Compd. A was eliminated primarily by metab. in rats, with biliary excretion accounting for 30% of its clearance.  Metab. was mainly mediated by cyclohexyl hydroxylation, with N-deethylation and acyl glucuronide formation constituting minor metabolic pathways.  Qual., the same metabolites were identified using in vitro systems from all species studied, including humans.  The low oral bioavailability of compd. A in rats was mostly due to poor intestinal absorption.  This conclusion was borne out by the findings that hepatic extn. in the rat was only 30%, i.p. bioavailability was good, and compd. A was poorly absorbed from the rat isolated intestinal loop, with no detectable intestinal metab.  Compd. A was not an inhibitor of major human cytochrome P 450 enzymes, indicating minimal potential for clin. drug-drug interactions.  The metabolic clearance of compd. A in rat, dog and monkey hepatocytes correlated with the systemic clearance obsd. in these species.  Since compd. A was very stable in human hepatocytes, the results suggest that it will be a low clearance drug in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAvzCrg7n-1LVg90H21EOLACvtfcHk0liadSl5xvKgYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlGhurjJ&md5=a8b429d163e1f1f935271e31fdb289e6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F00498250500356548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250500356548%26sid%3Dliteratum%253Aachs%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DDi%2BMarco%26aufirst%3DA.%26aulast%3DPadron%2BVelazquez%26aufirst%3DJ.%26aulast%3DBishop%26aufirst%3DA.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DGonzalez-Paz%26aufirst%3DO.%26aulast%3DMarcucci%26aufirst%3DI.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DPacini%26aufirst%3DB.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DLaufer%26aufirst%3DR.%26atitle%3DPreclinical%2520pharmacokinetics%2520and%2520metabolism%2520of%2520a%2520potent%2520non-nucleoside%2520inhibitor%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DXenobiotics%26date%3D2005%26volume%3D35%26spage%3D1035%26epage%3D1054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ontoria, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin Hernando, J. I</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malancona, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attenni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stansfield, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conte, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercolani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Filippo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Identification of thieno[3,2-<i>b</i>]pyrroles as allosteric inhibitors of hepatitis C virus NS5B polymerase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4026</span><span class="NLM_x">–</span> <span class="NLM_lpage">4030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4026-4030&author=J.+M.+Ontoriaauthor=J.+I+Martin+Hernandoauthor=S.+Malanconaauthor=B.+Attenniauthor=I.+Stansfieldauthor=I.+Conteauthor=C.+Ercolaniauthor=J.+Habermannauthor=S.+Ponziauthor=M.+Di+Filippoauthor=U.+Kochauthor=M.+Rowleyauthor=F.+Narjes&title=Identification+of+thieno%5B3%2C2-b%5Dpyrroles+as+allosteric+inhibitors+of+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOntoria%26aufirst%3DJ.%2BM.%26aulast%3DMartin%2BHernando%26aufirst%3DJ.%2BI%26aulast%3DMalancona%26aufirst%3DS.%26aulast%3DAttenni%26aufirst%3DB.%26aulast%3DStansfield%26aufirst%3DI.%26aulast%3DConte%26aufirst%3DI.%26aulast%3DErcolani%26aufirst%3DC.%26aulast%3DHabermann%26aufirst%3DJ.%26aulast%3DPonzi%26aufirst%3DS.%26aulast%3DDi%2BFilippo%26aufirst%3DM.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DIdentification%2520of%2520thieno%255B3%252C2-b%255Dpyrroles%2520as%2520allosteric%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4026%26epage%3D4030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Martin Hernando, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ontoria, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malancona, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attenni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colarusso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gennari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico Ferreira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Optimization of thienopyrrole-based finger-loop inhibitors of the hepatitis C virus NS5B polymerase</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1695</span><span class="NLM_x">–</span> <span class="NLM_lpage">1713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1695-1713&author=J.+I.+Martin+Hernandoauthor=J.+M.+Ontoriaauthor=S.+Malanconaauthor=B.+Attenniauthor=F.+Fioreauthor=F.+Bonelliauthor=U.+Kochauthor=S.+Di+Marcoauthor=S.+Colarussoauthor=S.+Ponziauthor=N.+Gennariauthor=M.+Rico+Ferreiraauthor=R.+Delauthor=J.+Habermannauthor=M.+Rowleyauthor=F.+Narjes&title=Optimization+of+thienopyrrole-based+finger-loop+inhibitors+of+the+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%2BHernando%26aufirst%3DJ.%2BI.%26aulast%3DOntoria%26aufirst%3DJ.%2BM.%26aulast%3DMalancona%26aufirst%3DS.%26aulast%3DAttenni%26aufirst%3DB.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DDi%2BMarco%26aufirst%3DS.%26aulast%3DColarusso%26aufirst%3DS.%26aulast%3DPonzi%26aufirst%3DS.%26aulast%3DGennari%26aufirst%3DN.%26aulast%3DRico%2BFerreira%26aufirst%3DM.%26aulast%3DDel%26aufirst%3DR.%26aulast%3DHabermann%26aufirst%3DJ.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DOptimization%2520of%2520thienopyrrole-based%2520finger-loop%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1695%26epage%3D1713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Habermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capitò, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico Ferreira, M. d. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Discovery of pentacyclic compounds as potent inhibitors of hepatitis C virus NS5B polymerase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=633-638&author=J.+Habermannauthor=E.+Capit%C3%B2author=M.+d.+R.+Rico+Ferreiraauthor=U.+Kochauthor=F.+Narjes&title=Discovery+of+pentacyclic+compounds+as+potent+inhibitors+of+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHabermann%26aufirst%3DJ.%26aulast%3DCapit%25C3%25B2%26aufirst%3DE.%26aulast%3DRico%2BFerreira%26aufirst%3DM.%2Bd.%2BR.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520pentacyclic%2520compounds%2520as%2520potent%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D633%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ponzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico Ferreira, M. del R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Synthesis of indolo[2,1-<i>a</i>][2]benzazepine and indolo[2,1-<i>a</i>][2]benzazocine</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">1395</span><span class="NLM_x">–</span> <span class="NLM_lpage">1400</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=1395-1400&author=S.+Ponziauthor=J.+Habermannauthor=M.+del+R.+Rico+Ferreiraauthor=F.+Narjes&title=Synthesis+of+indolo%5B2%2C1-a%5D%5B2%5Dbenzazepine+and+indolo%5B2%2C1-a%5D%5B2%5Dbenzazocine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPonzi%26aufirst%3DS.%26aulast%3DHabermann%26aufirst%3DJ.%26aulast%3DRico%2BFerreira%26aufirst%3DM.%2Bdel%2BR.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DSynthesis%2520of%2520indolo%255B2%252C1-a%255D%255B2%255Dbenzazepine%2520and%2520indolo%255B2%252C1-a%255D%255B2%255Dbenzazocine%26jtitle%3DSynlett%26date%3D2009%26spage%3D1395%26epage%3D1400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mercer, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinfret, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Addison, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakey, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kneteman, N. M.</span><span> </span><span class="NLM_article-title">Hepatitis C Virus Replication in Mice with Chimeric Human Livers</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=927-933&author=D.+F.+Mercerauthor=D.+E.+Schillerauthor=J.+F.+Elliottauthor=D.+N.+Douglasauthor=C.+Haoauthor=A.+Rinfretauthor=W.+R.+Addisonauthor=K.+P.+Fischerauthor=T.+A.+Churchillauthor=J.+R.+Lakeyauthor=D.+L.+Tyrrellauthor=N.+M.+Kneteman&title=Hepatitis+C+Virus+Replication+in+Mice+with+Chimeric+Human+Livers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMercer%26aufirst%3DD.%2BF.%26aulast%3DSchiller%26aufirst%3DD.%2BE.%26aulast%3DElliott%26aufirst%3DJ.%2BF.%26aulast%3DDouglas%26aufirst%3DD.%2BN.%26aulast%3DHao%26aufirst%3DC.%26aulast%3DRinfret%26aufirst%3DA.%26aulast%3DAddison%26aufirst%3DW.%2BR.%26aulast%3DFischer%26aufirst%3DK.%2BP.%26aulast%3DChurchill%26aufirst%3DT.%2BA.%26aulast%3DLakey%26aufirst%3DJ.%2BR.%26aulast%3DTyrrell%26aufirst%3DD.%2BL.%26aulast%3DKneteman%26aufirst%3DN.%2BM.%26atitle%3DHepatitis%2520C%2520Virus%2520Replication%2520in%2520Mice%2520with%2520Chimeric%2520Human%2520Livers%26jtitle%3DNature%2520Med.%26date%3D2001%26volume%3D7%26spage%3D927%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Meulemann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux-Roels, G.</span><span> </span><span class="NLM_article-title">The human liver-upa-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2008&pages=231-238&author=P.+Meulemannauthor=G.+Leroux-Roels&title=The+human+liver-upa-SCID+mouse%3A+a+model+for+the+evaluation+of+antiviral+compounds+against+HBV+and+HCV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeulemann%26aufirst%3DP.%26aulast%3DLeroux-Roels%26aufirst%3DG.%26atitle%3DThe%2520human%2520liver-upa-SCID%2520mouse%253A%2520a%2520model%2520for%2520the%2520evaluation%2520of%2520antiviral%2520compounds%2520against%2520HBV%2520and%2520HCV%26jtitle%3DAntiviral%2520Res.%26date%3D2008%26volume%3D80%26spage%3D231%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Klunder, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">Arenesulfonate derivatives of homochiral glycidol: versatile chiral building blocks for organic synthesis</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1304</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00267a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADyaL1MXhtlCqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1989&pages=1295-1304&author=J.+M.+Klunderauthor=T.+Onamiauthor=K.+B.+Sharpless&title=Arenesulfonate+derivatives+of+homochiral+glycidol%3A+versatile+chiral+building+blocks+for+organic+synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Arenesulfonate derivatives of homochiral glycidol:  versatile chiral building blocks for organic synthesis</span></div><div class="casAuthors">Klunder, Janice M.; Onami, Tetsuo; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1295-304</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The prepn. of a series of cryst. arenesulfonate derivs. of enantiomerically enriched glycidol is described.  The enhancement of optical purity by recrystn. was particularly successful for two of these derivs., glycidyl tosylate and glycidyl 3-nitrobenzenesulfonate, which were obtained in 97% ee and 99% ee, resp.  Very high regioselectivity was obsd. in the reactions of these compds. with a variety of nucleophiles, including aryl oxides, Et2AlCN, organometallic reagents, and BH3-NaBH4.  The application of this methodol. to the synthesis of homochiral β-adrenergic blocking agents and homochiral terminal epoxides is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqupfXNm6dqrVg90H21EOLACvtfcHk0lh10aoqKMykhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhtlCqurc%253D&md5=a7b12df2ca30fa1b1b3f5fdead5d08f0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo00267a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00267a014%26sid%3Dliteratum%253Aachs%26aulast%3DKlunder%26aufirst%3DJ.%2BM.%26aulast%3DOnami%26aufirst%3DT.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DArenesulfonate%2520derivatives%2520of%2520homochiral%2520glycidol%253A%2520versatile%2520chiral%2520building%2520blocks%2520for%2520organic%2520synthesis%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1989%26volume%3D54%26spage%3D1295%26epage%3D1304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Soli, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manoso, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeShong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favor, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirschmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  III.</span><span> </span><span class="NLM_article-title">Azide and cyanide displacements via hypervalent silicate intermediates</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">3171</span><span class="NLM_x">–</span> <span class="NLM_lpage">3177</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo982302d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1999&pages=3171-3177&author=E.+D.+Soliauthor=A.+S.+Manosoauthor=M.+C.+Pattersonauthor=P.+DeShongauthor=D.+A.+Favorauthor=R.+Hirschmannauthor=A.+B.+Smith&title=Azide+and+cyanide+displacements+via+hypervalent+silicate+intermediates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjo982302d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo982302d%26sid%3Dliteratum%253Aachs%26aulast%3DSoli%26aufirst%3DE.%2BD.%26aulast%3DManoso%26aufirst%3DA.%2BS.%26aulast%3DPatterson%26aufirst%3DM.%2BC.%26aulast%3DDeShong%26aufirst%3DP.%26aulast%3DFavor%26aufirst%3DD.%2BA.%26aulast%3DHirschmann%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DAzide%2520and%2520cyanide%2520displacements%2520via%2520hypervalent%2520silicate%2520intermediates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1999%26volume%3D64%26spage%3D3171%26epage%3D3177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Nishizono, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, A.</span><span> </span><span class="NLM_article-title">Nucleosides and nucleotides. 159. Synthesis of thietane nucleosides via the Pummerer reaction as a key step</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">7569</span><span class="NLM_x">–</span> <span class="NLM_lpage">7572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=7569-7572&author=N.+Nishizonoauthor=N.+Koikeauthor=Y.+Yamagataauthor=S.+Fujiiauthor=A.+Matsuda&title=Nucleosides+and+nucleotides.+159.+Synthesis+of+thietane+nucleosides+via+the+Pummerer+reaction+as+a+key+step"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNishizono%26aufirst%3DN.%26aulast%3DKoike%26aufirst%3DN.%26aulast%3DYamagata%26aufirst%3DY.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DMatsuda%26aufirst%3DA.%26atitle%3DNucleosides%2520and%2520nucleotides.%2520159.%2520Synthesis%2520of%2520thietane%2520nucleosides%2520via%2520the%2520Pummerer%2520reaction%2520as%2520a%2520key%2520step%26jtitle%3DTetrahedron%2520Lett.%26date%3D1996%26volume%3D37%26spage%3D7569%26epage%3D7572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFemina, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span> </span><span class="NLM_article-title">A Genotype 2b NS5B Polymerase with Novel Substitutions Supports Replication of a Chimeric HCV 1b:2b Replicon Containing a Genotype 1b NS3-5A Background</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=24-30&author=D.+J.+Grahamauthor=M.+Stahlhutauthor=O.+Floresauthor=D.+B.+Olsenauthor=D.+J.+Hazudaauthor=R.+L.+LaFeminaauthor=S.+W.+Ludmerer&title=A+Genotype+2b+NS5B+Polymerase+with+Novel+Substitutions+Supports+Replication+of+a+Chimeric+HCV+1b%3A2b+Replicon+Containing+a+Genotype+1b+NS3-5A+Background"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DFlores%26aufirst%3DO.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DLaFemina%26aufirst%3DR.%2BL.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26atitle%3DA%2520Genotype%25202b%2520NS5B%2520Polymerase%2520with%2520Novel%2520Substitutions%2520Supports%2520Replication%2520of%2520a%2520Chimeric%2520HCV%25201b%253A2b%2520Replicon%2520Containing%2520a%2520Genotype%25201b%2520NS3-5A%2520Background%26jtitle%3DAntiviral%2520Res.%26date%3D2006%26volume%3D69%26spage%3D24%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Herlihy, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumpf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patick, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S. T.</span><span> </span><span class="NLM_article-title">Development of Intergenotypic Replicons to Determine the Broad-Spectrum Antiviral Activities of Hepatitis C Virus Polymerase Inhibitors</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3523</span><span class="NLM_x">–</span> <span class="NLM_lpage">3531</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3523-3531&author=K.+J.+Herlihyauthor=J.+P.+Grahamauthor=R.+Kumpfauthor=A.+K.+Patickauthor=R.+Duggalauthor=S.+T.+Shi&title=Development+of+Intergenotypic+Replicons+to+Determine+the+Broad-Spectrum+Antiviral+Activities+of+Hepatitis+C+Virus+Polymerase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHerlihy%26aufirst%3DK.%2BJ.%26aulast%3DGraham%26aufirst%3DJ.%2BP.%26aulast%3DKumpf%26aufirst%3DR.%26aulast%3DPatick%26aufirst%3DA.%2BK.%26aulast%3DDuggal%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DS.%2BT.%26atitle%3DDevelopment%2520of%2520Intergenotypic%2520Replicons%2520to%2520Determine%2520the%2520Broad-Spectrum%2520Antiviral%2520Activities%2520of%2520Hepatitis%2520C%2520Virus%2520Polymerase%2520Inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3523%26epage%3D3531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Rydberg, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartholomew, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbato, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paonessa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carfi, A.</span><span> </span><span class="NLM_article-title">Structural basis for resistance of the genotype 2b hepatitis C virus NS5B polymerase to site A non-nucleoside Inhibitors</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">390</span><span class="NLM_x">, </span> <span class="NLM_fpage">1048</span><span class="NLM_x">–</span> <span class="NLM_lpage">1059</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2009&pages=1048-1059&author=E.+H.+Rydbergauthor=A.+Cellucciauthor=L.+Bartholomewauthor=M.+Mattuauthor=G.+Barbatoauthor=S.+W.+Ludmererauthor=D.+J.+Grahamauthor=S.+Altamuraauthor=G.+Paonessaauthor=R.+De+Francescoauthor=G.+Migliaccioauthor=A.+Carfi&title=Structural+basis+for+resistance+of+the+genotype+2b+hepatitis+C+virus+NS5B+polymerase+to+site+A+non-nucleoside+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRydberg%26aufirst%3DE.%2BH.%26aulast%3DCellucci%26aufirst%3DA.%26aulast%3DBartholomew%26aufirst%3DL.%26aulast%3DMattu%26aufirst%3DM.%26aulast%3DBarbato%26aufirst%3DG.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DPaonessa%26aufirst%3DG.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DCarfi%26aufirst%3DA.%26atitle%3DStructural%2520basis%2520for%2520resistance%2520of%2520the%2520genotype%25202b%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%2520to%2520site%2520A%2520non-nucleoside%2520Inhibitors%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D390%26spage%3D1048%26epage%3D1059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="note"><p class="first last">The atomic coordinates and structure factors have been deposited with the Protein Data Bank (accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xwy">2xwy</a>). Further information about soaking conditions and structure determination is available in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Figures were generated with PyMOL (DeLano Scientific).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span>MacroModel version 7.0; <span class="NLM_publisher-name">Schrodinger Inc.</span>: <span class="NLM_publisher-loc">Portland OR 97201</span>; <a href="http://www.schrodinger.com/Products/macromodel.html" class="extLink">http://www.schrodinger.com/Products/macromodel.html</a>,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MacroModel+version+7.0%3B+Schrodinger+Inc.%3A+Portland+OR+97201%3B+http%3A%2F%2Fwww.schrodinger.com%2FProducts%2Fmacromodel.html%2C+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMacroModel%2520version%25207.0%26pub%3DSchrodinger%2520Inc%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Meuleman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libbrecht, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Hemptinne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevaert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandekerckhove, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roskams, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux-Roels, G.</span><span> </span><span class="NLM_article-title">Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">856</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=847-856&author=P.+Meulemanauthor=L.+Libbrechtauthor=R.+de+Vosauthor=B.+de+Hemptinneauthor=K.+Gevaertauthor=J.+Vandekerckhoveauthor=T.+Roskamsauthor=G.+Leroux-Roels&title=Morphological+and+biochemical+characterization+of+a+human+liver+in+a+uPA-SCID+mouse+chimera"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeuleman%26aufirst%3DP.%26aulast%3DLibbrecht%26aufirst%3DL.%26aulast%3Dde%2BVos%26aufirst%3DR.%26aulast%3Dde%2BHemptinne%26aufirst%3DB.%26aulast%3DGevaert%26aufirst%3DK.%26aulast%3DVandekerckhove%26aufirst%3DJ.%26aulast%3DRoskams%26aufirst%3DT.%26aulast%3DLeroux-Roels%26aufirst%3DG.%26atitle%3DMorphological%2520and%2520biochemical%2520characterization%2520of%2520a%2520human%2520liver%2520in%2520a%2520uPA-SCID%2520mouse%2520chimera%26jtitle%3DHepatology%26date%3D2005%26volume%3D41%26spage%3D847%26epage%3D856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lindenbach, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meuleman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanwolleghem, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syder, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeating, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanford, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstone, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux-Roels, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">3805</span><span class="NLM_x">–</span> <span class="NLM_lpage">3809</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=3805-3809&author=B.+D.+Lindenbachauthor=P.+Meulemanauthor=A.+Plossauthor=T.+Vanwolleghemauthor=A.+J.+Syderauthor=J.+A.+McKeatingauthor=R.+E.+Lanfordauthor=S.+M.+Feinstoneauthor=M.+E.+Majorauthor=G.+Leroux-Roelsauthor=C.+M.+Rice&title=Cell+culture-grown+hepatitis+C+virus+is+infectious+in+vivo+and+can+be+recultured+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindenbach%26aufirst%3DB.%2BD.%26aulast%3DMeuleman%26aufirst%3DP.%26aulast%3DPloss%26aufirst%3DA.%26aulast%3DVanwolleghem%26aufirst%3DT.%26aulast%3DSyder%26aufirst%3DA.%2BJ.%26aulast%3DMcKeating%26aufirst%3DJ.%2BA.%26aulast%3DLanford%26aufirst%3DR.%2BE.%26aulast%3DFeinstone%26aufirst%3DS.%2BM.%26aulast%3DMajor%26aufirst%3DM.%2BE.%26aulast%3DLeroux-Roels%26aufirst%3DG.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DCell%2520culture-grown%2520hepatitis%2520C%2520virus%2520is%2520infectious%2520in%2520vivo%2520and%2520can%2520be%2520recultured%2520in%2520vitro%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D3805%26epage%3D3809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bukh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meuleman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engle, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstone, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satterfield, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Govindarajan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krawczynski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux-Roels, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, R. H.</span><span> </span><span class="NLM_article-title">Challenge pools of hepatitis C virus genotypes 1−6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">201</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">–</span> <span class="NLM_lpage">1389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1086%2F651579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=20353362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlSmtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=201&publication_year=2010&pages=1381-1389&author=J.+Bukhauthor=P.+Meulemanauthor=R.+Tellierauthor=R.+E.+Engleauthor=S.+M.+Feinstoneauthor=G.+Ederauthor=W.+C.+Satterfieldauthor=S.+Govindarajanauthor=K.+Krawczynskiauthor=R.+H.+Millerauthor=G.+Leroux-Roelsauthor=R.+H.+Purcell&title=Challenge+pools+of+hepatitis+C+virus+genotypes+1%E2%88%926+prototype+strains%3A+replication+fitness+and+pathogenicity+in+chimpanzees+and+human+liver-chimeric+mouse+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40bR"><div class="casContent"><span class="casTitleNuber">40b</span><div class="casTitle"><span class="NLM_cas:atitle">Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models</span></div><div class="casAuthors">Bukh, Jens; Meuleman, Philip; Tellier, Raymond; Engle, Ronald E.; Feinstone, Stephen M.; Eder, Gerald; Satterfield, William C.; Govindarajan, Sugantha; Krawczynski, Krzysztof; Miller, Roger H.; Leroux-Roels, Geert; Purcell, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">201</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1381-1389</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Chimpanzees represent the only animal model for studies of the natural history of hepatitis C virus (HCV).  To generate virus stocks of important HCV variants, we infected chimpanzees with HCV strains of genotypes 1-6 and detd. the infectivity titer of acute-phase plasma pools in addnl. animals.  The courses of first- and second-passage infections were similar, with early appearance of viremia, HCV RNA titers of >104.7 IU/mL, and development of acute hepatitis; the chronicity rate was 56%.  The challenge pools had titers of 103-105 chimpanzee infectious doses/mL.  Human liver-chimeric mice developed high-titer infections after inoculation with the challenge viruses of genotypes 1-6.  Inoculation studies with different doses of the genotype 1b pool suggested that a relatively high virus dose is required to consistently infect chimeric mice.  The challenge pools represent a unique resource for studies of HCV mol. virol. and for studies of pathogenesis, protective immunity, and vaccine efficacy in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgwPI9Ftj_hrVg90H21EOLACvtfcHk0ljmn7utnkTv0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlSmtLw%253D&md5=81236a78a964efe801dd4648a5832d60</span></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1086%2F651579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F651579%26sid%3Dliteratum%253Aachs%26aulast%3DBukh%26aufirst%3DJ.%26aulast%3DMeuleman%26aufirst%3DP.%26aulast%3DTellier%26aufirst%3DR.%26aulast%3DEngle%26aufirst%3DR.%2BE.%26aulast%3DFeinstone%26aufirst%3DS.%2BM.%26aulast%3DEder%26aufirst%3DG.%26aulast%3DSatterfield%26aufirst%3DW.%2BC.%26aulast%3DGovindarajan%26aufirst%3DS.%26aulast%3DKrawczynski%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DR.%2BH.%26aulast%3DLeroux-Roels%26aufirst%3DG.%26aulast%3DPurcell%26aufirst%3DR.%2BH.%26atitle%3DChallenge%2520pools%2520of%2520hepatitis%2520C%2520virus%2520genotypes%25201%25E2%2588%25926%2520prototype%2520strains%253A%2520replication%2520fitness%2520and%2520pathogenicity%2520in%2520chimpanzees%2520and%2520human%2520liver-chimeric%2520mouse%2520models%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2010%26volume%3D201%26spage%3D1381%26epage%3D1389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kneteman, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aukerman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovelsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, Z.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashash, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kline, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D. L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, D. F.</span><span> </span><span class="NLM_article-title">Anti-HCV therapies in chimeric Scid-Alb/Upa mice parallel outcomes in human clinical application</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1346</span><span class="NLM_x">–</span> <span class="NLM_lpage">1353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2006&pages=1346-1353&author=N.+M.+Knetemanauthor=A.+J.+Weinerauthor=J.+O%E2%80%99Connellauthor=M.+Collettauthor=T.+Gaoauthor=L.+Aukermanauthor=R.+Kovelskyauthor=Z.-J.+Niauthor=A.+Hashashauthor=J.+Klineauthor=B.+Hsiauthor=D.+Schillerauthor=D.+Douglasauthor=D.+L.+J.+Tyrrellauthor=D.+F.+Mercer&title=Anti-HCV+therapies+in+chimeric+Scid-Alb%2FUpa+mice+parallel+outcomes+in+human+clinical+application"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKneteman%26aufirst%3DN.%2BM.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DCollett%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DAukerman%26aufirst%3DL.%26aulast%3DKovelsky%26aufirst%3DR.%26aulast%3DNi%26aufirst%3DZ.-J.%26aulast%3DHashash%26aufirst%3DA.%26aulast%3DKline%26aufirst%3DJ.%26aulast%3DHsi%26aufirst%3DB.%26aulast%3DSchiller%26aufirst%3DD.%26aulast%3DDouglas%26aufirst%3DD.%26aulast%3DTyrrell%26aufirst%3DD.%2BL.%2BJ.%26aulast%3DMercer%26aufirst%3DD.%2BF.%26atitle%3DAnti-HCV%2520therapies%2520in%2520chimeric%2520Scid-Alb%252FUpa%2520mice%2520parallel%2520outcomes%2520in%2520human%2520clinical%2520application%26jtitle%3DHepatology%26date%3D2006%26volume%3D43%26spage%3D1346%26epage%3D1353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit41b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vanwolleghem, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meuleman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libbrecht, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roskams, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux-Roels, G.</span><span> </span><span class="NLM_article-title">Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2007&pages=1144-1155&author=T.+Vanwolleghemauthor=P.+Meulemanauthor=L.+Libbrechtauthor=T.+Roskamsauthor=R.+De+Vosauthor=G.+Leroux-Roels&title=Ultra-rapid+cardiotoxicity+of+the+hepatitis+C+virus+protease+inhibitor+BILN+2061+in+the+urokinase-type+plasminogen+activator+mouse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVanwolleghem%26aufirst%3DT.%26aulast%3DMeuleman%26aufirst%3DP.%26aulast%3DLibbrecht%26aufirst%3DL.%26aulast%3DRoskams%26aufirst%3DT.%26aulast%3DDe%2BVos%26aufirst%3DR.%26aulast%3DLeroux-Roels%26aufirst%3DG.%26atitle%3DUltra-rapid%2520cardiotoxicity%2520of%2520the%2520hepatitis%2520C%2520virus%2520protease%2520inhibitor%2520BILN%25202061%2520in%2520the%2520urokinase-type%2520plasminogen%2520activator%2520mouse%26jtitle%3DGastroenterology%26date%3D2007%26volume%3D133%26spage%3D1144%26epage%3D1155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit41c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kneteman, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, A. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevear, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, D. F.; D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immermann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villano, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collett, M.</span><span> </span><span class="NLM_article-title">HCV796: a selective nonstructural protein 5B polymerase inhibitor with potent anti-Hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with Hepatitis C virus</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1002%2Fhep.22717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=19072827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFOnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=745-752&author=N.+M.+Knetemanauthor=A.+Y.+M.+Howeauthor=T.+Gaoauthor=J.+Lewisauthor=D.+Pevearauthor=G.+Lundauthor=D.+Douglasauthor=D.+F.%3B+D.+Mercerauthor=D.+L.+Tyrrellauthor=F.+Immermannauthor=I.+Chaudharyauthor=J.+Spethauthor=S.+A.+Villanoauthor=J.+O%E2%80%99Connellauthor=M.+Collett&title=HCV796%3A+a+selective+nonstructural+protein+5B+polymerase+inhibitor+with+potent+anti-Hepatitis+C+virus+activity+in+vitro%2C+in+mice+with+chimeric+human+livers%2C+and+in+humans+infected+with+Hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41cR"><div class="casContent"><span class="casTitleNuber">41c</span><div class="casTitle"><span class="NLM_cas:atitle">HCCV796: a selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus</span></div><div class="casAuthors">Kneteman, Norman M.; Howe, Anita Y. M.; Gao, Tiejun; Lewis, Jamie; Pevear, Dan; Lund, Gary; Douglas, Donna; Mercer, David F.; Tyrrell, D. Lorne J.; Immermann, Frederick; Chaudhary, Inder; Speth, John; Villano, Stephen A.; O'Connell, John; Collett, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">745-752</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Anti-hepatitis C virus (HCV) drug development has been challenged by a lack of experience with inhibitors inclusive of in vitro, animal model, and clin. study.  This manuscript outlines activity and correlation across such a spectrum of models and into clin. trials with a novel selective nonstructural protein 5B (NS5B) polymerase inhibitor, HCV796.  Enzyme assays yielded median inhibitory concn. (IC50) values of 0.01 to 0.14 μM for genotype 1, with half maximal effective concn. (EC50s) of 5 nM and 9 nM against genotype 1a and 1b replicons.  In the chimeric mouse model, a 2.02 ± 0.55 log redn. in HCV titer was seen with monotherapy, whereas a suboptimal dose of 30 mg/kg three times per day in combination with interferon demonstrated a 2.44 log redn. (P = 0.001 vs. interferon alone) Clin. outcomes in combination with pegylated interferon and ribavirin have revealed additive efficacy in treatment naive patients.  Abnormal liver function test results were obsd. in 8% of HCV-796 patients treated for over 8 wk, resulting in suspension of further trial activity.  Conclusion: The RNA-dependent RNA polymerase inhibitor HCV796 demonstrated potent anti-HCV activity consistently through enzyme inhibition assays, subgenomic replicon, and chimeric mouse studies.  Strong correlations of outcomes in the mouse model were seen with subsequent clin. trials, including a plateau in dose-related antiviral activity and additive impact from combination therapy with interferon.  These outcomes demonstrate the utility of the range of in vitro and in vivo models now available for anti-HCV drug development and support the potential utility of polymerase inhibitors in future combination therapies for HCV treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7ZCtNeI0RLLVg90H21EOLACvtfcHk0lhXRV_xO2484A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFOnu70%253D&md5=0dcebc9c1e93051ad46eae43b352e7cf</span></div><a href="/servlet/linkout?suffix=cit41c&amp;dbid=16384&amp;doi=10.1002%2Fhep.22717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22717%26sid%3Dliteratum%253Aachs%26aulast%3DKneteman%26aufirst%3DN.%2BM.%26aulast%3DHowe%26aufirst%3DA.%2BY.%2BM.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DPevear%26aufirst%3DD.%26aulast%3DLund%26aufirst%3DG.%26aulast%3DDouglas%26aufirst%3DD.%26aulast%3DMercer%26aufirst%3DD.%2BF.%253B%2BD.%26aulast%3DTyrrell%26aufirst%3DD.%2BL.%26aulast%3DImmermann%26aufirst%3DF.%26aulast%3DChaudhary%26aufirst%3DI.%26aulast%3DSpeth%26aufirst%3DJ.%26aulast%3DVillano%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DCollett%26aufirst%3DM.%26atitle%3DHCV796%253A%2520a%2520selective%2520nonstructural%2520protein%25205B%2520polymerase%2520inhibitor%2520with%2520potent%2520anti-Hepatitis%2520C%2520virus%2520activity%2520in%2520vitro%252C%2520in%2520mice%2520with%2520chimeric%2520human%2520livers%252C%2520and%2520in%2520humans%2520infected%2520with%2520Hepatitis%2520C%2520virus%26jtitle%3DHepatology%26date%3D2009%26volume%3D49%26spage%3D745%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit41d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">LaPorte, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draper, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaboury, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussey, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rippin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benetatos, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chunduru, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, A. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collett, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevear, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D. L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kneteman, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, S. M.</span><span> </span><span class="NLM_article-title">The discovery of pyrano[3,4-<i>b</i>]indole-based allosteric inhibitors of HCV NS5B polymerase with in vivo activity</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1508</span><span class="NLM_x">–</span> <span class="NLM_lpage">1515</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1508-1515&author=M.+G.+LaPorteauthor=R.+W.+Jacksonauthor=T.+L.+Draperauthor=J.+A.+Gabouryauthor=K.+Galieauthor=T.+Herbertzauthor=A.+R.+Husseyauthor=S.+R.+Rippinauthor=C.+A.+Benetatosauthor=S.+K.+Chunduruauthor=J.+S.+Christensenauthor=G.+A.+Coburnauthor=C.+J.+Rizzoauthor=G.+Rhodesauthor=J.+O%E2%80%99Connellauthor=A.+Y.+M.+Howeauthor=T.+S.+Mansourauthor=M.+S.+Collettauthor=D.+C.+Pevearauthor=D.+C.+Youngauthor=T.+Gaoauthor=D.+L.+J.+Tyrrellauthor=N.+M.+Knetemanauthor=C.+J.+Burnsauthor=S.+M.+Condon&title=The+discovery+of+pyrano%5B3%2C4-b%5Dindole-based+allosteric+inhibitors+of+HCV+NS5B+polymerase+with+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaPorte%26aufirst%3DM.%2BG.%26aulast%3DJackson%26aufirst%3DR.%2BW.%26aulast%3DDraper%26aufirst%3DT.%2BL.%26aulast%3DGaboury%26aufirst%3DJ.%2BA.%26aulast%3DGalie%26aufirst%3DK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DHussey%26aufirst%3DA.%2BR.%26aulast%3DRippin%26aufirst%3DS.%2BR.%26aulast%3DBenetatos%26aufirst%3DC.%2BA.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DChristensen%26aufirst%3DJ.%2BS.%26aulast%3DCoburn%26aufirst%3DG.%2BA.%26aulast%3DRizzo%26aufirst%3DC.%2BJ.%26aulast%3DRhodes%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DHowe%26aufirst%3DA.%2BY.%2BM.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DCollett%26aufirst%3DM.%2BS.%26aulast%3DPevear%26aufirst%3DD.%2BC.%26aulast%3DYoung%26aufirst%3DD.%2BC.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DTyrrell%26aufirst%3DD.%2BL.%2BJ.%26aulast%3DKneteman%26aufirst%3DN.%2BM.%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26atitle%3DThe%2520discovery%2520of%2520pyrano%255B3%252C4-b%255Dindole-based%2520allosteric%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%2520with%2520in%2520vivo%2520activity%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D1508%26epage%3D1515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit41e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Meuleman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesselgesser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanwolleghem, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desombere, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux-Roels, G.</span><span> </span><span class="NLM_article-title">Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1761</span><span class="NLM_x">–</span> <span class="NLM_lpage">1768</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=1761-1768&author=P.+Meulemanauthor=J.+Hesselgesserauthor=M.+Paulsonauthor=T.+Vanwolleghemauthor=I.+Desombereauthor=H.+Reiserauthor=G.+Leroux-Roels&title=Anti-CD81+antibodies+can+prevent+a+hepatitis+C+virus+infection+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeuleman%26aufirst%3DP.%26aulast%3DHesselgesser%26aufirst%3DJ.%26aulast%3DPaulson%26aufirst%3DM.%26aulast%3DVanwolleghem%26aufirst%3DT.%26aulast%3DDesombere%26aufirst%3DI.%26aulast%3DReiser%26aufirst%3DH.%26aulast%3DLeroux-Roels%26aufirst%3DG.%26atitle%3DAnti-CD81%2520antibodies%2520can%2520prevent%2520a%2520hepatitis%2520C%2520virus%2520infection%2520in%2520vivo%26jtitle%3DHepatology%26date%3D2008%26volume%3D48%26spage%3D1761%26epage%3D1768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Conte, I.; Ercolani, C.; Narjes, F.; Pompei, M.; Rowley, M.; Stansfield, I.</span><span> </span><span class="NLM_article-title">Preparation of tetracyclic indole derivatives as antiviral agents</span>. PCT Int. Appl. WO 2006/046030,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=I.+Conte&author=C.+Ercolani&author=F.+Narjes&author=M.+Pompei&author=M.+Rowley&author=I.+Stansfield&title=Preparation+of+tetracyclic+indole+derivatives+as+antiviral+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DConte%26aufirst%3DI.%26atitle%3DPreparation%2520of%2520tetracyclic%2520indole%2520derivatives%2520as%2520antiviral%2520agents%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">De Francesco, R.; Paonessa, G.; Olsen, D.; Rowley, M.; Crescenzi, B.; Habermann, J.; Narjes, F.; Laufer, R.</span><span> </span><span class="NLM_article-title">Robust antiviral efficacy of a “finger-loop” allosteric inhibitor of the HCV polymerase in HCV infected chimpanzees [abstract 24]</span>. Presented at <span class="NLM_conf-name">Hep DART 2007</span>, <span class="NLM_conf-loc">Lahaina, HI</span>, <span class="NLM_conf-date">December 9−13, 2007</span><span class="NLM_year"></span>; <span class="NLM_year"></span>; <span class="NLM_publisher-loc"></span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=De+Francesco%2C+R.%3B+Paonessa%2C+G.%3B+Olsen%2C+D.%3B+Rowley%2C+M.%3B+Crescenzi%2C+B.%3B+Habermann%2C+J.%3B+Narjes%2C+F.%3B+Laufer%2C+R.+Robust+antiviral+efficacy+of+a+%E2%80%9Cfinger-loop%E2%80%9D+allosteric+inhibitor+of+the+HCV+polymerase+in+HCV+infected+chimpanzees+%5Babstract+24%5D.+Presented+at+Hep+DART+2007%2C+Lahaina%2C+HI%2C+December+9%E2%88%9213%2C+2007%3B+%3B+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26atitle%3DRobust%2520antiviral%2520efficacy%2520of%2520a%2520%25E2%2580%259Cfinger-loop%25E2%2580%259D%2520allosteric%2520inhibitor%2520of%2520the%2520HCV%2520polymerase%2520in%2520HCV%2520infected%2520chimpanzees%2520%255Babstract%252024%255D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit43b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brainard, D. M.; Anderson, M. S.; Petry, A.; Van Dyck, K.; De Lepeleire, I.; Sneddon, K.; Cummings, C. E.; Nachbar, R. B.; Barnard, R. J.; Sun, P.; Panorchan, P.; Sanderson, J. P.; Udezue, E.; Wagner, F.; Iwamoto, M.; Chodakewitz, J.; A.; Wagner, J.</span><span> </span><span class="NLM_article-title">Safety and Antiviral Activity of NS5B Polymerase Inhibitor MK-3281, in Treatment-Naïve Genotype 1A, 1B and 3 HCV-Infected Patients</span>. Presented at the <span class="NLM_conf-name">60th Annual Meeting of the American Association for the Study of Liver Diseasesm</span>, <span class="NLM_conf-loc">Boston, MA</span>, <span class="NLM_conf-date">October 30−November 3, 2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Brainard%2C+D.+M.%3B+Anderson%2C+M.+S.%3B+Petry%2C+A.%3B+Van+Dyck%2C+K.%3B+De+Lepeleire%2C+I.%3B+Sneddon%2C+K.%3B+Cummings%2C+C.+E.%3B+Nachbar%2C+R.+B.%3B+Barnard%2C+R.+J.%3B+Sun%2C+P.%3B+Panorchan%2C+P.%3B+Sanderson%2C+J.+P.%3B+Udezue%2C+E.%3B+Wagner%2C+F.%3B+Iwamoto%2C+M.%3B+Chodakewitz%2C+J.%3B+A.%3B+Wagner%2C+J.+Safety+and+Antiviral+Activity+of+NS5B+Polymerase+Inhibitor+MK-3281%2C+in+Treatment-Na%C3%AFve+Genotype+1A%2C+1B+and+3+HCV-Infected+Patients.+Presented+at+the+60th+Annual+Meeting+of+the+American+Association+for+the+Study+of+Liver+Diseasesm%2C+Boston%2C+MA%2C+October+30%E2%88%92November+3%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBrainard%26aufirst%3DD.%2BM.%26atitle%3DSafety%2520and%2520Antiviral%2520Activity%2520of%2520NS5B%2520Polymerase%2520Inhibitor%2520MK-3281%252C%2520in%2520Treatment-Na%25C3%25AFve%2520Genotype%25201A%252C%25201B%2520and%25203%2520HCV-Infected%2520Patients" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><div class="note"><p class="first last">The enantiomeric excess of alcohol <b>10a</b> (or <b>10b</b>) has not been determined at this stage. A full account of the process development of compound <b>33</b>, which uses this initial sequence but modified reaction conditions, will be available soon.</p></div><span class="NLM_contrib-group">Scott, J. P.; Alam, M.; Bremeyer, N.; Goodyear, A.; Thientu Lam, T.; Wilson, R. D.; Zhou, G.</span><span> </span><span class="NLM_article-title">Mitsunobu Inversion of a Secondary Alcohol with Diphenylphosphoryl Azide. Application to the Enantioselective Multikilogram Synthesis of a HCV Polymerase Inhibitor</span>.  <span class="citation_source-journal">Org. Process Res. Dev.</span><div class="note"><p class="first last">submitted for publication.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+enantiomeric+excess+of+alcohol+10a+%28or+10b%29+has+not+been+determined+at+this+stage.+A+full+account+of+the+process+development+of+compound+33%2C+which+uses+this+initial+sequence+but+modified+reaction+conditions%2C+will+be+available+soon.Scott%2C+J.+P.%3B+Alam%2C+M.%3B+Bremeyer%2C+N.%3B+Goodyear%2C+A.%3B+Thientu+Lam%2C+T.%3B+Wilson%2C+R.+D.%3B+Zhou%2C+G.+Mitsunobu+Inversion+of+a+Secondary+Alcohol+with+Diphenylphosphoryl+Azide.+Application+to+the+Enantioselective+Multikilogram+Synthesis+of+a+HCV+Polymerase+Inhibitor.+Org.+Process+Res.+Dev.submitted+for+publication."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BP.%26atitle%3DMitsunobu%2520Inversion%2520of%2520a%2520Secondary%2520Alcohol%2520with%2520Diphenylphosphoryl%2520Azide.%2520Application%2520to%2520the%2520Enantioselective%2520Multikilogram%2520Synthesis%2520of%2520a%2520HCV%2520Polymerase%2520Inhibitor%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c'],'ref8':['cit8'],'ref9':['cit9a','cit9b','cit9c','cit9d','cit9e'],'ref10':['cit10a','cit10b','cit10c','cit10d','cit10e'],'ref11':['cit11a','cit11b'],'ref12':['cit12a','cit12b','cit12c'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15a','cit15b','cit15c','cit15d'],'ref16':['cit16'],'ref17':['cit17a','cit17b','cit17c','cit17d'],'ref18':['cit18a','cit18b'],'ref19':['cit19a','cit19b','cit19c','cit19d','cit19e'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30a','cit30b'],'ref31':['cit31a','cit31b'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35a','cit35b'],'ref36':['cit36'],'ref37':[],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40a','cit40b'],'ref41':['cit41a','cit41b','cit41c','cit41d','cit41e'],'ref42':['cit42'],'ref43':['cit43a','cit43b'],'ref44':['cit44']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 50 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenxing  Zhang</span>, <span class="hlFld-ContribAuthor ">Hao  Jiang</span>, and <span class="hlFld-ContribAuthor ">Yong  Huang</span>  . </span><span class="cited-content_cbyCitation_article-title">Ruthenium-Catalyzed Redox-Neutral C–H Activation via N–N Cleavage: Synthesis of N-Substituted Indoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2014,</strong> <em>16 </em>
                                    (22)
                                     , 5976-5979. <a href="https://doi.org/10.1021/ol502998n" title="DOI URL">https://doi.org/10.1021/ol502998n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol502998n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol502998n%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRuthenium-Catalyzed%252BRedox-Neutral%252BC%2525E2%252580%252593H%252BActivation%252Bvia%252BN%2525E2%252580%252593N%252BCleavage%25253A%252BSynthesis%252Bof%252BN-Substituted%252BIndoles%26aulast%3DZhang%26aufirst%3DZhenxing%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D12102014%26date%3D07112014%26date%3D21112014%26volume%3D16%26issue%3D22%26spage%3D5976%26epage%3D5979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lars Krogager  Ransborg</span>, <span class="hlFld-ContribAuthor ">Mette  Overgaard</span>, <span class="hlFld-ContribAuthor ">Joanna  Hejmanowska</span>, <span class="hlFld-ContribAuthor ">Sebastian  Barfüsser</span>, <span class="hlFld-ContribAuthor ">Karl Anker  Jørgensen</span>, and <span class="hlFld-ContribAuthor ">Łukasz  Albrecht</span>  . </span><span class="cited-content_cbyCitation_article-title">Asymmetric Formation of Bridged Benzoxazocines through an Organocatalytic Multicomponent Dienamine-Mediated One-Pot Cascade. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2014,</strong> <em>16 </em>
                                    (16)
                                     , 4182-4185. <a href="https://doi.org/10.1021/ol501882x" title="DOI URL">https://doi.org/10.1021/ol501882x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol501882x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol501882x%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAsymmetric%252BFormation%252Bof%252BBridged%252BBenzoxazocines%252Bthrough%252Ban%252BOrganocatalytic%252BMulticomponent%252BDienamine-Mediated%252BOne-Pot%252BCascade%26aulast%3DRansborg%26aufirst%3DLars%2BKrogager%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D30062014%26date%3D01082014%26date%3D15082014%26volume%3D16%26issue%3D16%26spage%3D4182%26epage%3D4185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maxwell D.  Cummings</span>, <span class="hlFld-ContribAuthor ">Tse-I  Lin</span>, <span class="hlFld-ContribAuthor ">Lili  Hu</span>, <span class="hlFld-ContribAuthor ">Abdellah  Tahri</span>, <span class="hlFld-ContribAuthor ">David  McGowan</span>, <span class="hlFld-ContribAuthor ">Katie  Amssoms</span>, <span class="hlFld-ContribAuthor ">Stefaan  Last</span>, <span class="hlFld-ContribAuthor ">Benoit  Devogelaere</span>, <span class="hlFld-ContribAuthor ">Marie-Claude  Rouan</span>, <span class="hlFld-ContribAuthor ">Leen  Vijgen</span>, <span class="hlFld-ContribAuthor ">Jan Martin  Berke</span>, <span class="hlFld-ContribAuthor ">Pascale  Dehertogh</span>, <span class="hlFld-ContribAuthor ">Els  Fransen</span>, <span class="hlFld-ContribAuthor ">Erna  Cleiren</span>, <span class="hlFld-ContribAuthor ">Liesbet  van der Helm</span>, <span class="hlFld-ContribAuthor ">Gregory  Fanning</span>, <span class="hlFld-ContribAuthor ">Origène  Nyanguile</span>, <span class="hlFld-ContribAuthor ">Kenny  Simmen</span>, <span class="hlFld-ContribAuthor ">Pieter  Van Remoortere</span>, <span class="hlFld-ContribAuthor ">Pierre  Raboisson</span>, and <span class="hlFld-ContribAuthor ">Sandrine  Vendeville</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Early Development of TMC647055, a Non-Nucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1880-1892. <a href="https://doi.org/10.1021/jm401396p" title="DOI URL">https://doi.org/10.1021/jm401396p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401396p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401396p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BEarly%252BDevelopment%252Bof%252BTMC647055%25252C%252Ba%252BNon-Nucleoside%252BInhibitor%252Bof%252Bthe%252BHepatitis%252BC%252BVirus%252BNS5B%252BPolymerase%26aulast%3DCummings%26aufirst%3DMaxwell%2BD.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D10092013%26date%3D08112013%26date%3D13032014%26date%3D21102013%26volume%3D57%26issue%3D5%26spage%3D1880%26epage%3D1892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert G.  Gentles</span>, <span class="hlFld-ContribAuthor ">Min  Ding</span>, <span class="hlFld-ContribAuthor ">John A.  Bender</span>, <span class="hlFld-ContribAuthor ">Carl P.  Bergstrom</span>, <span class="hlFld-ContribAuthor ">Katharine  Grant-Young</span>, <span class="hlFld-ContribAuthor ">Piyasena  Hewawasam</span>, <span class="hlFld-ContribAuthor ">Thomas  Hudyma</span>, <span class="hlFld-ContribAuthor ">Scott  Martin</span>, <span class="hlFld-ContribAuthor ">Andrew  Nickel</span>, <span class="hlFld-ContribAuthor ">Alicia  Regueiro-Ren</span>, <span class="hlFld-ContribAuthor ">Yong  Tu</span>, <span class="hlFld-ContribAuthor ">Zhong  Yang</span>, <span class="hlFld-ContribAuthor ">Kap-Sun  Yeung</span>, <span class="hlFld-ContribAuthor ">Xiaofan  Zheng</span>, <span class="hlFld-ContribAuthor ">Sam  Chao</span>, <span class="hlFld-ContribAuthor ">Jung-Hui  Sun</span>, <span class="hlFld-ContribAuthor ">Brett R.  Beno</span>, <span class="hlFld-ContribAuthor ">Daniel M.  Camac</span>, <span class="hlFld-ContribAuthor ">Chong-Hwan  Chang</span>, <span class="hlFld-ContribAuthor ">Mian  Gao</span>, <span class="hlFld-ContribAuthor ">Paul E.  Morin</span>, <span class="hlFld-ContribAuthor ">Steven  Sheriff</span>, <span class="hlFld-ContribAuthor ">Jeff  Tredup</span>, <span class="hlFld-ContribAuthor ">John  Wan</span>, <span class="hlFld-ContribAuthor ">Mark R.  Witmer</span>, <span class="hlFld-ContribAuthor ">Dianlin  Xie</span>, <span class="hlFld-ContribAuthor ">Umesh  Hanumegowda</span>, <span class="hlFld-ContribAuthor ">Jay  Knipe</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Kenneth S.  Santone</span>, <span class="hlFld-ContribAuthor ">Dawn D.  Parker</span>, <span class="hlFld-ContribAuthor ">Xiaoliang  Zhuo</span>, <span class="hlFld-ContribAuthor ">Julie  Lemm</span>, <span class="hlFld-ContribAuthor ">Mengping  Liu</span>, <span class="hlFld-ContribAuthor ">Lenore  Pelosi</span>, <span class="hlFld-ContribAuthor ">Karen  Rigat</span>, <span class="hlFld-ContribAuthor ">Stacey  Voss</span>, <span class="hlFld-ContribAuthor ">Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Ying-Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Richard J.  Colonno</span>, <span class="hlFld-ContribAuthor ">Min  Gao</span>, <span class="hlFld-ContribAuthor ">Susan B.  Roberts</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Alicia  Ng</span>, <span class="hlFld-ContribAuthor ">Nicholas A  Meanwell</span>, and <span class="hlFld-ContribAuthor ">John F.  Kadow</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1855-1879. <a href="https://doi.org/10.1021/jm4016894" title="DOI URL">https://doi.org/10.1021/jm4016894</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4016894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4016894%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BPreclinical%252BCharacterization%252Bof%252Bthe%252BCyclopropylindolobenzazepine%252BBMS-791325%25252C%252BA%252BPotent%252BAllosteric%252BInhibitor%252Bof%252Bthe%252BHepatitis%252BC%252BVirus%252BNS5B%252BPolymerase%26aulast%3DGentles%26aufirst%3DRobert%2BG.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D31102013%26date%3D07012014%26date%3D13032014%26volume%3D57%26issue%3D5%26spage%3D1855%26epage%3D1879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiu-Hua  Xu</span>, <span class="hlFld-ContribAuthor ">Misaki  Taniguchi</span>, <span class="hlFld-ContribAuthor ">Ayaka  Azuma</span>, <span class="hlFld-ContribAuthor ">Guo Kai  Liu</span>, <span class="hlFld-ContribAuthor ">Etsuko  Tokunaga</span>, and <span class="hlFld-ContribAuthor ">Norio  Shibata</span>  . </span><span class="cited-content_cbyCitation_article-title">Remote Anionic Fries Rearrangement of Sulfonates: Regioselective Synthesis of Indole Triflones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2013,</strong> <em>15 </em>
                                    (3)
                                     , 686-689. <a href="https://doi.org/10.1021/ol3035559" title="DOI URL">https://doi.org/10.1021/ol3035559</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol3035559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol3035559%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRemote%252BAnionic%252BFries%252BRearrangement%252Bof%252BSulfonates%25253A%252BRegioselective%252BSynthesis%252Bof%252BIndole%252BTriflones%26aulast%3DXu%26aufirst%3DXiu-Hua%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D28122012%26date%3D23012013%26date%3D01022013%26volume%3D15%26issue%3D3%26spage%3D686%26epage%3D689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony D.  Alorati</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Gibb</span>, <span class="hlFld-ContribAuthor ">Peter R.  Mullens</span>, and <span class="hlFld-ContribAuthor ">Gavin W.  Stewart</span>  . </span><span class="cited-content_cbyCitation_article-title">An Efficient Process for the Large-Scale Synthesis of a 2,3,6-Trisubstituted Indole. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2012,</strong> <em>16 </em>
                                    (12)
                                     , 1947-1952. <a href="https://doi.org/10.1021/op300303p" title="DOI URL">https://doi.org/10.1021/op300303p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op300303p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop300303p%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DAn%252BEfficient%252BProcess%252Bfor%252Bthe%252BLarge-Scale%252BSynthesis%252Bof%252Ba%252B2%25252C3%25252C6-Trisubstituted%252BIndole%26aulast%3DAlorati%26aufirst%3DAnthony%2BD.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D25102012%26date%3D26112012%26date%3D21122012%26date%3D15112012%26volume%3D16%26issue%3D12%26spage%3D1947%26epage%3D1952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierre L.  Beaulieu</span>, <span class="hlFld-ContribAuthor ">Michael  Bös</span>, <span class="hlFld-ContribAuthor ">Michael G.  Cordingley</span>, <span class="hlFld-ContribAuthor ">Catherine  Chabot</span>, <span class="hlFld-ContribAuthor ">Gulrez  Fazal</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">James R.  Gillard</span>, <span class="hlFld-ContribAuthor ">Eric  Jolicoeur</span>, <span class="hlFld-ContribAuthor ">Steven  LaPlante</span>, <span class="hlFld-ContribAuthor ">Ginette  McKercher</span>, <span class="hlFld-ContribAuthor ">Martin  Poirier</span>, <span class="hlFld-ContribAuthor ">Marc-André  Poupart</span>, <span class="hlFld-ContribAuthor ">Youla S.  Tsantrizos</span>, <span class="hlFld-ContribAuthor ">Jianmin  Duan</span>, and <span class="hlFld-ContribAuthor ">George  Kukolj</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (17)
                                     , 7650-7666. <a href="https://doi.org/10.1021/jm3006788" title="DOI URL">https://doi.org/10.1021/jm3006788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3006788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3006788%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthe%252BFirst%252BThumb%252BPocket%252B1%252BNS5B%252BPolymerase%252BInhibitor%252B%252528BILB%252B1941%252529%252Bwith%252BDemonstrated%252BAntiviral%252BActivity%252Bin%252BPatients%252BChronically%252BInfected%252Bwith%252BGenotype%252B1%252BHepatitis%252BC%252BVirus%252B%252528HCV%252529%26aulast%3DBeaulieu%26aufirst%3DPierre%2BL.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D15052012%26date%3D16082012%26date%3D13092012%26date%3D31072012%26volume%3D55%26issue%3D17%26spage%3D7650%26epage%3D7666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nirmal  Das Adhikary</span> and <span class="hlFld-ContribAuthor ">Partha  Chattopadhyay</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of 1,2,3-Triazole-Fused Chiral Medium-Ring Benzo-Heterocycles, Scaffolds Mimicking Benzolactams. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2012,</strong> <em>77 </em>
                                    (12)
                                     , 5399-5405. <a href="https://doi.org/10.1021/jo3004327" title="DOI URL">https://doi.org/10.1021/jo3004327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo3004327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo3004327%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252B1%25252C2%25252C3-Triazole-Fused%252BChiral%252BMedium-Ring%252BBenzo-Heterocycles%25252C%252BScaffolds%252BMimicking%252BBenzolactams%26aulast%3DDas%2BAdhikary%26aufirst%3DNirmal%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D29022012%26date%3D06062012%26date%3D15062012%26date%3D30052012%26volume%3D77%26issue%3D12%26spage%3D5399%26epage%3D5405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael J.  Sofia</span>, <span class="hlFld-ContribAuthor ">Wonsuk  Chang</span>, <span class="hlFld-ContribAuthor ">Phillip A.  Furman</span>, <span class="hlFld-ContribAuthor ">Ralph T.  Mosley</span>, and <span class="hlFld-ContribAuthor ">Bruce S.  Ross</span>  . </span><span class="cited-content_cbyCitation_article-title">Nucleoside, Nucleotide, and Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA-Polymerase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (6)
                                     , 2481-2531. <a href="https://doi.org/10.1021/jm201384j" title="DOI URL">https://doi.org/10.1021/jm201384j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201384j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201384j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNucleoside%25252C%252BNucleotide%25252C%252Band%252BNon-Nucleoside%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%252BNS5B%252BRNA-Dependent%252BRNA-Polymerase%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D13102011%26date%3D23012012%26date%3D22032012%26date%3D16122011%26volume%3D55%26issue%3D6%26spage%3D2481%26epage%3D2531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeremy P.  Scott</span>, <span class="hlFld-ContribAuthor ">Mahbub  Alam</span>, <span class="hlFld-ContribAuthor ">Nadine  Bremeyer</span>, <span class="hlFld-ContribAuthor ">Adrian  Goodyear</span>, <span class="hlFld-ContribAuthor ">Thientu  Lam</span>, <span class="hlFld-ContribAuthor ">Robert D.  Wilson</span>, and <span class="hlFld-ContribAuthor ">George  Zhou</span>  . </span><span class="cited-content_cbyCitation_article-title">Mitsunobu Inversion of a Secondary Alcohol with Diphenylphosphoryl azide. Application to the Enantioselective Multikilogram Synthesis of a HCV Polymerase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2011,</strong> <em>15 </em>
                                    (5)
                                     , 1116-1123. <a href="https://doi.org/10.1021/op200002u" title="DOI URL">https://doi.org/10.1021/op200002u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op200002u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop200002u%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DMitsunobu%252BInversion%252Bof%252Ba%252BSecondary%252BAlcohol%252Bwith%252BDiphenylphosphoryl%252Bazide.%252BApplication%252Bto%252Bthe%252BEnantioselective%252BMultikilogram%252BSynthesis%252Bof%252Ba%252BHCV%252BPolymerase%252BInhibitor%26aulast%3DScott%26aufirst%3DJeremy%2BP.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D04012011%26date%3D02032011%26date%3D16092011%26volume%3D15%26issue%3D5%26spage%3D1116%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Romain  Haudecoeur</span>, <span class="hlFld-ContribAuthor ">Abdelhakim  Ahmed-Belkacem</span>, <span class="hlFld-ContribAuthor ">Wei  Yi</span>, <span class="hlFld-ContribAuthor ">Antoine  Fortuné</span>, <span class="hlFld-ContribAuthor ">Rozenn  Brillet</span>, <span class="hlFld-ContribAuthor ">Catherine  Belle</span>, <span class="hlFld-ContribAuthor ">Edwige  Nicolle</span>, <span class="hlFld-ContribAuthor ">Coralie  Pallier</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Pawlotsky</span>, and <span class="hlFld-ContribAuthor ">Ahcène  Boumendjel</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Naturally Occurring Aurones That Are Potent Allosteric Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (15)
                                     , 5395-5402. <a href="https://doi.org/10.1021/jm200242p" title="DOI URL">https://doi.org/10.1021/jm200242p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200242p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200242p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNaturally%252BOccurring%252BAurones%252BThat%252BAre%252BPotent%252BAllosteric%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%252BRNA-Dependent%252BRNA%252BPolymerase%26aulast%3DHaudecoeur%26aufirst%3DRomain%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D01032011%26date%3D06072011%26date%3D11082011%26date%3D23062011%26volume%3D54%26issue%3D15%26spage%3D5395%26epage%3D5402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James J.  Sahn</span>, <span class="hlFld-ContribAuthor ">Justin Y.  Su</span>, and <span class="hlFld-ContribAuthor ">Stephen F.  Martin</span>  . </span><span class="cited-content_cbyCitation_article-title">Facile and Unified Approach to Skeletally Diverse, Privileged Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2011,</strong> <em>13 </em>
                                    (10)
                                     , 2590-2593. <a href="https://doi.org/10.1021/ol200709h" title="DOI URL">https://doi.org/10.1021/ol200709h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol200709h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol200709h%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DFacile%252Band%252BUnified%252BApproach%252Bto%252BSkeletally%252BDiverse%25252C%252BPrivileged%252BScaffolds%26aulast%3DSahn%26aufirst%3DJames%2BJ.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D16032011%26date%3D22042011%26date%3D20052011%26volume%3D13%26issue%3D10%26spage%3D2590%26epage%3D2593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rahul  Kumar</span>, <span class="hlFld-ContribAuthor ">Sahil  Mishra</span>, <span class="hlFld-ContribAuthor ">Shreya</span>, <span class="hlFld-ContribAuthor ">Sushil K.  Maurya</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the discovery of potent RNA-dependent RNA-polymerase (RdRp) inhibitors targeting viruses. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 306-320. <a href="https://doi.org/10.1039/D0MD00318B" title="DOI URL">https://doi.org/10.1039/D0MD00318B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00318B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00318B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdiscovery%252Bof%252Bpotent%252BRNA-dependent%252BRNA-polymerase%252B%252528RdRp%252529%252Binhibitors%252Btargeting%252Bviruses%26aulast%3DKumar%26aufirst%3DRahul%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D3%26spage%3D306%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Tian</span>, <span class="hlFld-ContribAuthor ">Taotao  Qiang</span>, <span class="hlFld-ContribAuthor ">Chengyuan  Liang</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ren</span>, <span class="hlFld-ContribAuthor ">Minyi  Jia</span>, <span class="hlFld-ContribAuthor ">Jiayun  Zhang</span>, <span class="hlFld-ContribAuthor ">Jingyi  Li</span>, <span class="hlFld-ContribAuthor ">Minge  Wan</span>, <span class="hlFld-ContribAuthor ">Xin  YuWen</span>, <span class="hlFld-ContribAuthor ">Han  Li</span>, <span class="hlFld-ContribAuthor ">Wenqiang  Cao</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113201. <a href="https://doi.org/10.1016/j.ejmech.2021.113201" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113201%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRNA-dependent%252BRNA%252Bpolymerase%252B%252528RdRp%252529%252Binhibitors%25253A%252BThe%252Bcurrent%252Blandscape%252Band%252Brepurposing%252Bfor%252Bthe%252BCOVID-19%252Bpandemic%26aulast%3DTian%26aufirst%3DLei%26date%3D2021%26volume%3D213%26spage%3D113201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manivel  Pitchai</span>, <span class="hlFld-ContribAuthor ">Sankar  Ulaganathan</span>, <span class="hlFld-ContribAuthor ">Suresh Shagathur  Venkateshappa</span>, <span class="hlFld-ContribAuthor ">Arun  Akunuri</span>, <span class="hlFld-ContribAuthor ">Richard  Rampulla</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Anuradha  Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">Concise synthesis of chiral pyrazolo[4,3‐
              f
              ] [1,4]oxazepines and pyrazolo[4,3‐
              f
              ] [1,4]thiazepines bearing pyrazole unit. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2021,</strong> <em>58 </em>
                                    (2)
                                     , 558-568. <a href="https://doi.org/10.1002/jhet.4195" title="DOI URL">https://doi.org/10.1002/jhet.4195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.4195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.4195%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DConcise%252Bsynthesis%252Bof%252Bchiral%252Bpyrazolo%25255B4%25252C3%2525E2%252580%252590%252Bf%252B%25255D%252B%25255B1%25252C4%25255Doxazepines%252Band%252Bpyrazolo%25255B4%25252C3%2525E2%252580%252590%252Bf%252B%25255D%252B%25255B1%25252C4%25255Dthiazepines%252Bbearing%252Bpyrazole%252Bunit%26aulast%3DPitchai%26aufirst%3DManivel%26date%3D2021%26date%3D2020%26volume%3D58%26issue%3D2%26spage%3D558%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krishnan  Balasubramanian</span>. </span><span class="cited-content_cbyCitation_article-title">Computational and Artificial Intelligence Techniques for Drug Discovery and Administration. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-820472-6.00015-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-820472-6.00015-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820472-6.00015-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820472-6.00015-3%26sid%3Dliteratum%253Aachs%26atitle%3DComputational%252Band%252BArtificial%252BIntelligence%252BTechniques%252Bfor%252BDrug%252BDiscovery%252Band%252BAdministration%26aulast%3DBalasubramanian%26aufirst%3DKrishnan%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BBiomedical%252BSciences%26date%3D2021%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rail R.  Gataullin</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Synthesis of Benzo‐Fused Spiro Nitrogen Heterocycles: New Approaches and Modification of Old Strategies. </span><span class="cited-content_cbyCitation_journal-name">Helvetica Chimica Acta</span><span> <strong>2020,</strong> <em>103 </em>
                                    (12)
                                     <a href="https://doi.org/10.1002/hlca.202000137" title="DOI URL">https://doi.org/10.1002/hlca.202000137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hlca.202000137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhlca.202000137%26sid%3Dliteratum%253Aachs%26jtitle%3DHelvetica%2520Chimica%2520Acta%26atitle%3DAdvances%252Bin%252Bthe%252BSynthesis%252Bof%252BBenzo%2525E2%252580%252590Fused%252BSpiro%252BNitrogen%252BHeterocycles%25253A%252BNew%252BApproaches%252Band%252BModification%252Bof%252BOld%252BStrategies%26aulast%3DGataullin%26aufirst%3DRail%2BR.%26date%3D2020%26date%3D2020%26volume%3D103%26issue%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prasanthi  Polamreddy</span>, <span class="hlFld-ContribAuthor ">Vinita  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">Premkumar  Arumugam</span>, <span class="hlFld-ContribAuthor ">Raghu  Bheemanati</span>, <span class="hlFld-ContribAuthor ">Poornima  Esram</span>, <span class="hlFld-ContribAuthor ">Manoj Kumar  Mahto</span>, <span class="hlFld-ContribAuthor ">Puneet  Kacker</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of hit molecules targeting allosteric site of hepatitis C virus NS5B polymerase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (5)
                                     , 1448-1466. <a href="https://doi.org/10.1080/07391102.2019.1608864" title="DOI URL">https://doi.org/10.1080/07391102.2019.1608864</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1608864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1608864%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DDiscovery%252Bof%252Bhit%252Bmolecules%252Btargeting%252Ballosteric%252Bsite%252Bof%252Bhepatitis%252BC%252Bvirus%252BNS5B%252Bpolymerase%26aulast%3DPolamreddy%26aufirst%3DPrasanthi%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D5%26spage%3D1448%26epage%3D1466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatemeh  Madani Qamsari</span>, <span class="hlFld-ContribAuthor ">Shahram  Moradi</span>, <span class="hlFld-ContribAuthor ">Alireza  Foroumadi</span>, <span class="hlFld-ContribAuthor ">Mohammad  Mahdavi</span>, <span class="hlFld-ContribAuthor ">Abolghasem  Moghimi</span>. </span><span class="cited-content_cbyCitation_article-title">Tandem synthesis of benzo[d]naphtho[2,3-g][1,3]oxazocine-8,13(6H,14H)-dione derivatives. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2019,</strong> <em>150 </em>
                                    (2)
                                     , 347-352. <a href="https://doi.org/10.1007/s00706-018-2322-8" title="DOI URL">https://doi.org/10.1007/s00706-018-2322-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-018-2322-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-018-2322-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DTandem%252Bsynthesis%252Bof%252Bbenzo%25255Bd%25255Dnaphtho%25255B2%25252C3-g%25255D%25255B1%25252C3%25255Doxazocine-8%25252C13%2525286H%25252C14H%252529-dione%252Bderivatives%26aulast%3DMadani%2BQamsari%26aufirst%3DFatemeh%26date%3D2019%26date%3D2019%26volume%3D150%26issue%3D2%26spage%3D347%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William J.  Watkins</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of HCV NS5B Non-nucleoside Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 171-191. <a href="https://doi.org/10.1007/7355_2018_35" title="DOI URL">https://doi.org/10.1007/7355_2018_35</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_35&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_35%26sid%3Dliteratum%253Aachs%26atitle%3DEvolution%252Bof%252BHCV%252BNS5B%252BNon-nucleoside%252BInhibitors%26aulast%3DWatkins%26aufirst%3DWilliam%2BJ.%26date%3D2019%26date%3D2019%26spage%3D171%26epage%3D191%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krishnan  Balasubramanian</span>, <span class="hlFld-ContribAuthor ">Vaishali M.  Patil</span>. </span><span class="cited-content_cbyCitation_article-title">Quantum molecular modeling of hepatitis C virus inhibition through non-structural protein 5B polymerase receptor binding of C5-arylidene rhodanines. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2018,</strong> <em>73 </em>, 147-158. <a href="https://doi.org/10.1016/j.compbiolchem.2018.01.008" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2018.01.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2018.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2018.01.008%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DQuantum%252Bmolecular%252Bmodeling%252Bof%252Bhepatitis%252BC%252Bvirus%252Binhibition%252Bthrough%252Bnon-structural%252Bprotein%252B5B%252Bpolymerase%252Breceptor%252Bbinding%252Bof%252BC5-arylidene%252Brhodanines%26aulast%3DBalasubramanian%26aufirst%3DKrishnan%26date%3D2018%26volume%3D73%26spage%3D147%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Navriti  Chadha</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Indoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 285-321. <a href="https://doi.org/10.1016/B978-0-08-102083-8.00008-X" title="DOI URL">https://doi.org/10.1016/B978-0-08-102083-8.00008-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102083-8.00008-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102083-8.00008-X%26sid%3Dliteratum%253Aachs%26atitle%3DIndoles%26aulast%3DChadha%26aufirst%3DNavriti%26date%3D2018%26spage%3D285%26epage%3D321%26pub%3DElsevier%26atitle%3DKey%252BHeterocycle%252BCores%252Bfor%252BDesigning%252BMultitargeting%252BMolecules%26date%3D2018%26volume%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alex  Muthengi</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Gagan  Dhawan</span>, <span class="hlFld-ContribAuthor ">Wensheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Francesca  Corsini</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Sequential (3 + 2) cycloaddition and (5 +
              n
              ) annulation for modular synthesis of dihydrobenzoxazines, tetrahydrobenzoxazepines and tetrahydrobenzoxazocines. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2018,</strong> <em>20 </em>
                                    (13)
                                     , 3134-3139. <a href="https://doi.org/10.1039/C8GC01099D" title="DOI URL">https://doi.org/10.1039/C8GC01099D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8GC01099D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8GC01099D%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DSequential%252B%2525283%252B%25252B%252B2%252529%252Bcycloaddition%252Band%252B%2525285%252B%25252B%252Bn%252B%252529%252Bannulation%252Bfor%252Bmodular%252Bsynthesis%252Bof%252Bdihydrobenzoxazines%25252C%252Btetrahydrobenzoxazepines%252Band%252Btetrahydrobenzoxazocines%26aulast%3DMuthengi%26aufirst%3DAlex%26date%3D2018%26date%3D2018%26volume%3D20%26issue%3D13%26spage%3D3134%26epage%3D3139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Navriti  Chadha</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>134 </em>, 159-184. <a href="https://doi.org/10.1016/j.ejmech.2017.04.003" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.04.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.04.003%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIndoles%252Bas%252Btherapeutics%252Bof%252Binterest%252Bin%252Bmedicinal%252Bchemistry%25253A%252BBird%252527s%252Beye%252Bview%26aulast%3DChadha%26aufirst%3DNavriti%26date%3D2017%26volume%3D134%26spage%3D159%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Terry  Tomakinian</span>, <span class="hlFld-ContribAuthor ">Hussein Abou  Hamdan</span>, <span class="hlFld-ContribAuthor ">Natacha  Denizot</span>, <span class="hlFld-ContribAuthor ">Régis  Guillot</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Baltaze</span>, <span class="hlFld-ContribAuthor ">Cyrille  Kouklovsky</span>, <span class="hlFld-ContribAuthor ">Guillaume  Vincent</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of an NIS-Mediated Oxidative Cyclisation of Phenol-Containing
              N
              -Acyltryptamine Precursors towards Phalarine: Synthesis of 4′,5′-Dihydrospiro[indole-3,6′-[1,3]oxazine]s. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (19)
                                     , 2757-2763. <a href="https://doi.org/10.1002/ejoc.201601563" title="DOI URL">https://doi.org/10.1002/ejoc.201601563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201601563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201601563%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DEvaluation%252Bof%252Ban%252BNIS-Mediated%252BOxidative%252BCyclisation%252Bof%252BPhenol-Containing%252BN%252B-Acyltryptamine%252BPrecursors%252Btowards%252BPhalarine%25253A%252BSynthesis%252Bof%252B4%2525E2%252580%2525B2%25252C5%2525E2%252580%2525B2-Dihydrospiro%25255Bindole-3%25252C6%2525E2%252580%2525B2-%25255B1%25252C3%25255Doxazine%25255Ds%26aulast%3DTomakinian%26aufirst%3DTerry%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D19%26spage%3D2757%26epage%3D2763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 553-627. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12406-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12406-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12406-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12406-0%26sid%3Dliteratum%253Aachs%26atitle%3DDirect-Acting%252BAntiviral%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DMeanwell%26aufirst%3DN.A.%26date%3D2017%26spage%3D553%26epage%3D627%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debasis  Das</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Development of HCV NS5B Polymerase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 189-219. <a href="https://doi.org/10.1016/B978-0-12-809712-0.00008-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-809712-0.00008-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-809712-0.00008-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-809712-0.00008-3%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Band%252BDevelopment%252Bof%252BHCV%252BNS5B%252BPolymerase%252BInhibitors%26aulast%3DDas%26aufirst%3DDebasis%26date%3D2017%26spage%3D189%26epage%3D219%26pub%3DElsevier%26atitle%3DViral%252BProteases%252Band%252BTheir%252BInhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koen  Vercauteren</span>, <span class="hlFld-ContribAuthor ">Ype P.  de Jong</span>, <span class="hlFld-ContribAuthor ">Philip  Meuleman</span>. </span><span class="cited-content_cbyCitation_article-title">Animal models for the study of HCV. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Virology</span><span> <strong>2015,</strong> <em>13 </em>, 67-74. <a href="https://doi.org/10.1016/j.coviro.2015.04.009" title="DOI URL">https://doi.org/10.1016/j.coviro.2015.04.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coviro.2015.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coviro.2015.04.009%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Virology%26atitle%3DAnimal%252Bmodels%252Bfor%252Bthe%252Bstudy%252Bof%252BHCV%26aulast%3DVercauteren%26aufirst%3DKoen%26date%3D2015%26volume%3D13%26spage%3D67%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Milan  Subedi</span>, <span class="hlFld-ContribAuthor ">Jianbo  Chen</span>, <span class="hlFld-ContribAuthor ">Eunsol  Kang</span>, <span class="hlFld-ContribAuthor ">Kyung Im  Kim</span>, <span class="hlFld-ContribAuthor ">Youngjoo  Byun</span>. </span><span class="cited-content_cbyCitation_article-title">Facile Synthesis of 2-(4-Hydroxybiphenyl-3-yl)-1
              H
              -indoles from Anilines and 5′-Bromo-2′-hydroxyacetophenone. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2015,</strong> <em>45 </em>
                                    (14)
                                     , 1704-1709. <a href="https://doi.org/10.1080/00397911.2015.1043390" title="DOI URL">https://doi.org/10.1080/00397911.2015.1043390</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2015.1043390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2015.1043390%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DFacile%252BSynthesis%252Bof%252B2-%2525284-Hydroxybiphenyl-3-yl%252529-1%252BH%252B-indoles%252Bfrom%252BAnilines%252Band%252B5%2525E2%252580%2525B2-Bromo-2%2525E2%252580%2525B2-hydroxyacetophenone%26aulast%3DSubedi%26aufirst%3DMilan%26date%3D2015%26date%3D2015%26volume%3D45%26issue%3D14%26spage%3D1704%26epage%3D1709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabao  Zhao</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xuemei  Jiang</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of HCV NS5B thumb site I inhibitors: Core-refining from benzimidazole to indole scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>94 </em>, 218-228. <a href="https://doi.org/10.1016/j.ejmech.2015.03.012" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.03.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.03.012%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BHCV%252BNS5B%252Bthumb%252Bsite%252BI%252Binhibitors%25253A%252BCore-refining%252Bfrom%252Bbenzimidazole%252Bto%252Bindole%252Bscaffold%26aulast%3DZhao%26aufirst%3DFabao%26date%3D2015%26volume%3D94%26spage%3D218%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pauline  Petiot</span>, <span class="hlFld-ContribAuthor ">Julien  Dansereau</span>, <span class="hlFld-ContribAuthor ">Martin  Hébert</span>, <span class="hlFld-ContribAuthor ">Imene  Khene</span>, <span class="hlFld-ContribAuthor ">Tabinda  Ahmad</span>, <span class="hlFld-ContribAuthor ">Samira  Samaali</span>, <span class="hlFld-ContribAuthor ">Maxime  Leroy</span>, <span class="hlFld-ContribAuthor ">Francis  Pinsonneault</span>, <span class="hlFld-ContribAuthor ">Claude Y.  Legault</span>, <span class="hlFld-ContribAuthor ">Alexandre  Gagnon</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalyzed O-arylation of N-protected 1,2-aminoalcohols using functionalized trivalent organobismuth reagents. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2015,</strong> <em>13 </em>
                                    (5)
                                     , 1322-1327. <a href="https://doi.org/10.1039/C4OB02497D" title="DOI URL">https://doi.org/10.1039/C4OB02497D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB02497D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB02497D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DCopper-catalyzed%252BO-arylation%252Bof%252BN-protected%252B1%25252C2-aminoalcohols%252Busing%252Bfunctionalized%252Btrivalent%252Borganobismuth%252Breagents%26aulast%3DPetiot%26aufirst%3DPauline%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D5%26spage%3D1322%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David A.  Wilfret</span>, <span class="hlFld-ContribAuthor ">Jill  Walker</span>, <span class="hlFld-ContribAuthor ">Christian  Voitenleitner</span>, <span class="hlFld-ContribAuthor ">Sharon  Baptiste-Brown</span>, <span class="hlFld-ContribAuthor ">Mark  Lovern</span>, <span class="hlFld-ContribAuthor ">Joseph  Kim</span>, <span class="hlFld-ContribAuthor ">Kimberly  Adkison</span>, <span class="hlFld-ContribAuthor ">Brad  Shotwell</span>, <span class="hlFld-ContribAuthor ">Amanda  Mathis</span>, <span class="hlFld-ContribAuthor ">Lee  Moss</span>, <span class="hlFld-ContribAuthor ">Daniel  Lee</span>, <span class="hlFld-ContribAuthor ">Lou  Yu</span>, <span class="hlFld-ContribAuthor ">Jianjun  Gan</span>, <span class="hlFld-ContribAuthor ">Andrew  Spaltenstein</span>. </span><span class="cited-content_cbyCitation_article-title">A randomized, double blind, dose escalation, first time in human study to assess the safety, tolerability, pharmacokinetics, and antiviral activity of single doses of GSK2485852 in chronically infected hepatitis C subjects. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology in Drug Development</span><span> <strong>2014,</strong> <em>3 </em>
                                    (6)
                                     , 439-448. <a href="https://doi.org/10.1002/cpdd.142" title="DOI URL">https://doi.org/10.1002/cpdd.142</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpdd.142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpdd.142%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520in%2520Drug%2520Development%26atitle%3DA%252Brandomized%25252C%252Bdouble%252Bblind%25252C%252Bdose%252Bescalation%25252C%252Bfirst%252Btime%252Bin%252Bhuman%252Bstudy%252Bto%252Bassess%252Bthe%252Bsafety%25252C%252Btolerability%25252C%252Bpharmacokinetics%25252C%252Band%252Bantiviral%252Bactivity%252Bof%252Bsingle%252Bdoses%252Bof%252BGSK2485852%252Bin%252Bchronically%252Binfected%252Bhepatitis%252BC%252Bsubjects%26aulast%3DWilfret%26aufirst%3DDavid%2BA.%26date%3D2014%26date%3D2014%26volume%3D3%26issue%3D6%26spage%3D439%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koen  Vercauteren</span>, <span class="hlFld-ContribAuthor ">Ype P.  de Jong</span>, <span class="hlFld-ContribAuthor ">Philip  Meuleman</span>. </span><span class="cited-content_cbyCitation_article-title">HCV animal models and liver disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hepatology</span><span> <strong>2014,</strong> <em>61 </em>
                                    (1)
                                     , S26-S33. <a href="https://doi.org/10.1016/j.jhep.2014.07.013" title="DOI URL">https://doi.org/10.1016/j.jhep.2014.07.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jhep.2014.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jhep.2014.07.013%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hepatology%26atitle%3DHCV%252Banimal%252Bmodels%252Band%252Bliver%252Bdisease%26aulast%3DVercauteren%26aufirst%3DKoen%26date%3D2014%26volume%3D61%26issue%3D1%26spage%3DS26%26epage%3DS33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karen L.  Rigat</span>, <span class="hlFld-ContribAuthor ">Hao  Lu</span>, <span class="hlFld-ContribAuthor ">Ying-Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Argyrides  Argyrou</span>, <span class="hlFld-ContribAuthor ">Caroline  Fanslau</span>, <span class="hlFld-ContribAuthor ">Brett  Beno</span>, <span class="hlFld-ContribAuthor ">Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Jovita  Marcinkeviciene</span>, <span class="hlFld-ContribAuthor ">Min  Ding</span>, <span class="hlFld-ContribAuthor ">Robert G.  Gentles</span>, <span class="hlFld-ContribAuthor ">Min  Gao</span>, <span class="hlFld-ContribAuthor ">Lynn M.  Abell</span>, <span class="hlFld-ContribAuthor ">Susan B.  Roberts</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanism of Inhibition for BMS-791325, a Novel Non-nucleoside Inhibitor of Hepatitis C Virus NS5B Polymerase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2014,</strong> <em>289 </em>
                                    (48)
                                     , 33456-33468. <a href="https://doi.org/10.1074/jbc.M114.613653" title="DOI URL">https://doi.org/10.1074/jbc.M114.613653</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M114.613653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M114.613653%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DMechanism%252Bof%252BInhibition%252Bfor%252BBMS-791325%25252C%252Ba%252BNovel%252BNon-nucleoside%252BInhibitor%252Bof%252BHepatitis%252BC%252BVirus%252BNS5B%252BPolymerase%26aulast%3DRigat%26aufirst%3DKaren%2BL.%26date%3D2014%26volume%3D289%26issue%3D48%26spage%3D33456%26epage%3D33468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Romain  Haudecoeur</span>, <span class="hlFld-ContribAuthor ">Marine  Peuchmaur</span>, <span class="hlFld-ContribAuthor ">Abdelhakim  Ahmed-Belkacem</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Pawlotsky</span>, <span class="hlFld-ContribAuthor ">Ahcène  Boumendjel</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Activity Relationships in the Development of Allosteric Hepatitis C Virus RNA-Dependent RNA Polymerase Inhibitors: Ten Years of Research. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2013,</strong> <em>33 </em>
                                    (5)
                                     , 934-984. <a href="https://doi.org/10.1002/med.21271" title="DOI URL">https://doi.org/10.1002/med.21271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21271%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DStructure-Activity%252BRelationships%252Bin%252Bthe%252BDevelopment%252Bof%252BAllosteric%252BHepatitis%252BC%252BVirus%252BRNA-Dependent%252BRNA%252BPolymerase%252BInhibitors%25253A%252BTen%252BYears%252Bof%252BResearch%26aulast%3DHaudecoeur%26aufirst%3DRomain%26date%3D2013%26date%3D2012%26volume%3D33%26issue%3D5%26spage%3D934%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhargav A.  Patel</span>, <span class="hlFld-ContribAuthor ">Ramalingam  Krishnan</span>, <span class="hlFld-ContribAuthor ">Nikhil  Khadtare</span>, <span class="hlFld-ContribAuthor ">K.R.  Gurukumar</span>, <span class="hlFld-ContribAuthor ">Amartya  Basu</span>, <span class="hlFld-ContribAuthor ">Payal  Arora</span>, <span class="hlFld-ContribAuthor ">Aaditya  Bhatt</span>, <span class="hlFld-ContribAuthor ">Maulik R.  Patel</span>, <span class="hlFld-ContribAuthor ">Dibyendu  Dana</span>, <span class="hlFld-ContribAuthor ">Sanjai  Kumar</span>, <span class="hlFld-ContribAuthor ">Neerja  Kaushik-Basu</span>, <span class="hlFld-ContribAuthor ">Tanaji T.  Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of l- and d-phenylalanine derived rhodanines with novel C5-arylidenes as inhibitors of HCV NS5B polymerase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (11)
                                     , 3262-3271. <a href="https://doi.org/10.1016/j.bmc.2013.03.041" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.03.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.03.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.03.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bl-%252Band%252Bd-phenylalanine%252Bderived%252Brhodanines%252Bwith%252Bnovel%252BC5-arylidenes%252Bas%252Binhibitors%252Bof%252BHCV%252BNS5B%252Bpolymerase%26aulast%3DPatel%26aufirst%3DBhargav%2BA.%26date%3D2013%26volume%3D21%26issue%3D11%26spage%3D3262%26epage%3D3271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel B.  Nichols</span>, <span class="hlFld-ContribAuthor ">Raquel A. C.  Leão</span>, <span class="hlFld-ContribAuthor ">Amartya  Basu</span>, <span class="hlFld-ContribAuthor ">Maksim  Chudayeu</span>, <span class="hlFld-ContribAuthor ">Paula de F.  de Moraes</span>, <span class="hlFld-ContribAuthor ">Tanaji T.  Talele</span>, <span class="hlFld-ContribAuthor ">Paulo R. R.  Costa</span>, <span class="hlFld-ContribAuthor ">Neerja  Kaushik-Basu</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of Coumarin and Neoflavone Derivatives as HCV NS5B Polymerase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2013,</strong> <em>81 </em>
                                    (5)
                                     , 607-614. <a href="https://doi.org/10.1111/cbdd.12105" title="DOI URL">https://doi.org/10.1111/cbdd.12105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12105%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DEvaluation%252Bof%252BCoumarin%252Band%252BNeoflavone%252BDerivatives%252Bas%252BHCV%252BNS5B%252BPolymerase%252BInhibitors%26aulast%3DNichols%26aufirst%3DDaniel%2BB.%26date%3D2013%26date%3D2013%26volume%3D81%26issue%3D5%26spage%3D607%26epage%3D614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Stanley V.  D'Andrea</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Cianci</span>, <span class="hlFld-ContribAuthor ">Ira B.  Dicker</span>, <span class="hlFld-ContribAuthor ">Kap-Sun  Yeung</span>, <span class="hlFld-ContribAuthor ">Makonen  Belema</span>, <span class="hlFld-ContribAuthor ">Mark  Krystal</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 439-515. <a href="https://doi.org/10.1002/9781118354483.ch11" title="DOI URL">https://doi.org/10.1002/9781118354483.ch11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118354483.ch11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118354483.ch11%26sid%3Dliteratum%253Aachs%26atitle%3DAntiviral%252BDrug%252BDiscovery%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2013%26date%3D2013%26spage%3D439%26epage%3D515%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DDrug%252BDiscovery%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2013%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amr H.  Mahmoud</span>, <span class="hlFld-ContribAuthor ">Mohamed S. A.  Elsayed</span>, <span class="hlFld-ContribAuthor ">Mahmoud  ElHefnawi</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based predictive model for some benzimidazole inhibitors of hepatitis C virus NS5B polymerase. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2013,</strong> <em>22 </em>
                                    (4)
                                     , 1866-1883. <a href="https://doi.org/10.1007/s00044-012-0186-8" title="DOI URL">https://doi.org/10.1007/s00044-012-0186-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-012-0186-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-012-0186-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DStructure-based%252Bpredictive%252Bmodel%252Bfor%252Bsome%252Bbenzimidazole%252Binhibitors%252Bof%252Bhepatitis%252BC%252Bvirus%252BNS5B%252Bpolymerase%26aulast%3DMahmoud%26aufirst%3DAmr%2BH.%26date%3D2013%26date%3D2012%26volume%3D22%26issue%3D4%26spage%3D1866%26epage%3D1883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yasir  Waheed</span>, <span class="hlFld-ContribAuthor ">Attya  Bhatti</span>, <span class="hlFld-ContribAuthor ">Muhammad  Ashraf</span>. </span><span class="cited-content_cbyCitation_article-title">RNA dependent RNA polymerase of HCV: A potential target for the development of antiviral drugs. </span><span class="cited-content_cbyCitation_journal-name">Infection, Genetics and Evolution</span><span> <strong>2013,</strong> <em>14 </em>, 247-257. <a href="https://doi.org/10.1016/j.meegid.2012.12.004" title="DOI URL">https://doi.org/10.1016/j.meegid.2012.12.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.meegid.2012.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.meegid.2012.12.004%26sid%3Dliteratum%253Aachs%26jtitle%3DInfection%252C%2520Genetics%2520and%2520Evolution%26atitle%3DRNA%252Bdependent%252BRNA%252Bpolymerase%252Bof%252BHCV%25253A%252BA%252Bpotential%252Btarget%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bantiviral%252Bdrugs%26aulast%3DWaheed%26aufirst%3DYasir%26date%3D2013%26volume%3D14%26spage%3D247%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ş.  Küçükgüzel</span>, <span class="hlFld-ContribAuthor ">İnci  Coşkun</span>, <span class="hlFld-ContribAuthor ">Sevil  Aydın</span>, <span class="hlFld-ContribAuthor ">Göknur  Aktay</span>, <span class="hlFld-ContribAuthor ">Şule  Gürsoy</span>, <span class="hlFld-ContribAuthor ">Özge  Çevik</span>, <span class="hlFld-ContribAuthor ">Özlem  Özakpınar</span>, <span class="hlFld-ContribAuthor ">Derya  Özsavcı</span>, <span class="hlFld-ContribAuthor ">Azize  Şener</span>, <span class="hlFld-ContribAuthor ">Neerja  Kaushik-Basu</span>, <span class="hlFld-ContribAuthor ">Amartya  Basu</span>, <span class="hlFld-ContribAuthor ">Tanaji  Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of Celecoxib Derivatives as Possible Anti-Inflammatory, Analgesic, Antioxidant,  Anticancer and Anti-HCV Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2013,</strong> <em>18 </em>
                                    (3)
                                     , 3595-3614. <a href="https://doi.org/10.3390/molecules18033595" title="DOI URL">https://doi.org/10.3390/molecules18033595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules18033595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules18033595%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252BCelecoxib%252BDerivatives%252Bas%252BPossible%252BAnti-Inflammatory%25252C%252BAnalgesic%25252C%252BAntioxidant%25252C%252BAnticancer%252Band%252BAnti-HCV%252BAgents%26aulast%3DK%25C3%25BC%25C3%25A7%25C3%25BCkg%25C3%25BCzel%26aufirst%3D%25C5%259E.%26date%3D2013%26date%3D2013%26volume%3D18%26issue%3D3%26spage%3D3595%26epage%3D3614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leen  Delang</span>, <span class="hlFld-ContribAuthor ">Johan  Neyts</span>, <span class="hlFld-ContribAuthor ">Inge  Vliegen</span>, <span class="hlFld-ContribAuthor ">Sergio  Abrignani</span>, <span class="hlFld-ContribAuthor ">Petra  Neddermann</span>, <span class="hlFld-ContribAuthor ">Raffaele  De Francesco</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatitis C Virus-Specific Directly Acting Antiviral Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 289-320. <a href="https://doi.org/10.1007/978-3-642-27340-7_12" title="DOI URL">https://doi.org/10.1007/978-3-642-27340-7_12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-642-27340-7_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-642-27340-7_12%26sid%3Dliteratum%253Aachs%26atitle%3DHepatitis%252BC%252BVirus-Specific%252BDirectly%252BActing%252BAntiviral%252BDrugs%26aulast%3DDelang%26aufirst%3DLeen%26date%3D2013%26spage%3D289%26epage%3D320%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DHepatitis%252BC%252BVirus%25253A%252BFrom%252BMolecular%252BVirology%252Bto%252BAntiviral%252BTherapy%26aulast%3DBartenschlager%26aufirst%3DRalf%26date%3D2013%26volume%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandrine  Vendeville</span>, <span class="hlFld-ContribAuthor ">Maxwell D.  Cummings</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Macrocycles in Small-Molecule Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 371-386. <a href="https://doi.org/10.1016/B978-0-12-417150-3.00023-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-417150-3.00023-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-417150-3.00023-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-417150-3.00023-5%26sid%3Dliteratum%253Aachs%26atitle%3DSynthetic%252BMacrocycles%252Bin%252BSmall-Molecule%252BDrug%252BDiscovery%26aulast%3DVendeville%26aufirst%3DSandrine%26date%3D2013%26spage%3D371%26epage%3D386%26pub%3DElsevier%26date%3D2013%26volume%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  McGowan</span>, <span class="hlFld-ContribAuthor ">Sandrine  Vendeville</span>, <span class="hlFld-ContribAuthor ">Tse-I  Lin</span>, <span class="hlFld-ContribAuthor ">Abdellah  Tahri</span>, <span class="hlFld-ContribAuthor ">Lili  Hu</span>, <span class="hlFld-ContribAuthor ">Maxwell D.  Cummings</span>, <span class="hlFld-ContribAuthor ">Katie  Amssoms</span>, <span class="hlFld-ContribAuthor ">Jan Martin  Berke</span>, <span class="hlFld-ContribAuthor ">Maxime  Canard</span>, <span class="hlFld-ContribAuthor ">Erna  Cleiren</span>, <span class="hlFld-ContribAuthor ">Pascale  Dehertogh</span>, <span class="hlFld-ContribAuthor ">Stefaan  Last</span>, <span class="hlFld-ContribAuthor ">Els  Fransen</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Van Der Helm</span>, <span class="hlFld-ContribAuthor ">Iris  Van den Steen</span>, <span class="hlFld-ContribAuthor ">Leen  Vijgen</span>, <span class="hlFld-ContribAuthor ">Marie-Claude  Rouan</span>, <span class="hlFld-ContribAuthor ">Gregory  Fanning</span>, <span class="hlFld-ContribAuthor ">Origène  Nyanguile</span>, <span class="hlFld-ContribAuthor ">Kristof  Van Emelen</span>, <span class="hlFld-ContribAuthor ">Kenneth  Simmen</span>, <span class="hlFld-ContribAuthor ">Pierre  Raboisson</span>. </span><span class="cited-content_cbyCitation_article-title">Finger-loop inhibitors of the HCV NS5b polymerase. Part 1: Discovery and optimization of novel 1,6- and 2,6-macrocyclic indole series. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (13)
                                     , 4431-4436. <a href="https://doi.org/10.1016/j.bmcl.2012.03.097" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.03.097</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.03.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.03.097%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFinger-loop%252Binhibitors%252Bof%252Bthe%252BHCV%252BNS5b%252Bpolymerase.%252BPart%252B1%25253A%252BDiscovery%252Band%252Boptimization%252Bof%252Bnovel%252B1%25252C6-%252Band%252B2%25252C6-macrocyclic%252Bindole%252Bseries%26aulast%3DMcGowan%26aufirst%3DDavid%26date%3D2012%26volume%3D22%26issue%3D13%26spage%3D4431%26epage%3D4436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maxwell D.  Cummings</span>, <span class="hlFld-ContribAuthor ">Tse-I  Lin</span>, <span class="hlFld-ContribAuthor ">Lili  Hu</span>, <span class="hlFld-ContribAuthor ">Abdellah  Tahri</span>, <span class="hlFld-ContribAuthor ">David  McGowan</span>, <span class="hlFld-ContribAuthor ">Katie  Amssoms</span>, <span class="hlFld-ContribAuthor ">Stefaan  Last</span>, <span class="hlFld-ContribAuthor ">Benoit  Devogelaere</span>, <span class="hlFld-ContribAuthor ">Marie-Claude  Rouan</span>, <span class="hlFld-ContribAuthor ">Leen  Vijgen</span>, <span class="hlFld-ContribAuthor ">Jan Martin  Berke</span>, <span class="hlFld-ContribAuthor ">Pascale  Dehertogh</span>, <span class="hlFld-ContribAuthor ">Els  Fransen</span>, <span class="hlFld-ContribAuthor ">Erna  Cleiren</span>, <span class="hlFld-ContribAuthor ">Liesbet  van der Helm</span>, <span class="hlFld-ContribAuthor ">Gregory  Fanning</span>, <span class="hlFld-ContribAuthor ">Kristof  Van Emelen</span>, <span class="hlFld-ContribAuthor ">Origène  Nyanguile</span>, <span class="hlFld-ContribAuthor ">Kenny  Simmen</span>, <span class="hlFld-ContribAuthor ">Pierre  Raboisson</span>, <span class="hlFld-ContribAuthor ">Sandrine  Vendeville</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Macrocyclization Yields Hepatitis C Virus NS5B Inhibitors with Improved Binding Affinities and Pharmacokinetic Properties. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2012,</strong> <em>124 </em>
                                    (19)
                                     , 4715-4718. <a href="https://doi.org/10.1002/ange.201200110" title="DOI URL">https://doi.org/10.1002/ange.201200110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201200110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201200110%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DStructure-Based%252BMacrocyclization%252BYields%252BHepatitis%2525E2%252580%252585C%252BVirus%252BNS5B%252BInhibitors%252Bwith%252BImproved%252BBinding%252BAffinities%252Band%252BPharmacokinetic%252BProperties%26aulast%3DCummings%26aufirst%3DMaxwell%2BD.%26date%3D2012%26date%3D2012%26volume%3D124%26issue%3D19%26spage%3D4715%26epage%3D4718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maxwell D.  Cummings</span>, <span class="hlFld-ContribAuthor ">Tse-I  Lin</span>, <span class="hlFld-ContribAuthor ">Lili  Hu</span>, <span class="hlFld-ContribAuthor ">Abdellah  Tahri</span>, <span class="hlFld-ContribAuthor ">David  McGowan</span>, <span class="hlFld-ContribAuthor ">Katie  Amssoms</span>, <span class="hlFld-ContribAuthor ">Stefaan  Last</span>, <span class="hlFld-ContribAuthor ">Benoit  Devogelaere</span>, <span class="hlFld-ContribAuthor ">Marie-Claude  Rouan</span>, <span class="hlFld-ContribAuthor ">Leen  Vijgen</span>, <span class="hlFld-ContribAuthor ">Jan Martin  Berke</span>, <span class="hlFld-ContribAuthor ">Pascale  Dehertogh</span>, <span class="hlFld-ContribAuthor ">Els  Fransen</span>, <span class="hlFld-ContribAuthor ">Erna  Cleiren</span>, <span class="hlFld-ContribAuthor ">Liesbet  van der Helm</span>, <span class="hlFld-ContribAuthor ">Gregory  Fanning</span>, <span class="hlFld-ContribAuthor ">Kristof  Van Emelen</span>, <span class="hlFld-ContribAuthor ">Origène  Nyanguile</span>, <span class="hlFld-ContribAuthor ">Kenny  Simmen</span>, <span class="hlFld-ContribAuthor ">Pierre  Raboisson</span>, <span class="hlFld-ContribAuthor ">Sandrine  Vendeville</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Macrocyclization Yields Hepatitis C Virus NS5B Inhibitors with Improved Binding Affinities and Pharmacokinetic Properties. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2012,</strong> <em>51 </em>
                                    (19)
                                     , 4637-4640. <a href="https://doi.org/10.1002/anie.201200110" title="DOI URL">https://doi.org/10.1002/anie.201200110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201200110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201200110%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DStructure-Based%252BMacrocyclization%252BYields%252BHepatitis%2525E2%252580%252585C%252BVirus%252BNS5B%252BInhibitors%252Bwith%252BImproved%252BBinding%252BAffinities%252Band%252BPharmacokinetic%252BProperties%26aulast%3DCummings%26aufirst%3DMaxwell%2BD.%26date%3D2012%26date%3D2012%26volume%3D51%26issue%3D19%26spage%3D4637%26epage%3D4640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdelrahman S.  Mayhoub</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatitis C RNA-dependent RNA polymerase inhibitors: A review of structure–activity and resistance relationships; different scaffolds and mutations. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (10)
                                     , 3150-3161. <a href="https://doi.org/10.1016/j.bmc.2012.03.049" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.03.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.03.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DHepatitis%252BC%252BRNA-dependent%252BRNA%252Bpolymerase%252Binhibitors%25253A%252BA%252Breview%252Bof%252Bstructure%2525E2%252580%252593activity%252Band%252Bresistance%252Brelationships%25253B%252Bdifferent%252Bscaffolds%252Band%252Bmutations%26aulast%3DMayhoub%26aufirst%3DAbdelrahman%2BS.%26date%3D2012%26volume%3D20%26issue%3D10%26spage%3D3150%26epage%3D3161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jens  Bukh</span>. </span><span class="cited-content_cbyCitation_article-title">Animal Models for the Study of Hepatitis C Virus Infection and Related Liver Disease. </span><span class="cited-content_cbyCitation_journal-name">Gastroenterology</span><span> <strong>2012,</strong> <em>142 </em>
                                    (6)
                                     , 1279-1287.e3. <a href="https://doi.org/10.1053/j.gastro.2012.02.016" title="DOI URL">https://doi.org/10.1053/j.gastro.2012.02.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1053/j.gastro.2012.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1053%2Fj.gastro.2012.02.016%26sid%3Dliteratum%253Aachs%26jtitle%3DGastroenterology%26atitle%3DAnimal%252BModels%252Bfor%252Bthe%252BStudy%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%252Band%252BRelated%252BLiver%252BDisease%26aulast%3DBukh%26aufirst%3DJens%26date%3D2012%26volume%3D142%26issue%3D6%26spage%3D1279%26epage%3D1287.e3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott W.  Martin</span>, <span class="hlFld-ContribAuthor ">Peter  Glunz</span>, <span class="hlFld-ContribAuthor ">Brett R.  Beno</span>, <span class="hlFld-ContribAuthor ">Carl  Bergstrom</span>, <span class="hlFld-ContribAuthor ">Jeffrey L.  Romine</span>, <span class="hlFld-ContribAuthor ">E.  Scott Priestley</span>, <span class="hlFld-ContribAuthor ">Makenzie  Newman</span>, <span class="hlFld-ContribAuthor ">Min  Gao</span>, <span class="hlFld-ContribAuthor ">Susan  Roberts</span>, <span class="hlFld-ContribAuthor ">Karen  Rigat</span>, <span class="hlFld-ContribAuthor ">Robert  Fridell</span>, <span class="hlFld-ContribAuthor ">Dike  Qiu</span>, <span class="hlFld-ContribAuthor ">Galina  Knobloh</span>, <span class="hlFld-ContribAuthor ">Ying-Kai  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">The Synthesis and evaluation of a novel class of (E)-3-(1-cyclohexyl-1H-pyrazol-3-yl)-2-methylacrylic acid Hepatitis C virus polymerase NS5B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (10)
                                     , 2869-2872. <a href="https://doi.org/10.1016/j.bmcl.2011.03.086" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.03.086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.03.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.03.086%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252BSynthesis%252Band%252Bevaluation%252Bof%252Ba%252Bnovel%252Bclass%252Bof%252B%252528E%252529-3-%2525281-cyclohexyl-1H-pyrazol-3-yl%252529-2-methylacrylic%252Bacid%252BHepatitis%252BC%252Bvirus%252Bpolymerase%252BNS5B%252Binhibitors%26aulast%3DMartin%26aufirst%3DScott%2BW.%26date%3D2011%26volume%3D21%26issue%3D10%26spage%3D2869%26epage%3D2872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Ding</span>, <span class="hlFld-ContribAuthor ">Feng  He</span>, <span class="hlFld-ContribAuthor ">Michael A.  Poss</span>, <span class="hlFld-ContribAuthor ">Karen L.  Rigat</span>, <span class="hlFld-ContribAuthor ">Ying-Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Susan B.  Roberts</span>, <span class="hlFld-ContribAuthor ">Dike  Qiu</span>, <span class="hlFld-ContribAuthor ">Robert A.  Fridell</span>, <span class="hlFld-ContribAuthor ">Min  Gao</span>, <span class="hlFld-ContribAuthor ">Robert G.  Gentles</span>. </span><span class="cited-content_cbyCitation_article-title">The synthesis of novel heteroaryl-fused 7,8,9,10-tetrahydro-6H-azepino[1,2-a]indoles, 4-oxo-2,3-dihydro-1H-[1,4]diazepino[1,7-a]indoles and 1,2,4,5-tetrahydro-[1,4]oxazepino[4,5-a]indoles. Effective inhibitors of HCV NS5B polymerase. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2011,</strong> <em>9 </em>
                                    (19)
                                     , 6654. <a href="https://doi.org/10.1039/c1ob05525a" title="DOI URL">https://doi.org/10.1039/c1ob05525a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c1ob05525a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc1ob05525a%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DThe%252Bsynthesis%252Bof%252Bnovel%252Bheteroaryl-fused%252B7%25252C8%25252C9%25252C10-tetrahydro-6H-azepino%25255B1%25252C2-a%25255Dindoles%25252C%252B4-oxo-2%25252C3-dihydro-1H-%25255B1%25252C4%25255Ddiazepino%25255B1%25252C7-a%25255Dindoles%252Band%252B1%25252C2%25252C4%25252C5-tetrahydro-%25255B1%25252C4%25255Doxazepino%25255B4%25252C5-a%25255Dindoles.%252BEffective%252Binhibitors%252Bof%252BHCV%252BNS5B%252Bpolymerase%26aulast%3DDing%26aufirst%3DMin%26date%3D2011%26volume%3D9%26issue%3D19%26spage%3D6654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (2-hydroxyphenyl)boronic acid, PdCl<sub>2</sub>[P(Ph)<sub>3</sub>]<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane, 110 °C; (b) (<i>S</i>)-glycidyl 3-nitrobenzenesulfonate, CsF, DMF, RT; (c) Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C; (d) (i) (<i>R</i>)-glycidyl 3-nitrobenzenesulfonate, CsF, DMF, RT, (ii) Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C; (e) DMP, DCM (f) <b>12</b>−<b>20</b>: R<sup>1</sup>R<sup>2</sup>NH, NaBH(OAc)<sub>3</sub>, AcOH, 1,2-DCE, rt; <b>21</b>−<b>27</b>: (i) R<sup>1</sup>NH<sub>2</sub>, NaBH(OAc)<sub>3</sub>, AcOH, 1,2-DCE, (ii) R<sup>2</sup>CHO, NaBH(OAc)<sub>3</sub>; (g) KOH, MeOH/THF (1:1), reflux.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NH<sub>4</sub>OAc or MeNH<sub>2</sub>·HCl NaOAc; NaBH<sub>3</sub>CN, MeOH, RT; (b) <b>28</b>: (i) <i>N</i>,<i>N</i>-dimethylglycine, HATU, DIPEA, DCM, RT, (ii) BBr<sub>3</sub>, DCM; <b>29</b>: (i) KOH, 75 °C; (ii) <i>N</i>,<i>N</i>-dimethylglycine, HATU, DIPEA, DCM, RT.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TsCl, pyridine; (b) TMSN<sub>3</sub>, TBAT, THF, 70 °C; (c) H<sub>2</sub>, Pd/C, MeOH; (d) <i>N</i>-Boc-aminoacetaldehyde, HC(OMe)<sub>3</sub>; NaCNBH<sub>3</sub>, HOAc, MeOH; (e) DCM/TFA (1:1); HCHO, NaOAc, NaCNBH<sub>3</sub>, DCM; (f) KOH, dioxane/H<sub>2</sub>O (2:1); (g) separation by SFC.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-chloro-<i>N</i>,<i>N</i>-dimethylethanamine, Bu<sub>4</sub>NBr, toluene/30% NaOH, 60 °C.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, DMF, 70 °C; 5,5-bis(bromomethyl)-2,2-dimethyl-1,3-dioxane, 70 °C, 50%; (b) TsOH·H<sub>2</sub>O, MeOH/THF, RT, 89%; (c) Tf<sub>2</sub>O, MeCN, DIPEA, 0 °C, then <i>i</i>PrNH<sub>2</sub> (<b>38</b>) or H<sub>2</sub>N(CH<sub>2</sub>)<sub>2</sub>NMe<sub>2</sub> (<b>39</b>), 70 °C; (d) KOH, dioxane, 75 °C.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of HCV ΔC<sub>55</sub> NS5B polymerase from genotype 1b in complex with compound <b>33</b><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (2.53 Å resolution, compound is in stick representation in green, with nitrogen in blue and oxygen in red). The lipophilic protein surface is in white and light gray, except for Arg503, shown in stick representation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/medium/jm-2010-013105_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0014.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Antiviral response induced by treatment with compound <b>33</b> of humanized uPA<sup>+/+</sup>-SCID mice (A, B, C) infected with HCV of genotype 1b. LOQ: lower limit of detection of HCV RNA (= 315 IU/mL). Vehicle = PEG400/water 30%/70%.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-1/jm1013105/production/images/large/jm-2010-013105_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1013105&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88748" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88748" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 44 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>Hepatitis C; <span class="NLM_series">Fact Sheet No. 164</span>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_month">October</span><span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>available from <a href="http://www.who.int/mediacentre/factsheets/fs164/en/index.html" class="extLink">http://www.who.int/mediacentre/factsheets/fs164/en/index.html</a>].</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hepatitis+C%3B+Fact+Sheet+No.+164%3B+World+Health+Organization%3A+Geneva%2C+October+2000%3B+available+from+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs164%2Fen%2Findex.html%5D."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatitis%2520C%26pub%3DWorld%2520Health%2520Organization%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cohen, J.</span><span> </span><span class="NLM_article-title">The scientific challenge of Hepatitis C</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=26-30&author=J.+Cohen&title=The+scientific+challenge+of+Hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DJ.%26atitle%3DThe%2520scientific%2520challenge%2520of%2520Hepatitis%2520C%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D26%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lauer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, B. D.</span><span> </span><span class="NLM_article-title">Hepatitis C virus infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">345</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1056%2FNEJM200107053450107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=11439948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A280%3ADC%252BD3MzosFGrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2001&pages=41-52&author=G.+M.+Lauerauthor=B.+D.+Walker&title=Hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C virus infection</span></div><div class="casAuthors">Lauer G M; Walker B D</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-52</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRy0bRRzrSTmLesJRIHUP1ofW6udTcc2eYGiNYcEhuqG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MzosFGrug%253D%253D&md5=668267468c81fe82d22e1679fbe4af41</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1056%2FNEJM200107053450107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200107053450107%26sid%3Dliteratum%253Aachs%26aulast%3DLauer%26aufirst%3DG.%2BM.%26aulast%3DWalker%26aufirst%3DB.%2BD.%26atitle%3DHepatitis%2520C%2520virus%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D345%26spage%3D41%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Brown, R. S.</span><span> </span><span class="NLM_article-title">Hepatitis C and liver transplantation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=973-978&author=R.+S.+Brown&title=Hepatitis+C+and+liver+transplantation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BS.%26atitle%3DHepatitis%2520C%2520and%2520liver%2520transplantation%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D973%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Salmon-Ceron, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewden, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morlat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bévilacqua, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jougla, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Héripret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costagliola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chêne, G.</span><span> </span><span class="NLM_article-title">Liver disease as a major cause of death among HIV infected patients: role of hepatitis B and C virus and alcohol</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1016%2Fj.jhep.2005.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=15973779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktVGmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2005&pages=799-805&author=D.+Salmon-Ceronauthor=C.+Lewdenauthor=P.+Morlatauthor=S.+B%C3%A9vilacquaauthor=E.+Jouglaauthor=F.+Bonnetauthor=L.+H%C3%A9ripretauthor=D.+Costagliolaauthor=T.+Mayauthor=G.+Ch%C3%AAne&title=Liver+disease+as+a+major+cause+of+death+among+HIV+infected+patients%3A+role+of+hepatitis+B+and+C+virus+and+alcohol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol</span></div><div class="casAuthors">Salmon-Ceron, Dominique; Lewden, Charlotte; Morlat, Philippe; Bevilacqua, Sibylle; Jougla, Eric; Bonnet, Fabrice; Heripret, Laurence; Costagliola, Dominique; May, Thierry; Chene, Genevieve</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">799-805</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We analyzed the characteristics of HIV-infected patients who died from liver disease, focusing on hepatitis virus co-infection.  One-hundred and eighty-five French hospital departments involved in HIV/AIDS management prospectively notified all deaths occurring in 2000.  Patients whose hepatitis C (HCV) and hepatitis B (HBV) serostatus was known were classified as being infected by HCV alone, HBV alone (HBsAg pos.), both HCV and HBV, or neither HCV nor HBV.  Among 822 HIV infected patients, 29% were infected by HCV alone, 8% by HBV alone, and 4% by both HCV and HBV.  The most frequent causes of death were liver disease (31% of cases) and AIDS (29%) among HIV-HCV co-infected patients, and AIDS (38%) and liver disease (22%) among HIV-HBV co-infected patients.  Liver disease was a more frequent cause of death among patients co-infected by both HCV and HBV (44% of cases).  Hepatocellular carcinoma was present in 15% of patients who died from liver disease, and was assocd. with HBV co-infection.  Nearly half the patients who died from liver disease had more than 200 CD4/mm3.  Liver disease is now a leading cause of death among HIV-HCV co-infected patients and is becoming an important cause of death among HIV-HBV co-infected patients.  The risk of death from liver disease is highest in patients co-infected by both HCV and HBV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxiRIxXPw237Vg90H21EOLACvtfcHk0lj7LE4-rGnsjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktVGmtrk%253D&md5=dcedbbba9e185f1783e680b6da3fa4ce</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2005.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2005.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DSalmon-Ceron%26aufirst%3DD.%26aulast%3DLewden%26aufirst%3DC.%26aulast%3DMorlat%26aufirst%3DP.%26aulast%3DB%25C3%25A9vilacqua%26aufirst%3DS.%26aulast%3DJougla%26aufirst%3DE.%26aulast%3DBonnet%26aufirst%3DF.%26aulast%3DH%25C3%25A9ripret%26aufirst%3DL.%26aulast%3DCostagliola%26aufirst%3DD.%26aulast%3DMay%26aufirst%3DT.%26aulast%3DCh%25C3%25AAne%26aufirst%3DG.%26atitle%3DLiver%2520disease%2520as%2520a%2520major%2520cause%2520of%2520death%2520among%2520HIV%2520infected%2520patients%253A%2520role%2520of%2520hepatitis%2520B%2520and%2520C%2520virus%2520and%2520alcohol%26jtitle%3DJ.%2520Hepatol.%26date%3D2005%26volume%3D42%26spage%3D799%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Deuffic-Burban, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poynard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J. B.</span><span> </span><span class="NLM_article-title">Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States</span> <span class="citation_source-journal">J. Virol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1111%2Fj.1365-2893.2006.00785.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=17244250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FksFShtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=107-115&author=S.+Deuffic-Burbanauthor=T.+Poynardauthor=M.+S.+Sulkowskiauthor=J.+B.+Wong&title=Estimating+the+future+health+burden+of+chronic+hepatitis+C+and+human+immunodeficiency+virus+infections+in+the+United+States"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States</span></div><div class="casAuthors">Deuffic-Burban S; Poynard T; Sulkowski M S; Wong J B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of viral hepatitis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-15</span>
        ISSN:<span class="NLM_cas:issn">1352-0504</span>.
    </div><div class="casAbstract">The aim of this work was to estimate the future disease burden of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections in the United States until the year 2030.  Two back-calculation models of the HIV and the HCV epidemic were developed.  They were based on US epidemiological data regarding prevalence, age and gender of incident cases, AIDS, hepatocellular carcinoma (HCC) mortality and general population mortality from the Centers for Disease Control and WHO.  Based on the HCV back-calculation model, HCV incidence peaked in 1984 at 350,000 new infections and then fell to about 77,000 in 1998.  Based on the HIV back-calculation model, HIV incidence reached its maximum in 1989 at 142,000 new infections and then declined to 79,000 in 1998.  Mortality related to HCV (death from liver failure or HCC) rose from about 3,700 in 1998 and is expected to peak at about 13,000 in 2030.  Predicted HCV mortality would fall only if increased access to or more effective antiviral therapy occurs.  For comparison, observed HIV-related mortality was 14,400 in 1998 and projected to be 4,200 for 2030.  With the availability of effective highly active antiretroviral therapy for HIV infection, mortality from HIV appears to have declined substantially, whereas HCV-related deaths as a result of pre-1999 infections will likely continue to increase over the next 25 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPlShw69z_4nqj_yg7twvpfW6udTcc2eYBLOHxnnPUIbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FksFShtA%253D%253D&md5=fcc55db23dcfc935b7de5ccebe641df3</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2893.2006.00785.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2893.2006.00785.x%26sid%3Dliteratum%253Aachs%26aulast%3DDeuffic-Burban%26aufirst%3DS.%26aulast%3DPoynard%26aufirst%3DT.%26aulast%3DSulkowski%26aufirst%3DM.%2BS.%26aulast%3DWong%26aufirst%3DJ.%2BB.%26atitle%3DEstimating%2520the%2520future%2520health%2520burden%2520of%2520chronic%2520hepatitis%2520C%2520and%2520human%2520immunodeficiency%2520virus%2520infections%2520in%2520the%2520United%2520States%26jtitle%3DJ.%2520Virol.%2520Hepatol.%26date%3D2007%26volume%3D14%26spage%3D107%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallet, V. O.</span><span> </span><span class="NLM_article-title">Improving Anti-Hepatitis C Virus Therapy</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1517%2F14712598.6.9.923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=16918259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot12isbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=923-933&author=S.+Polauthor=V.+O.+Mallet&title=Improving+Anti-Hepatitis+C+Virus+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Improving anti-hepatitis C virus therapy</span></div><div class="casAuthors">Pol, Stanislas; Mallet, Vincent O.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">923-933</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The estd. prevalence of hepatitis C virus (HCV) infection is 2%, representing 123 million infected individuals worldwide.  HCV infection burdens public health in relation to hepatic (cirrhosis and its complications in 20% of patients) and extrahepatic (vasculitis) complications, and lessens quality of life.  Major progress has been made in the last two decades for the diagnosis and treatment of HCV, including more appropriate screening strategies for HCV infection (improved sensitivity of serol. and virol. tests); a better evaluation of the impact of chronic HCV infection on the liver (semi-quant. scoring systems of necro-inflammation and fibrosis on liver biopsy, non-invasive evaluation of fibrosis with biochem. markers and elastometry); and improved therapeutic regimens.  This progress provides a better definition of who to treat (clin. impact or significant fibrosis); how to treat; tailoring therapies for doses and durations of the pegylated interferon plus ribavirin combination according to virol. (mainly genotype and early viral kinetics, but also baseline viral load) and hosts factors (fibrosis, immune status, wt.); and how to monitor efficacy and tolerance of therapy.  The progress has now resulted in a 50% rate of complete HCV eradication, ranging 45 - 90% according to the genotype and esp. in those patients with early viral response.  New therapies, specifically HCV protease or polymerase inhibitors, in combination with pegylated interferon, or more potent and less toxic new formulations of interferons or ribavirin, will increase these encouraging results in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhZqk5PT8mg7Vg90H21EOLACvtfcHk0ljZURlAy0mqsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot12isbw%253D&md5=f2ccc4c6c2eb131607f6cd3c4f2cde7e</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1517%2F14712598.6.9.923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.6.9.923%26sid%3Dliteratum%253Aachs%26aulast%3DPol%26aufirst%3DS.%26aulast%3DMallet%26aufirst%3DV.%2BO.%26atitle%3DImproving%2520Anti-Hepatitis%2520C%2520Virus%2520Therapy%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2006%26volume%3D6%26spage%3D923%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Houghton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrigani, S.</span><span> </span><span class="NLM_article-title">Prospects for a vaccine against the hepatitis C virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=961-966&author=M.+Houghtonauthor=S.+Abrigani&title=Prospects+for+a+vaccine+against+the+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoughton%26aufirst%3DM.%26aulast%3DAbrigani%26aufirst%3DS.%26atitle%3DProspects%2520for%2520a%2520vaccine%2520against%2520the%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D961%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Heathcote, A. J.</span><span> </span><span class="NLM_article-title">Antiviral therapy: chronic hepatitis C</span> <span class="citation_source-journal">J. Viral Hepatitis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1111%2Fj.1365-2893.2007.00921.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=17958648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A280%3ADC%252BD2snosVKkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=82-88&issue=Suppl.+1&author=A.+J.+Heathcote&title=Antiviral+therapy%3A+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Antiviral therapy: chronic hepatitis C</span></div><div class="casAuthors">Heathcote E Jenny</div><div class="citationInfo"><span class="NLM_cas:title">Journal of viral hepatitis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14 Suppl 1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">82-8</span>
        ISSN:<span class="NLM_cas:issn">1352-0504</span>.
    </div><div class="casAbstract">The combination of pegylated interferon (IFN) with ribavirin is the standard of care for chronic hepatitis C.  Response rates range from 50 to 90% for genotype 1 and 2/3 which also differ in the duration of treatment (48 vs 24 weeks, respectively).  Therapy if given with weight-based dosing may be shortened from 24 to 12, 14 or 16 weeks (genotypes 2 and 3), and from 48 to 24 weeks (genotype 1) in case of hepatitis C virus (HCV) clearance at week 4, without reducing sustained virologic response (SVR).  Conversely, prolonging treatment for 72 weeks in those with only a decrease of viral load at week 4, i.e. "slow responders" increases SVR rates by preventing relapse.  In spite of such progress, over half of patients are relapsers or nonresponders.  If the previous treatment was suboptimal, retreatment with higher doses or longer duration may be beneficial unless an individual was a 'null responder' previously.  New promising anti-HCV molecules (antiproteases and antipolymerases), some with potent antiviral activity, are in phase II trials but appear to require the addition of IFN and ribavirin to maintain viral suppression.  Other immunomodulatory agents such as new IFN or therapeutic vaccines and alternatives to ribavirin are also under development.  Future regimens should improve efficacy and provide shorter and better-tolerated combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRN6ybVoFnOvhKDYG3bNImrfW6udTcc2eaUvRursDiuS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snosVKkuw%253D%253D&md5=2567502b861d090343fda18d3b217a60</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2893.2007.00921.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2893.2007.00921.x%26sid%3Dliteratum%253Aachs%26aulast%3DHeathcote%26aufirst%3DA.%2BJ.%26atitle%3DAntiviral%2520therapy%253A%2520chronic%2520hepatitis%2520C%26jtitle%3DJ.%2520Viral%2520Hepatitis%26date%3D2007%26volume%3D14%26issue%3DSuppl.%25201%26spage%3D82%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hoofnagle, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeff, L. B.</span><span> </span><span class="NLM_article-title">Peginterferon and ribavirin for chronic hepatitis C</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1056%2FNEJMct061675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=17151366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12nt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=2444-2451&author=J.+H.+Hoofnagleauthor=L.+B.+Seeff&title=Peginterferon+and+ribavirin+for+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon and ribavirin for chronic hepatitis C</span></div><div class="casAuthors">Hoofnagle, Jay H.; Seeff, Leonard B.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2444-2451</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  A 44-yr-old woman with chronic hepatitis C has intermittent fatigue and persistent elevations in serum alanine aminotransferase levels.  She has had hepatitis C for 10 years.  The diagnosis was made after she attempted to donate blood and was found to have antibodies against the hepatitis C virus (HCV).  On questioning, she reports having used illicit injection drugs in her early 20s.  The phys. examn. is normal except for obesity.  The results of lab. tests show an alanine aminotransferase level of 86 U per L (normal value, <42); the alk. phosphatase level, direct and total bilirubin levels, albumin level, prothrombin time, and complete blood count are normal.  The serum HCV RNA level is 3.5 million IU per mL (genotype 1), and a liver biopsy specimen shows bridging fibrosis.  The patient is evaluated by a hepatologist, who recommends treatment with pegylated interferon and ribavirin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEoSFaZ9BVhbVg90H21EOLACvtfcHk0ljZURlAy0mqsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12nt7%252FK&md5=fc356db5608b52c75cd96a652f8c2d4a</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1056%2FNEJMct061675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMct061675%26sid%3Dliteratum%253Aachs%26aulast%3DHoofnagle%26aufirst%3DJ.%2BH.%26aulast%3DSeeff%26aufirst%3DL.%2BB.%26atitle%3DPeginterferon%2520and%2520ribavirin%2520for%2520chronic%2520hepatitis%2520C%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D2444%26epage%3D2451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Fried, M. W.</span><span> </span><span class="NLM_article-title">Side effects of therapy of hepatitis C and their management</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">S237</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=S237-244&author=M.+W.+Fried&title=Side+effects+of+therapy+of+hepatitis+C+and+their+management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFried%26aufirst%3DM.%2BW.%26atitle%3DSide%2520effects%2520of%2520therapy%2520of%2520hepatitis%2520C%2520and%2520their%2520management%26jtitle%3DHepatology%26date%3D2002%26volume%3D36%26spage%3DS237%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockstroh, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.; F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoulim, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">The way forward in HCV treatment—finding the right path</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=991-1000&author=M.+P.+Mannsauthor=G.+R.+Fosterauthor=J.+K.+Rockstrohauthor=S.%3B+F.+Zeuzemauthor=F.+Zoulimauthor=M.+Houghton&title=The+way+forward+in+HCV+treatment%E2%80%94finding+the+right+path"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DFoster%26aufirst%3DG.%2BR.%26aulast%3DRockstroh%26aufirst%3DJ.%2BK.%26aulast%3DZeuzem%26aufirst%3DS.%253B%2BF.%26aulast%3DZoulim%26aufirst%3DF.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DThe%2520way%2520forward%2520in%2520HCV%2520treatment%25E2%2580%2594finding%2520the%2520right%2520path%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D991%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="note"><p class="first last">For recent review see:</p></div><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gordon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. A.</span><span> </span><span class="NLM_article-title">Control of hepatitis C: a medicinal chemistry perspective</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0400101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1-20&author=C.+P.+Gordonauthor=P.+A.+Keller&title=Control+of+hepatitis+C%3A+a+medicinal+chemistry+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm0400101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0400101%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DC.%2BP.%26aulast%3DKeller%26aufirst%3DP.%2BA.%26atitle%3DControl%2520of%2520hepatitis%2520C%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span> </span><span class="NLM_article-title">Challenges and successes in developing new therapies for hepatitis C</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">463</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2005&pages=953-959&author=R.+De+Francescoauthor=G.+Migliaccio&title=Challenges+and+successes+in+developing+new+therapies+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMigliaccio%26aufirst%3DG.%26atitle%3DChallenges%2520and%2520successes%2520in%2520developing%2520new%2520therapies%2520for%2520hepatitis%2520C%26jtitle%3DNature%26date%3D2005%26volume%3D463%26spage%3D953%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kronenberger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span> </span><span class="NLM_article-title">Future treatment options for HCV: double, triple, what is the optimal combination?</span> <span class="citation_source-journal">Best Practi. Res. Clin. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1123</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1016%2Fj.bpg.2008.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=19187871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=1123-1136&author=B.+Kronenbergerauthor=S.+Zeuzem&title=Future+treatment+options+for+HCV%3A+double%2C+triple%2C+what+is+the+optimal+combination%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Future treatment options for HCV: Double, triple, what is the optimal combination?</span></div><div class="casAuthors">Kronenberger, Bernd; Zeuzem, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Best Practice & Research, Clinical Gastroenterology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1123-1136</span>CODEN:
                <span class="NLM_cas:coden">BPRCB6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Specifically targeted antiviral therapy against hepatitis virus (STAT-C) stands for a new era in the treatment of patients with chronic hepatitis C.  Results from recent trials with protease and polymerase inhibitors indicate that therapy with a single HCV specific compd. will not be sufficient to eradicate hepatitis C virus infection and that combination therapy will be necessary to improve sustained virol. response rates.  The search for the optimal combination of STAT-C compds. with peginterferon alfa with or without ribavirin is currently under investigation in several clin. trials.  Overall the current studies indicate that peginterferon alfa and ribavirin remain the backbone of antiviral therapy of chronic hepatitis C even in the era of STAT-C.  Nevertheless, it can be anticipated that combination of STAT-C compds. with non-overlapping resistance profiles could improve response to antiviral therapy.  Promising combinations are protease inhibitors plus nucleoside analog and non-nucleoside analog polymerase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrejE167j7rsrVg90H21EOLACvtfcHk0li416sCjx-EvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOitbw%253D&md5=89fe78486134b8f9eb688a4c7523eaed</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1016%2Fj.bpg.2008.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpg.2008.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DKronenberger%26aufirst%3DB.%26aulast%3DZeuzem%26aufirst%3DS.%26atitle%3DFuture%2520treatment%2520options%2520for%2520HCV%253A%2520double%252C%2520triple%252C%2520what%2520is%2520the%2520optimal%2520combination%253F%26jtitle%3DBest%2520Practi.%2520Res.%2520Clin.%2520Gastroenterol.%26date%3D2008%26volume%3D22%26spage%3D1123%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Schmitz, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, S.-L.</span><span> </span><span class="NLM_article-title">NS5A—from obscurity to new target for HCV therapy</span> <span class="citation_source-journal">Recent Pat. Anti-Infect. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.2174%2F157489108784746597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1Kjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=77-92&author=U.+Schmitzauthor=S.-L.+Tan&title=NS5A%E2%80%94from+obscurity+to+new+target+for+HCV+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">NS5A - from obscurity to new target for HCV therapy</span></div><div class="casAuthors">Schmitz, Uli; Tan, Seng-Lai</div><div class="citationInfo"><span class="NLM_cas:title">Recent Patents on Anti-Infective Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">77-92</span>CODEN:
                <span class="NLM_cas:coden">RPADCX</span>;
        ISSN:<span class="NLM_cas:issn">1574-891X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The hepatitis C virus (HCV) non-structural 5A (NS5A) protein is essential for viral RNA replication and may play a role in subverting host intracellular signaling pathways.  Although no intrinsic enzymic activity has been ascribed to NS5A, this proline-rich hydrophilic phosphoprotein is likely to exert its functions by interacting with viral and cellular factors.  Recent studies using the HCV replicon cell culture system as a model for HCV RNA replication as well as for high-throughput screening of pharmacol. inhibitors have revealed blockade of NS5A as a promising therapeutic strategy for the treatment of HCV.  This review will summarize our progress in understanding the role of NS5A in HCV RNA replication and will introduce the most recent patents on inhibitors of NS5A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEYaqZrcncjbVg90H21EOLACvtfcHk0li416sCjx-EvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1Kjs70%253D&md5=29d24e11907fe2c10f5649426b864a87</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.2174%2F157489108784746597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157489108784746597%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitz%26aufirst%3DU.%26aulast%3DTan%26aufirst%3DS.-L.%26atitle%3DNS5A%25E2%2580%2594from%2520obscurity%2520to%2520new%2520target%2520for%2520HCV%2520therapy%26jtitle%3DRecent%2520Pat.%2520Anti-Infect.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26spage%3D77%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Holler, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkinson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryde, D. C.</span><span> </span><span class="NLM_article-title">Targeting the non-structural proteins of hepatitis C virus: beyond hepatitis C virus protease and polymerase</span> <span class="citation_source-journal">Expert Opin. Drug Discovery.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=293-314&author=T.+P.+Hollerauthor=T.+Parkinsonauthor=D.+C.+Pryde&title=Targeting+the+non-structural+proteins+of+hepatitis+C+virus%3A+beyond+hepatitis+C+virus+protease+and+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoller%26aufirst%3DT.%2BP.%26aulast%3DParkinson%26aufirst%3DT.%26aulast%3DPryde%26aufirst%3DD.%2BC.%26atitle%3DTargeting%2520the%2520non-structural%2520proteins%2520of%2520hepatitis%2520C%2520virus%253A%2520beyond%2520hepatitis%2520C%2520virus%2520protease%2520and%2520polymerase%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery.%26date%3D2009%26volume%3D4%26spage%3D293%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">A review of HCV protease inhibitors</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=821-837&author=K.+X.+Chenauthor=F.+G.+Njoroge&title=A+review+of+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DA%2520review%2520of%2520HCV%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D821%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Macrocyclic inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Expert Opin. Ther. Patents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1277</span><span class="NLM_x">–</span> <span class="NLM_lpage">1303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1517%2F13543770903044994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=19563268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWitL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1277-1303&author=S.+Venkatramanauthor=F.+G.+Njoroge&title=Macrocyclic+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of HCV NS3 protease</span></div><div class="casAuthors">Venkatraman, Srikanth; Njoroge, F. George</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1277-1303</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  HCV NS3 is a serine protease that plays a pivotal role in catalyzing the cleavage of the single polyprotein encoded by HCV after infection of hepatocytes.  Anal. of the X-ray crystal structure of the enzyme reveals a shallow catalytic site located on the surface of the protein, which has made development of inhibitors a formidable task.  Attempts to discover leads by a traditional approach of screening of compd. libraries have proved futile and, therefore, researchers have adopted a structure-based drug design.  Anal. of the X-ray structure of NS3 protease reveals close proximity of S1-S3 and S2-S4 pockets.  Various novel approaches have been used to design preorganized, depeptidized macrocyclic inhibitors linking the P2-P4 groups and P1-P3 residues.  The article summarizes efforts by various groups to develop inhibitors that bind to the active site and inhibit viral replication.  Review of recent patents and scientific literature.  Macrocyclization has proved to be an effective tool for depeptidization of peptidic inhibitors with improved binding and pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodbzHliWVL17Vg90H21EOLACvtfcHk0lhLAs4BSwj2pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWitL%252FI&md5=4081e78be8e92b762d50501ca8fcb97c</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1517%2F13543770903044994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903044994%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2009%26volume%3D19%26spage%3D1277%26epage%3D1303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective and orally bioavailable inhibitor in hepatitis C virus NS3−4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.+P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective+and+orally+bioavailable+inhibitor+in+hepatitis+C+virus+NS3%E2%88%924A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.%2BP.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520inhibitor%2520in%2520hepatitis%2520C%2520virus%2520NS3%25E2%2588%25924A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Malcolm, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheyas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease,suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1013-1020&author=B.+A.+Malcolmauthor=R.+Liuauthor=F.+Lahserauthor=S.+Agrawalauthor=B.+Belangerauthor=N.+Butkiewiczauthor=R.+Chaseauthor=F.+Gheyasauthor=A.+Hartauthor=D.+Heskauthor=P.+Ingravalloauthor=C.+Jiangauthor=R.+Kongauthor=J.+Luauthor=J.+Pichardoauthor=A.+Prongayauthor=A.+Skeltonauthor=X.+Tongauthor=S.+Venkatramanauthor=E.+Xiaauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=SCH+503034%2C+a+mechanism-based+inhibitor+of+hepatitis+C+virus+NS3+protease%2Csuppresses+polyprotein+maturation+and+enhances+the+antiviral+activity+of+alpha+interferon+in+replicon+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalcolm%26aufirst%3DB.%2BA.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DBelanger%26aufirst%3DB.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DGheyas%26aufirst%3DF.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DSkelton%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DSCH%2520503034%252C%2520a%2520mechanism-based%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%252Csuppresses%2520polyprotein%2520maturation%2520and%2520enhances%2520the%2520antiviral%2520activity%2520of%2520alpha%2520interferon%2520in%2520replicon%2520cells%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1013%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">MK-7009, a potent and selective Inhibitor of hepatitis C virus NS3/4A protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=305-311&author=N.+J.+Livertonauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=D.+J.+Grahamauthor=D.+Hazudaauthor=M.+K.+Hollowayauthor=S.+W.+Ludmererauthor=J.+A.+McCauleyauthor=C.+J.+McIntyreauthor=D.+B.+Olsenauthor=M.+T.+Ruddauthor=M.+Stahlhutauthor=J.+P.+Vacca&title=MK-7009%2C+a+potent+and+selective+Inhibitor+of+hepatitis+C+virus+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMK-7009%252C%2520a%2520potent%2520and%2520selective%2520Inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D305%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Flisiak, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parfieniuk, A.</span><span> </span><span class="NLM_article-title">Investigational drugs for hepatitis C</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=63-75&author=R.+Flisiakauthor=A.+Parfieniuk&title=Investigational+drugs+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlisiak%26aufirst%3DR.%26aulast%3DParfieniuk%26aufirst%3DA.%26atitle%3DInvestigational%2520drugs%2520for%2520hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D63%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Legrand-Abravanel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izopet, J.</span><span> </span><span class="NLM_article-title">New NS5B polymerase inhibitors for Hepatitis C</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=963-975&author=F.+Legrand-Abravanelauthor=F.+Nicotauthor=J.+Izopet&title=New+NS5B+polymerase+inhibitors+for+Hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLegrand-Abravanel%26aufirst%3DF.%26aulast%3DNicot%26aufirst%3DF.%26aulast%3DIzopet%26aufirst%3DJ.%26atitle%3DNew%2520NS5B%2520polymerase%2520inhibitors%2520for%2520Hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D963%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Brown, N. A.</span><span> </span><span class="NLM_article-title">Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=709-725&author=N.+A.+Brown&title=Progress+towards+improving+antiviral+therapy+for+hepatitis+C+with+hepatitis+C+virus+polymerase+inhibitors.+Part+I%3A+Nucleoside+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DN.%2BA.%26atitle%3DProgress%2520towards%2520improving%2520antiviral%2520therapy%2520for%2520hepatitis%2520C%2520with%2520hepatitis%2520C%2520virus%2520polymerase%2520inhibitors.%2520Part%2520I%253A%2520Nucleoside%2520analogues%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26spage%3D709%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1517%2F13543770802672598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=145-164&author=P.+L.+Beaulieu&title=Recent+advances+in+the+development+of+NS5B+polymerase+inhibitors+for+the+treatment+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-164</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  170 To 200 million people worldwide are believed to suffer from chronic hepatitis C virus (HCV) infection, a blood-born disease that targets the liver and progresses to organ cirrhosis and primary cancer in a significant proportion of patients.  The currently available treatment has limited efficacy and suffers from restricting side effects.  HCV infection is the principal cause of liver transplant in industrialized nations and between 8000 and 10,000 deaths result annually from the disease in the United States alone.  Virus-specific, more efficacious, and better-tolerated anti-HCV therapies are thus required to address the unmet medical need.  Objective: To review progress achieved since 2005 in the development of HCV NS5B polymerase inhibitors as potential therapy for the treatment of HCV infection with a primary focus on available patent and medical literature.  Results/conclusion: Several classes of small-mol. inhibitors of HCV NS5B have progressed into clin. development and demonstrated efficacy in reducing viral load in infected patients.  The results so far provide an encouraging foundation for the development of novel, more tolerable therapies and addressing emergence of resistance through combination of antiviral agents with complementary mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo8VVFJs4oSbVg90H21EOLACvtfcHk0ljHlrs1GG4kUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D&md5=64b78562e2b4e3e8a166fdabf14f7efe</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1517%2F13543770802672598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770802672598%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520NS5B%2520polymerase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D145%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Recent Progress in the Development of Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1302</span><span class="NLM_x">–</span> <span class="NLM_lpage">1329</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.2174%2F156802607781212211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=17627559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1302-1329&author=U.+Kochauthor=F.+Narjes&title=Recent+Progress+in+the+Development+of+Inhibitors+of+the+Hepatitis+C+Virus+RNA-Dependent+RNA+Polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of inhibitors of the hepatitis C virus RNA-dependent RNA polymerase</span></div><div class="casAuthors">Koch, Uwe; Narjes, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1302-1329</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The global prevalence of hepatitis C virus (HCV) infection and the serious consequences assocd. with the chronic state of the disease have become a worldwide health problem.  A combination therapy comprising Interferon-alpha and Ribavirin represents the current std. treatment for chronic HCV infection, although it has demonstrated limited success and causes serious side effects.  Promising alternative approaches toward the control of HCV infection include the development of small mol. inhibitors of viral enzymes interfering with the essential steps in the life cycle of the virus.  In this review we will focus on inhibitors of the HCV-encoded NS5B RNA-dependent RNA polymerase (NS5B RdRp) which is essential for viral replication and has been recognized as a prime target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiFy9xnAKP5rVg90H21EOLACvtfcHk0ljHlrs1GG4kUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvI&md5=02ed6506840e322371e043ce557a31d4</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.2174%2F156802607781212211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607781212211%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Development%2520of%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520RNA-Dependent%2520RNA%2520Polymerase%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1302%26epage%3D1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNair, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, S.</span><span> </span><span class="NLM_article-title">Recent progress in the development of selected hepatitis C virus NS34A protease and NS5B polymerase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1016%2Fj.coph.2008.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=18835365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlaqsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=522-531&author=A.+D.+Kwongauthor=L.+McNairauthor=I.+Jacobsenauthor=S.+George&title=Recent+progress+in+the+development+of+selected+hepatitis+C+virus+NS34A+protease+and+NS5B+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of selected hepatitis C virus NS3·4A protease and NS5B polymerase inhibitors</span></div><div class="casAuthors">Kwong, Ann D.; McNair, Lindsay; Jacobson, Ira; George, Shelley</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">522-531</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Chronic hepatitis C virus (HCV) infection is a pressing medical problem worldwide.  Current therapy with pegylated interferon plus ribavirin (Peg-IFN/RBV) is assocd. with a poor risk benefit profile, a long treatment duration (48 wk) and inadequate success rate (∼40-50%) of SVR (sustained viral response) in patients infected with genotype 1 HCV.  This review is focused on recent clin. trial results with specifically targeted antiviral therapy for HCV (STAT-C) protease and polymerase inhibitors.  In the past decade, anti-HCV drug discovery has focused first on targeting host factors required for viral replication and second on multiple HCV antiviral agents.  Owing to the large no. of HCV inhibitors currently in pre-clin. and clin. development today, we have focused on the most advanced compds. in the HCV polymerase and HCV protease inhibitor classes.  Within each class, compds. will be used to illustrate some of the properties assocd. with inhibitors that bind to the active site of HCV polymerase, the active site of HCV protease (macrocyclic and linear ketoamide inhibitors) and allosteric polymerase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb0B_J-gyRGLVg90H21EOLACvtfcHk0ljHlrs1GG4kUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlaqsLrE&md5=0787600cc6e2a2c28c1240470bf6bf22</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DMcNair%26aufirst%3DL.%26aulast%3DJacobsen%26aufirst%3DI.%26aulast%3DGeorge%26aufirst%3DS.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520selected%2520hepatitis%2520C%2520virus%2520NS34A%2520protease%2520and%2520NS5B%2520polymerase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D522%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettles, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano-Wu, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, D. R.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1038%2Fnature08960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=20410884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=96-100&author=M.+Gaoauthor=R.+E.+Nettlesauthor=M.+Belemaauthor=L.+B.+Snyderauthor=V.+N.+Nguyenauthor=R.+A.+Fridellauthor=M.+H.+Serrano-Wuauthor=D.+R.+Langleyauthor=J.-H.+Sunauthor=D.+R.+O%E2%80%99Boyleauthor=J.+A.+Lemmauthor=C.+Wangauthor=J.+O.+Knipeauthor=C.+Chienauthor=R.+J.+Colonnoauthor=D.+M.+Graselaauthor=N.+A.+Meanwellauthor=L.+G.+Hamann&title=Chemical+genetics+strategy+identifies+an+HCV+NS5A+inhibitor+with+a+potent+clinical+effect"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span></div><div class="casAuthors">Gao, Min; Nettles, Richard E.; Belema, Makonen; Snyder, Lawrence B.; Nguyen, Van N.; Fridell, Robert A.; Serrano-Wu, Michael H.; Langley, David R.; Sun, Jin-Hua; O'Boyle, Donald R., II; Lemm, Julie A.; Wang, Chunfu; Knipe, Jay O.; Chien, Caly; Colonno, Richard J.; Grasela, Dennis M.; Meanwell, Nicholas A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7294</span>),
    <span class="NLM_cas:pages">96-100</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The worldwide prevalence of chronic hepatitis C virus (HCV) infection is estd. to be approaching 200 million people.  Current therapy relies upon a combination of pegylated interferon-α and ribavirin, a poorly tolerated regimen typically assocd. with less than 50% sustained virol. response rate in those infected with genotype 1 virus.  The development of direct-acting antiviral agents to treat HCV has focused predominantly on inhibitors of the viral enzymes NS3 protease and the RNA-dependent RNA polymerase NS5B.  Here we describe the profile of BMS-790052, a small mol. inhibitor of the HCV NS5A protein that exhibits picomolar half-max. effective concns. (EC50) towards replicons expressing a broad range of HCV genotypes and the JFH-1 genotype 2a infectious virus in cell culture.  In a phase I clin. trial in patients chronically infected with HCV, administration of a single 100-mg dose of BMS-790052 was assocd. with a 3.3 log10 redn. in mean viral load measured 24 h post-dose that was sustained for an addnl. 120 h in two patients infected with genotype 1b virus.  Genotypic anal. of samples taken at baseline, 24 and 144 h post-dose revealed that the major HCV variants obsd. had substitutions at amino-acid positions identified using the in vitro replicon system.  These results provide the first clin. validation of an inhibitor of HCV NS5A, a protein with no known enzymic function, as an approach to the suppression of virus replication that offers potential as part of a therapeutic regimen based on combinations of HCV inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAY7Lig0xT9LVg90H21EOLACvtfcHk0ljUGJ1mPXYbww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D&md5=620427e987f2bccd153270cde2ef5027</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature08960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08960%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DM.%26aulast%3DNettles%26aufirst%3DR.%2BE.%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.-H.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DChemical%2520genetics%2520strategy%2520identifies%2520an%2520HCV%2520NS5A%2520inhibitor%2520with%2520a%2520potent%2520clinical%2520effect%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D96%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">O’Farrell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trowbridge, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jager, J.</span><span> </span><span class="NLM_article-title">Substrate Complexes of Hepatitis C Virus RNA Polymerase (HC-J4): Structural Evidence for Nucleotide Import and De Novo Initiation</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1035</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2003&pages=1025-1035&author=D.+O%E2%80%99Farrellauthor=R.+Trowbridgeauthor=D.+Rowlandsauthor=J.+Jager&title=Substrate+Complexes+of+Hepatitis+C+Virus+RNA+Polymerase+%28HC-J4%29%3A+Structural+Evidence+for+Nucleotide+Import+and+De+Novo+Initiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Farrell%26aufirst%3DD.%26aulast%3DTrowbridge%26aufirst%3DR.%26aulast%3DRowlands%26aufirst%3DD.%26aulast%3DJager%26aufirst%3DJ.%26atitle%3DSubstrate%2520Complexes%2520of%2520Hepatitis%2520C%2520Virus%2520RNA%2520Polymerase%2520%2528HC-J4%2529%253A%2520Structural%2520Evidence%2520for%2520Nucleotide%2520Import%2520and%2520De%2520Novo%2520Initiation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D326%26spage%3D1025%26epage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Butcher, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimes, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makeyev, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, D. I. A</span><span> </span><span class="NLM_article-title">Mechanism for Initiating RNA-Dependent RNA Polymerization</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">410</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2001&pages=235-240&author=S.+J.+Butcherauthor=J.+M.+Grimesauthor=E.+V.+Makeyevauthor=D.+H.+Bamfordauthor=D.+I.+A+Stuart&title=Mechanism+for+Initiating+RNA-Dependent+RNA+Polymerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DButcher%26aufirst%3DS.%2BJ.%26aulast%3DGrimes%26aufirst%3DJ.%2BM.%26aulast%3DMakeyev%26aufirst%3DE.%2BV.%26aulast%3DBamford%26aufirst%3DD.%2BH.%26aulast%3DStuart%26aufirst%3DD.%2BI.%2BA%26atitle%3DMechanism%2520for%2520Initiating%2520RNA-Dependent%2520RNA%2520Polymerization%26jtitle%3DNature%26date%3D2001%26volume%3D410%26spage%3D235%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racela, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigat, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span> </span><span class="NLM_article-title">De Novo Initiation of RNA Synthesis by the RNA-Dependent RNA Polymerase (NS5B) of Hepatitis C Virus</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">851</span><span class="NLM_x">–</span> <span class="NLM_lpage">863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1128%2FJVI.74.2.851-863.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=10623748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1CksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=851-863&author=G.+Luoauthor=R.+K.+Hamatakeauthor=D.+M.+Mathisauthor=J.+Racelaauthor=K.+L.+Rigatauthor=J.+Lemmauthor=R.+J.+Colonno&title=De+Novo+Initiation+of+RNA+Synthesis+by+the+RNA-Dependent+RNA+Polymerase+%28NS5B%29+of+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15c</span><div class="casTitle"><span class="NLM_cas:atitle">De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus</span></div><div class="casAuthors">Luo, Guangxiang; Hamatake, Robert K.; Mathis, Danielle M.; Racela, Jason; Rigat, Karen L.; Lemm, Julie; Colonno, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">851-863</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) NS5B protein possesses an RNA-dependent RNA polymerase (RdRp) activity, a major function responsible for replication of the viral RNA genome.  To further characterize the RdRp activity, NS5B proteins were expressed from recombinant baculoviruses, purified to near homogeneity, and examd. for their ability to synthesize RNA in vitro.  As a result, a highly active NS5B RdRp (1b-42), which contains an 18-amino acid C-terminal truncation resulting from a newly created stop codon, was identified among a no. of independent isolates.  The RdRp activity of the truncated NS5B is comparable to the activity of the full-length protein and is 20 times higher in the presence of Mn2+ than in the presence of Mg2+.  When a 384-nucleotide RNA was used as the template, two major RNA products were synthesized by 1b-42.  One is a complementary RNA identical in size to the input RNA template (monomer), while the other is a hairpin dimer RNA synthesized by a "copy-back" mechanism.  Substantial evidence derived from several expts. demonstrated that the RNA monomer was synthesized through de novo initiation by NS5B rather than by a terminal transferase activity.  Synthesis of the RNA monomer requires all four ribonucleotides.  The RNA monomer product was verified to be the result of de novo RNA synthesis, as two expected RNA products were generated from monomer RNA by RNase H digestion.  In addn., modification of the RNA template by the addn. of the chain terminator cordycepin at the 3' end did not affect synthesis of the RNA monomer but eliminated synthesis of the self-priming hairpin dimer RNA.  Moreover, synthesis of RNA on poly(C) and poly(U) homopolymer templates by 1b-42 NS5B did not require the oligonucleotide primer at high concns. (≥50 μM) of GTP and ATP, further supporting a de novo initiation mechanism.  These findings suggest that HCV NS5B is able to initiate RNA synthesis de novo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx7U3Pxol3JrVg90H21EOLACvtfcHk0ljUGJ1mPXYbww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1CksA%253D%253D&md5=59e871a13b1211af1a6ef6f48479f0cc</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1128%2FJVI.74.2.851-863.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.74.2.851-863.2000%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DHamatake%26aufirst%3DR.%2BK.%26aulast%3DMathis%26aufirst%3DD.%2BM.%26aulast%3DRacela%26aufirst%3DJ.%26aulast%3DRigat%26aufirst%3DK.%2BL.%26aulast%3DLemm%26aufirst%3DJ.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26atitle%3DDe%2520Novo%2520Initiation%2520of%2520RNA%2520Synthesis%2520by%2520the%2520RNA-Dependent%2520RNA%2520Polymerase%2520%2528NS5B%2529%2520of%2520Hepatitis%2520C%2520Virus%26jtitle%3DJ.%2520Virol.%26date%3D2000%26volume%3D74%26spage%3D851%26epage%3D863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Bressanelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Incitti, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, F. A.</span><span> </span><span class="NLM_article-title">Crystal Structure of the RNA-Dependent RNA Polymerase of Hepatitis C Virus</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">13034</span><span class="NLM_x">–</span> <span class="NLM_lpage">13039</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1073%2Fpnas.96.23.13034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=10557268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADyaK1MXns1Gmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=13034-13039&author=S.+Bressanelliauthor=L.+Tomeiauthor=A.+Rousselauthor=I.+Incittiauthor=R.+L.+Vitaleauthor=M.+Mathieuauthor=R.+De+Francescoauthor=F.+A.+Rey&title=Crystal+Structure+of+the+RNA-Dependent+RNA+Polymerase+of+Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15dR"><div class="casContent"><span class="casTitleNuber">15d</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span></div><div class="casAuthors">Bressanelli, Stephane; Tomei, Licia; Roussel, Alain; Incitti, Ilario; Vitale, Rosa Letizia; Mathieu, Magali; De Francesco, Raffaele; Rey, Felix A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">13034-13039</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The crystal structure of the RNA-dependent RNA polymerase (RNA replicase) (I) of hepatitis C virus, a major human pathogen, is reported to 2.8 Å resoln.  I is a key target for developing specific antiviral therapy.  The structure of the catalytic domain contained 531 residues folded in the characteristic fingers, palm, and thumb subdomains.  The fingers subdomain contained a region, the "fingertips," that shared the same fold with reverse transcriptases.  Superposition to the available structures of the latter showed that residues from the palm and fingertips were structurally equiv.  In addn., it showed that hepatitis C virus I was crystd. in a closed fingers conformation, similar to HIV-1 reverse transcriptase in ternary complex with DNA and dTTP.  This superposition revealed the majority of the amino acid residues of the hepatitis C virus enzyme that are likely to be implicated in binding to the replicating RNA mol. and to the incoming NTP.  It also suggested a rearrangement of the thumb domain as well as a possible concerted movement of thumb and fingertips during translocation of the RNA template-primer in successive polymn. rounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoMMlZvielKLVg90H21EOLACvtfcHk0lhXtJpUXEqpyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXns1Gmsrk%253D&md5=2ba97997c8a8e24c0db560260fb5ea9a</span></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.23.13034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.23.13034%26sid%3Dliteratum%253Aachs%26aulast%3DBressanelli%26aufirst%3DS.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DRoussel%26aufirst%3DA.%26aulast%3DIncitti%26aufirst%3DI.%26aulast%3DVitale%26aufirst%3DR.%2BL.%26aulast%3DMathieu%26aufirst%3DM.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DRey%26aufirst%3DF.%2BA.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520RNA-Dependent%2520RNA%2520Polymerase%2520of%2520Hepatitis%2520C%2520Virus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D13034%26epage%3D13039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span> </span><span class="NLM_article-title">Nucleoside Analog Inhibitors of Hepatitis C Virus Replication</span> <span class="citation_source-journal">Infect. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.2174%2F187152606776056698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=16787301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=17-29&author=S.+S.+Carrollauthor=D.+B.+Olsen&title=Nucleoside+Analog+Inhibitors+of+Hepatitis+C+Virus+Replication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside analog inhibitors of hepatitis C virus replication</span></div><div class="casAuthors">Carroll, S. S.; Olsen, D. B.</div><div class="citationInfo"><span class="NLM_cas:title">Infectious Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-29</span>CODEN:
                <span class="NLM_cas:coden">IDDTAD</span>;
        ISSN:<span class="NLM_cas:issn">1871-5265</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Of the 30 compds. currently marketed in the United States for treatment of viral infections, 15 are nucleoside analogs, demonstrating the utility of this class of compd. as a source of antiviral drugs.  The success of nucleoside analogs in treating other viral infections provides a compelling rationale for the significant effort that is currently being devoted to the discovery and development of nucleoside analogs to treat infection by hepatitis C virus (HCV) that may lead to improvements in response rates compared to currently available therapies.  Several different approaches were adopted to identify promising analogs, including the use of surrogate viruses in cell culture assays, screening in the cell-based bicistronic HCV replicon assay, and screening nucleoside triphosphates for the ability to inhibit the activity of the HCV RNA-dependent RNA polymerase in vitro.  Several classes of ribonucleoside analogs with modifications of the ribose inhibit HCV replication.  Nucleoside analogs incorporating a 2'-C-Me modification are potent inhibitors in the replicon assay in the absence of cytotoxicity, and appear to exert their inhibition by acting as functional chain terminators of RNA synthesis.  NM283, a prodrug of 2'-C-methylcytidine, has entered clin. trials and demonstrated viral load redns. in subjects infected with genotype 1 HCV, a genotype known to be difficult to treat effectively with currently approved therapies.  Overall, results to date offer encouragement that improved therapies to treat HCV infection including newly developed nucleoside analogs may become available within the next few years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVhFYWU3S1hbVg90H21EOLACvtfcHk0lhXtJpUXEqpyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7Y%253D&md5=27a3f74bc6da7bfd4ce02a1266511f5c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F187152606776056698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152606776056698%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26atitle%3DNucleoside%2520Analog%2520Inhibitors%2520of%2520Hepatitis%2520C%2520Virus%2520Replication%26jtitle%3DInfect.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2006%26volume%3D6%26spage%3D17%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tramontano, E.</span><span> </span><span class="NLM_article-title">The exploding field of the HCV polymerase non-nucleoside inhibitors: summary of a first generation compounds</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1298</span><span class="NLM_x">–</span> <span class="NLM_lpage">1310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1298-1310&author=E.+Tramontano&title=The+exploding+field+of+the+HCV+polymerase+non-nucleoside+inhibitors%3A+summary+of+a+first+generation+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTramontano%26aufirst%3DE.%26atitle%3DThe%2520exploding%2520field%2520of%2520the%2520HCV%2520polymerase%2520non-nucleoside%2520inhibitors%253A%2520summary%2520of%2520a%2520first%2520generation%2520compounds%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1298%26epage%3D1310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infection</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=17668364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKgsbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=614-634&author=P.+L.+Beaulieu&title=Non-nucleoside+inhibitors+of+the+HCV+NS5B+polymerase%3A+progress+in+the+discovery+and+development+of+novel+agents+for+the+treatment+of+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (Thomson Scientific)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">614-634</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">1472-4472</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  The severe health conditions assocd. with chronic HCV infection remain a global concern.  Small-mol. drugs that specifically target essential virally encoded enzymes have not yet progressed to market, and the current std. of care continues to rely on a combination of pegylated IFN with ribavirin.  This therapy has serious side effects and a significant proportion of patients infected with HCV genotype 1 (the major genotype in industrialized countries) have an unsatisfactory outcome with this therapy.  Major advances have been realized in the development of specific non-nucleoside inhibitors of the viral NS5B RNA-dependent RNA polymerase.  This well-characterized replicative enzyme is a highly drugable target that, in addn. to its active site, features at least three known allosteric binding pockets that regulate RNA synthesis and are suitable for inhibitor design.  Clin. proof-of-concept for allosteric non-nucleoside HCV polymerase inhibitors has been reported and several compds. have progressed into preclin. studies.  It is likely that in the future NS5B inhibitors will form an integral part of more effective anti-HCV therapies, combining the use of small-mol. antiviral drugs with or without the assistance of immune modulators such as IFNs in order to minimize the emergence of resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTl5U1TLVJ57Vg90H21EOLACvtfcHk0lhXtJpUXEqpyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKgsbvK&md5=347a7983497b1b50bba61a455783f302</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DNon-nucleoside%2520inhibitors%2520of%2520the%2520HCV%2520NS5B%2520polymerase%253A%2520progress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520novel%2520agents%2520for%2520the%2520treatment%2520of%2520HCV%2520infection%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D8%26spage%3D614%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Allosteric inhibition of the hepatitis C virus NS5B RNA dependent RNA polymerase</span> <span class="citation_source-journal">Infect. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.2174%2F187152606776056724" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=16787302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=31-41&author=U.+Kochauthor=F.+Narjes&title=Allosteric+inhibition+of+the+hepatitis+C+virus+NS5B+RNA+dependent+RNA+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibition of the hepatitis C virus NS5B RNA dependent RNA polymerase</span></div><div class="casAuthors">Koch, Uwe; Narjes, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Infectious Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-41</span>CODEN:
                <span class="NLM_cas:coden">IDDTAD</span>;
        ISSN:<span class="NLM_cas:issn">1871-5265</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The human and monetary costs of chronic hepatitis C and the complications arising from this disease emphasize the urgency to find a treatment for Hepatitis C Virus (HCV) infected patients.  The current std. of treatment for patients chronically infected with HCV is combination therapy with pegylated interferon plus ribavirin.  Recently, viral enzymes have become the target of efforts to develop small mol. inhibitors interfering with the essential steps in the life cycle of the virus.  Amongst these enzymes the HCV-encoded NS5B RNA-dependent RNA polymerase (NS5B RdRp) is essential for viral replication and has been recognized as a prime target for therapeutic intervention.  Several distinct classes of inhibitors of NS5B RdRp have been disclosed in the literature, including active site inhibitors such as nucleosides and pyrophosphate mimetics, as well as nonnucleoside inhibitors.  The latter, based on the success of allosteric inhibitors in the treatment of HIV infection, have been developed into compds. which show activity in the subgenomic cell-culture assay of HCV replication.  This review provides an account of the recent developments in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbJzS0wn4zMLVg90H21EOLACvtfcHk0lhXtJpUXEqpyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7c%253D&md5=d299870b484180aa4f9e179cb96eabe2</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.2174%2F187152606776056724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152606776056724%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DAllosteric%2520inhibition%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA%2520dependent%2520RNA%2520polymerase%26jtitle%3DInfect.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2006%26volume%3D6%26spage%3D31%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Condon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPorte, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span> </span><span class="NLM_article-title">Allosteric inhibitors of hepatitis C NS5B RNA-dependent RNA polymerase</span> <span class="citation_source-journal">Curr. Med. Chem.: Anti-Infect. Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.2174%2F1568012053506972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1Gjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=99-110&author=S.+M.+Condonauthor=M.+G.+LaPorteauthor=T.+Herbertz&title=Allosteric+inhibitors+of+hepatitis+C+NS5B+RNA-dependent+RNA+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibitors of hepatitis C NS5B RNA-dependent RNA polymerase</span></div><div class="casAuthors">Condon, Stephen M.; LaPorte, Matthew G.; Herbertz, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Infective Agents</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-110</span>CODEN:
                <span class="NLM_cas:coden">CMCAFL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0126</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Infection with HCV is a global concern.  Ests. from the WHO suggest that over 170 million people are infected worldwide with over 2.7 million people infected in the US.  Current therapies including interferon (IFN-α) and ribavirin are ineffective against many HCV genotypes and a sustained viral response is difficult to achieve in many HCV patients.  Inconvenient dosing regimens and overall toxicity conspire to make these current therapies inadequate.  Although the recent development of pegylated interferons have shown signs of improved genotype applicability and reduced toxicity, it is believed that alternative therapies will be needed to battle this disease on a global scale.  The incidence of HIV/HCV co-infection is a growing trend and the authors' ability to effectively treat these patients is anticipated to be a significant medical challenge.  For HIV-1, the successful development of nucleotide- and non-nucleotide-based reverse transcriptase inhibitors (NNRTIs) as well as HIV protease inhibitors (PIs) has afforded patients a variety of treatment options.  Although 5-times more prevalent than HIV-1 infection, the development of target-directed HCV treatments was less successful.  Like HIV, the 2 HCV targets receiving the most attention are the protease (NS3-4A) and the polymerase (NS5B).  Recently, the discovery of several classes of allosteric HCV NS5B inhibitors were reported in the patent and scientific literature and many have made their way into clin. trials.  This review will describe the nature of these novel inhibitors while drawing comparisons and contrasts to the structural biol., development, and clin. utility of HIV NNRTIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Vem_5eUtRLVg90H21EOLACvtfcHk0lhA8U9DSpVzCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1Gjtr0%253D&md5=fda8f3199c59c9f5fee4639d6f214ec5</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.2174%2F1568012053506972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568012053506972%26sid%3Dliteratum%253Aachs%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DLaPorte%26aufirst%3DM.%2BG.%26aulast%3DHerbertz%26aufirst%3DT.%26atitle%3DAllosteric%2520inhibitors%2520of%2520hepatitis%2520C%2520NS5B%2520RNA-dependent%2520RNA%2520polymerase%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Anti-Infect.%2520Agents%26date%3D2005%26volume%3D4%26spage%3D99%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avolio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Filippo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Development and Preliminary Optimization of Indole-<i>N</i>-Acetamide Inhibitors of Hepatitis C Virus NS5B Polymerase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1314</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049122i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1314-1317&author=S.+Harperauthor=B.+Paciniauthor=S.+Avolioauthor=M.+Di+Filippoauthor=G.+Migliaccioauthor=R.+Lauferauthor=R.+De+Francescoauthor=M.+Rowleyauthor=F.+Narjes&title=Development+and+Preliminary+Optimization+of+Indole-N-Acetamide+Inhibitors+of+Hepatitis+C+Virus+NS5B+Polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fjm049122i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049122i%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DPacini%26aufirst%3DB.%26aulast%3DAvolio%26aufirst%3DS.%26aulast%3DDi%2BFilippo%26aufirst%3DM.%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DDevelopment%2520and%2520Preliminary%2520Optimization%2520of%2520Indole-N-Acetamide%2520Inhibitors%2520of%2520Hepatitis%2520C%2520Virus%2520NS5B%2520Polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1314%26epage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Finger loop inhibitors of the HCV NS5B polymerase: discovery and prospects for new HCV therapy</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=618-626&author=P.+L.+Beaulieu&title=Finger+loop+inhibitors+of+the+HCV+NS5B+polymerase%3A+discovery+and+prospects+for+new+HCV+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DFinger%2520loop%2520inhibitors%2520of%2520the%2520HCV%2520NS5B%2520polymerase%253A%2520discovery%2520and%2520prospects%2520for%2520new%2520HCV%2520therapy%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D618%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valois, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Non-Nucleoside Benzimidazole-Based Allosteric Inhibitors of the Hepatitis C Virus NS5B Polymerase: Inhibition of Subgenomic Hepatitis C Virus RNA Replicons in Huh-7 Cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6884</span><span class="NLM_x">–</span> <span class="NLM_lpage">6892</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040134d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6884-6892&author=P.+L.+Beaulieuauthor=Y.+Bousquetauthor=J.+Gauthierauthor=J.+Gillardauthor=M.+Marquisauthor=G.+McKercherauthor=C.+Pellerinauthor=S.+Valoisauthor=G.+Kukolj&title=Non-Nucleoside+Benzimidazole-Based+Allosteric+Inhibitors+of+the+Hepatitis+C+Virus+NS5B+Polymerase%3A+Inhibition+of+Subgenomic+Hepatitis+C+Virus+RNA+Replicons+in+Huh-7+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1021%2Fjm040134d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040134d%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DBousquet%26aufirst%3DY.%26aulast%3DGauthier%26aufirst%3DJ.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DMarquis%26aufirst%3DM.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DPellerin%26aufirst%3DC.%26aulast%3DValois%26aufirst%3DS.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DNon-Nucleoside%2520Benzimidazole-Based%2520Allosteric%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS5B%2520Polymerase%253A%2520Inhibition%2520of%2520Subgenomic%2520Hepatitis%2520C%2520Virus%2520RNA%2520Replicons%2520in%2520Huh-7%2520Cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6884%26epage%3D6892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Plante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Non-Nucleoside Inhibitors of the Hepatitis C Virus NS5B Polymerase: Discovery and Preliminary SAR of Benzimidazole Derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=119-124&author=P.+L.+Beaulieuauthor=M.+Bosauthor=Y.+Bousquetauthor=G.+Fazalauthor=J.+Gauthierauthor=J.+Gillardauthor=S.+Gouletauthor=S.+La+Planteauthor=M.-A.+Poupartauthor=S.+Lefebvreauthor=G.+McKercherauthor=C.+Pellerinauthor=V.+Austelauthor=G.+Kukolj&title=Non-Nucleoside+Inhibitors+of+the+Hepatitis+C+Virus+NS5B+Polymerase%3A+Discovery+and+Preliminary+SAR+of+Benzimidazole+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DBos%26aufirst%3DM.%26aulast%3DBousquet%26aufirst%3DY.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGauthier%26aufirst%3DJ.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DLa%2BPlante%26aufirst%3DS.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DPellerin%26aufirst%3DC.%26aulast%3DAustel%26aufirst%3DV.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DNon-Nucleoside%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS5B%2520Polymerase%253A%2520Discovery%2520and%2520Preliminary%2520SAR%2520of%2520Benzimidazole%2520Derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D119%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Plante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thauvette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Specific Inhibitors of HCV Polymerase Identified Using an NS5B with Lower Affinity for Template/Primer Substrate</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=422-431&author=G.+McKercherauthor=P.+L.+Beaulieuauthor=D.+Lamarreauthor=S.+La+Planteauthor=S.+Lefebvreauthor=C.+Pellerinauthor=L.+Thauvetteauthor=G.+Kukolj&title=Specific+Inhibitors+of+HCV+Polymerase+Identified+Using+an+NS5B+with+Lower+Affinity+for+Template%2FPrimer+Substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DLa%2BPlante%26aufirst%3DS.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DPellerin%26aufirst%3DC.%26aulast%3DThauvette%26aufirst%3DL.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DSpecific%2520Inhibitors%2520of%2520HCV%2520Polymerase%2520Identified%2520Using%2520an%2520NS5B%2520with%2520Lower%2520Affinity%2520for%2520Template%252FPrimer%2520Substrate%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2004%26volume%3D32%26spage%3D422%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bykowski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansereau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duceppe, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hache, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakalian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagace, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stammers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thauvette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: from benzimidazole to indole scaffolds</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4987</span><span class="NLM_x">–</span> <span class="NLM_lpage">4993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4987-4993&author=P.+L.+Beaulieuauthor=J.+Gillardauthor=D.+Bykowskiauthor=C.+Brochuauthor=N.+Dansereauauthor=J.-S.+Duceppeauthor=B.+Hacheauthor=A.+Jakalianauthor=L.+Lagaceauthor=S.+LaPlanteauthor=G.+McKercherauthor=E.+Moreauauthor=S.+Perreaultauthor=T.+Stammersauthor=L.+Thauvetteauthor=J.+Warringtonauthor=G.+Kukolj&title=Improved+replicon+cellular+activity+of+non-nucleoside+allosteric+inhibitors+of+HCV+NS5B+polymerase%3A+from+benzimidazole+to+indole+scaffolds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DBykowski%26aufirst%3DD.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DDansereau%26aufirst%3DN.%26aulast%3DDuceppe%26aufirst%3DJ.-S.%26aulast%3DHache%26aufirst%3DB.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DLagace%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DMoreau%26aufirst%3DE.%26aulast%3DPerreault%26aufirst%3DS.%26aulast%3DStammers%26aufirst%3DT.%26aulast%3DThauvette%26aufirst%3DL.%26aulast%3DWarrington%26aufirst%3DJ.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DImproved%2520replicon%2520cellular%2520activity%2520of%2520non-nucleoside%2520allosteric%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%253A%2520from%2520benzimidazole%2520to%2520indole%2520scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4987%26epage%3D4993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansereau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Plante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thauvette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Benzimidazole thumb pocket I finger-loop inhibitors of HCV NS5B polymerase: Improved drug-like properties through C-2 SAR in three sub-series</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1825</span><span class="NLM_x">–</span> <span class="NLM_lpage">1829</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1825-1829&author=P.+L.+Beaulieuauthor=N.+Dansereauauthor=J.+Duanauthor=M.+Garneauauthor=J.+Gillardauthor=G.+McKercherauthor=S.+La+Planteauthor=L.+Lagaceeauthor=L.+Thauvetteauthor=G.+Kukolj&title=Benzimidazole+thumb+pocket+I+finger-loop+inhibitors+of+HCV+NS5B+polymerase%3A+Improved+drug-like+properties+through+C-2+SAR+in+three+sub-series"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DDansereau%26aufirst%3DN.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DLa%2BPlante%26aufirst%3DS.%26aulast%3DLagacee%26aufirst%3DL.%26aulast%3DThauvette%26aufirst%3DL.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DBenzimidazole%2520thumb%2520pocket%2520I%2520finger-loop%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%253A%2520Improved%2520drug-like%2520properties%2520through%2520C-2%2520SAR%2520in%2520three%2520sub-series%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1825%26epage%3D1829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ishida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirashima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, H.</span><span> </span><span class="NLM_article-title">Benzimidazole inhibitors of Hepatitis C virus NS5B polymerase: Identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1859</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1016%2Fj.bmcl.2006.01.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=16455252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVyrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1859-1863&author=T.+Ishidaauthor=T.+Suzukiauthor=S.+Hirashimaauthor=K.+Mizutaniauthor=A.+Yoshidaauthor=I.+Andoauthor=S.+Ikedaauthor=T.+Adachiauthor=H.+Hashimoto&title=Benzimidazole+inhibitors+of+Hepatitis+C+virus+NS5B+polymerase%3A+Identification+of+2-%5B%284-diarylmethoxy%29phenyl%5D-benzimidazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Benzimidazole inhibitors of hepatitis C virus NS5B polymerase: Identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole</span></div><div class="casAuthors">Ishida, Tomio; Suzuki, Takayoshi; Hirashima, Shintaro; Mizutani, Kenji; Yoshida, Atsuhito; Ando, Izuru; Ikeda, Satoru; Adachi, Tsuyoshi; Hashimoto, Hiromasa</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1859-1863</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 1-cycloalkyl-2-phenyl-1H-benzimidazole-5-carboxylic acid derivs. was synthesized and evaluated for inhibitory activity against hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase.  A SAR study led to identify the 2-[(4-diarylmethoxy)phenyl]benzimidazoles as potent inhibitors.  They inhibit subgenomic HCV RNA replication in the replicon cells at low micromolar concns. (EC50 ≥ 1.1 μM).  They are selective against DNA polymerases (IC50 > 10 μM) and exhibit low cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpafYllvKcYs7Vg90H21EOLACvtfcHk0lgNf44QT_LNvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVyrur4%253D&md5=0ae4f62a4f946596fafea62b1d543d13</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.01.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.01.032%26sid%3Dliteratum%253Aachs%26aulast%3DIshida%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DHirashima%26aufirst%3DS.%26aulast%3DMizutani%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DA.%26aulast%3DAndo%26aufirst%3DI.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DH.%26atitle%3DBenzimidazole%2520inhibitors%2520of%2520Hepatitis%2520C%2520virus%2520NS5B%2520polymerase%253A%2520Identification%2520of%25202-%255B%25284-diarylmethoxy%2529phenyl%255D-benzimidazole%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1859%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hirashima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noji, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, H.</span><span> </span><span class="NLM_article-title">Benzimidazole derivatives bearing substituted biphenyls as hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors: structure−activity relationship studies and identification of a potent and highly selective inhibitor JTK-109</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4721</span><span class="NLM_x">–</span> <span class="NLM_lpage">4736</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060269e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4721-4736&author=S.+Hirashimaauthor=T.+Suzukiauthor=T.+Ishidaauthor=S.+Nojiauthor=S.+Yataauthor=I.+Andoauthor=M.+Komatsuauthor=S.+Ikedaauthor=H.+Hashimoto&title=Benzimidazole+derivatives+bearing+substituted+biphenyls+as+hepatitis+C+virus+NS5B+RNA-dependent+RNA+polymerase+inhibitors%3A+structure%E2%88%92activity+relationship+studies+and+identification+of+a+potent+and+highly+selective+inhibitor+JTK-109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fjm060269e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060269e%26sid%3Dliteratum%253Aachs%26aulast%3DHirashima%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DIshida%26aufirst%3DT.%26aulast%3DNoji%26aufirst%3DS.%26aulast%3DYata%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DI.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DH.%26atitle%3DBenzimidazole%2520derivatives%2520bearing%2520substituted%2520biphenyls%2520as%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA-dependent%2520RNA%2520polymerase%2520inhibitors%253A%2520structure%25E2%2588%2592activity%2520relationship%2520studies%2520and%2520identification%2520of%2520a%2520potent%2520and%2520highly%2520selective%2520inhibitor%2520JTK-109%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4721%26epage%3D4736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartholomew, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biroccio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccacci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gennari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisbocci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Incitti, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsatti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stansfield, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span> </span><span class="NLM_article-title">Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">13225</span><span class="NLM_x">–</span> <span class="NLM_lpage">13231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1128%2FJVI.77.24.13225-13231.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=14645579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslSmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2003&pages=13225-13231&author=L.+Tomeiauthor=S.+Altamuraauthor=L.+Bartholomewauthor=A.+Biroccioauthor=A.+Ceccacciauthor=L.+Paciniauthor=F.+Narjesauthor=N.+Gennariauthor=M.+Bisbocciauthor=I.+Incittiauthor=L.+Orsattiauthor=S.+Harperauthor=I.+Stansfieldauthor=M.+Rowleyauthor=R.+De+Francescoauthor=G.+Migliaccio&title=Mechanism+of+action+and+antiviral+activity+of+benzimidazole-based+allosteric+inhibitors+of+the+hepatitis+C+virus+RNA-dependent+RNA+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase</span></div><div class="casAuthors">Tomei, Licia; Altamura, Sergio; Bartholomew, Linda; Biroccio, Antonino; Ceccacci, Alessandra; Pacini, Laura; Narjes, Frank; Gennari, Nadia; Bisbocci, Monica; Incitti, Ilario; Orsatti, Laura; Harper, Steven; Stansfield, Ian; Rowley, Michael; De Francesco, Raffaele; Migliaccio, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">13225-13231</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The RNA-dependent RNA polymerase of hepatitis C virus (HCV) is the catalytic subunit of the viral RNA amplification machinery and is an appealing target for the development of new therapeutic agents against HCV infection.  Nonnucleoside inhibitors based on a benzimidazole scaffold have been recently reported.  Compds. of this class are efficient inhibitors of HCV RNA replication in cell culture, thus providing attractive candidates for further development.  Here we report the detailed anal. of the mechanism of action of selected benzimidazole inhibitors.  Kinetic data and binding expts. indicated that these compds. act as allosteric inhibitors that block the activity of the polymerase prior to the elongation step.  Escape mutations that confer resistance to these compds. map to proline 495, a residue located on the surface of the polymerase thumb domain and away from the active site.  Substitution of this residue is sufficient to make the HCV enzyme and replicons resistant to the inhibitors.  Interestingly, proline 495 lies in a recently identified noncatalytic GTP-binding site, thus validating it as a potential allosteric site that can be targeted by small-mol. inhibitors of HCV polymerase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLeqFmAyaoXrVg90H21EOLACvtfcHk0lgYUHzo2K7e3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslSmsrY%253D&md5=05154e4c748a15ecdb96bc5fa2a4f6cb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1128%2FJVI.77.24.13225-13231.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.77.24.13225-13231.2003%26sid%3Dliteratum%253Aachs%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DBartholomew%26aufirst%3DL.%26aulast%3DBiroccio%26aufirst%3DA.%26aulast%3DCeccacci%26aufirst%3DA.%26aulast%3DPacini%26aufirst%3DL.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DGennari%26aufirst%3DN.%26aulast%3DBisbocci%26aufirst%3DM.%26aulast%3DIncitti%26aufirst%3DI.%26aulast%3DOrsatti%26aufirst%3DL.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DStansfield%26aufirst%3DI.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMigliaccio%26aufirst%3DG.%26atitle%3DMechanism%2520of%2520action%2520and%2520antiviral%2520activity%2520of%2520benzimidazole-based%2520allosteric%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520RNA-dependent%2520RNA%2520polymerase%26jtitle%3DJ.%2520Virol.%26date%3D2003%26volume%3D77%26spage%3D13225%26epage%3D13231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Di Marco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carfi, A.</span><span> </span><span class="NLM_article-title">Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">29765</span><span class="NLM_x">–</span> <span class="NLM_lpage">29770</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1074%2Fjbc.M505423200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=15955819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD2MXns1Sltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=29765-29770&author=S.+Di+Marcoauthor=C.+Volpariauthor=L.+Tomeiauthor=S.+Altamuraauthor=S.+Harperauthor=F.+Narjesauthor=U.+Kochauthor=M.+Rowleyauthor=R.+De+Francescoauthor=G.+Migliaccioauthor=A.+Carfi&title=Interdomain+communication+in+hepatitis+C+virus+polymerase+abolished+by+small+molecule+inhibitors+bound+to+a+novel+allosteric+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small Molecule Inhibitors Bound to a Novel Allosteric Site</span></div><div class="casAuthors">Di Marco, Stefania; Volpari, Cinzia; Tomei, Licia; Altamura, Sergio; Harper, Steven; Narjes, Frank; Koch, Uwe; Rowley, Michael; De Francesco, Raffaele; Migliaccio, Giovanni; Carfi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">29765-29770</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase is required for replication of the viral genome and is a key target for therapeutic intervention against HCV.  We have detd. the crystal structures of the HCV polymerase complexed with two indole-based allosteric inhibitors at 2.3- and 2.4-Å resoln.  The structures show that these inhibitors bind to a site on the surface of the thumb domain.  A cyclohexyl and Ph ring substituents, bridged by an indole moiety, fill two closely spaced pockets, whereas a carboxylate substituent forms a salt bridge with an exposed arginine side chain.  Interestingly, in the apoenzyme, the inhibitor binding site is occupied by a small α-helix at the tip of the N-terminal loop that connects the fingers and thumb domains.  Thus, these mols. inhibit the enzyme by preventing formation of intramol. contacts between these two domains and consequently precluding their coordinated movements during RNA synthesis.  Our structures identify a novel mechanism by which a new class of allosteric inhibitors inhibits the HCV polymerase and open the way to the development of novel antiviral agents against this clin. relevant human pathogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWHS1-2Y1C8LVg90H21EOLACvtfcHk0lgYUHzo2K7e3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXns1Sltr0%253D&md5=1192532b3624ec0032d9dff24c19a704</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M505423200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M505423200%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMarco%26aufirst%3DS.%26aulast%3DVolpari%26aufirst%3DC.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DCarfi%26aufirst%3DA.%26atitle%3DInterdomain%2520communication%2520in%2520hepatitis%2520C%2520virus%2520polymerase%2520abolished%2520by%2520small%2520molecule%2520inhibitors%2520bound%2520to%2520a%2520novel%2520allosteric%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D29765%26epage%3D29770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGibbon, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKercher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thauvette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">39260</span><span class="NLM_x">–</span> <span class="NLM_lpage">39267</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=39260-39267&author=G.+Kukoljauthor=G.+A.+McGibbonauthor=G.+McKercherauthor=M.+Marquisauthor=S.+Lefebvreauthor=L.+Thauvetteauthor=J.+Gauthierauthor=S.+Gouletauthor=M.-A.+Poupartauthor=P.+L.+Beaulieu&title=Binding+site+characterization+and+resistance+to+a+class+of+non-nucleoside+inhibitors+of+the+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DMcGibbon%26aufirst%3DG.%2BA.%26aulast%3DMcKercher%26aufirst%3DG.%26aulast%3DMarquis%26aufirst%3DM.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DThauvette%26aufirst%3DL.%26aulast%3DGauthier%26aufirst%3DJ.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DBinding%2520site%2520characterization%2520and%2520resistance%2520to%2520a%2520class%2520of%2520non-nucleoside%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D39260%26epage%3D39267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avolio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Filippo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paonessa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carfi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padron, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-<i>N</i>-acetamide allosteric inhibitors of the viral NS5B polymerase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4547</span><span class="NLM_x">–</span> <span class="NLM_lpage">4557</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050056%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4547-4557&author=S.+Harperauthor=S.+Avolioauthor=B.+Paciniauthor=M.+Di+Filippoauthor=S.+Altamuraauthor=L.+Tomeiauthor=G.+Paonessaauthor=S.+Di+Marcoauthor=A.+Carfiauthor=C.+Giulianoauthor=J.+Padronauthor=F.+Bonelliauthor=G.+Migliaccioauthor=R.+De+Francescoauthor=R.+Lauferauthor=M.+Rowleyauthor=F.+Narjes&title=Potent+inhibitors+of+subgenomic+hepatitis+C+virus+RNA+replication+through+optimization+of+indole-N-acetamide+allosteric+inhibitors+of+the+viral+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm050056%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050056%252B%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DAvolio%26aufirst%3DS.%26aulast%3DPacini%26aufirst%3DB.%26aulast%3DDi%2BFilippo%26aufirst%3DM.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DPaonessa%26aufirst%3DG.%26aulast%3DDi%2BMarco%26aufirst%3DS.%26aulast%3DCarfi%26aufirst%3DA.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DPadron%26aufirst%3DJ.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DPotent%2520inhibitors%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNA%2520replication%2520through%2520optimization%2520of%2520indole-N-acetamide%2520allosteric%2520inhibitors%2520of%2520the%2520viral%2520NS5B%2520polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4547%26epage%3D4557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Stansfield, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercolani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conte, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=627-632&author=I.+Stansfieldauthor=C.+Ercolaniauthor=A.+Mackayauthor=I.+Conteauthor=M.+Pompeiauthor=U.+Kochauthor=C.+Giulianoauthor=M.+Rowleyauthor=F.+Narjes&title=Tetracyclic+indole+inhibitors+of+hepatitis+C+virus+NS5B-polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStansfield%26aufirst%3DI.%26aulast%3DErcolani%26aufirst%3DC.%26aulast%3DMackay%26aufirst%3DA.%26aulast%3DConte%26aufirst%3DI.%26aulast%3DPompei%26aufirst%3DM.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DTetracyclic%2520indole%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS5B-polymerase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D627%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ikegashira, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirashima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noji, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruha, J.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, H.</span><span> </span><span class="NLM_article-title">Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6950</span><span class="NLM_x">–</span> <span class="NLM_lpage">6953</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0610245" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKrs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6950-6953&author=K.+Ikegashiraauthor=T.+Okaauthor=S.+Hirashimaauthor=S.+Nojiauthor=H.+Yamanakaauthor=Y.+Haraauthor=T.+Adachiauthor=J.-I.+Tsuruhaauthor=S.+Doiauthor=Y.+Haseauthor=T.+Noguchiauthor=I.+Andoauthor=N.+Oguraauthor=S.+Ikedaauthor=H.+Hashimoto&title=Discovery+of+conformationally+constrained+tetracyclic+compounds+as+potent+hepatitis+C+virus+NS5B+RNA+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors</span></div><div class="casAuthors">Ikegashira, Kazutaka; Oka, Takahiro; Hirashima, Shintaro; Noji, Satoru; Yamanaka, Hiroshi; Hara, Yoshinori; Adachi, Tsuyoshi; Tsuruha, Jun-Ichiro; Doi, Satoki; Hase, Yasunori; Noguchi, Toru; Ando, Izuru; Ogura, Naoki; Ikeda, Satoru; Hashimoto, Hiromasa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6950-6953</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report a new series of hepatitis C virus NS5B RNA polymerase inhibitors contg. a conformationally constrained tetracyclic scaffold.  SAR studies led to the identification of 6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indoles (I and II) bearing a basic pendent group with high biochem. and cellular potencies.  These compds. displayed a very small shift in cellular potency when the replicon assay was performed in the presence of human serum albumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF0S142h4FZLVg90H21EOLACvtfcHk0liF1NpoiLU-xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKrs7rF&md5=18234c5535779cf60484899c6e63770f</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fjm0610245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0610245%26sid%3Dliteratum%253Aachs%26aulast%3DIkegashira%26aufirst%3DK.%26aulast%3DOka%26aufirst%3DT.%26aulast%3DHirashima%26aufirst%3DS.%26aulast%3DNoji%26aufirst%3DS.%26aulast%3DYamanaka%26aufirst%3DH.%26aulast%3DHara%26aufirst%3DY.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DTsuruha%26aufirst%3DJ.-I.%26aulast%3DDoi%26aufirst%3DS.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DNoguchi%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DI.%26aulast%3DOgura%26aufirst%3DN.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520conformationally%2520constrained%2520tetracyclic%2520compounds%2520as%2520potent%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA%2520polymerase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6950%26epage%3D6953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">Similar results were reported by Japan Tobacca (ref <a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">26a</a>).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Similar+results+were+reported+by+Japan+Tobacca+%28ref+26a%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padron Velazquez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Paz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcucci, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span> </span><span class="NLM_article-title">Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase</span> <span class="citation_source-journal">Xenobiotics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1054</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1080%2F00498250500356548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=16393860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlGhurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=1035-1054&author=C.+Giulianoauthor=F.+Fioreauthor=A.+Di+Marcoauthor=J.+Padron+Velazquezauthor=A.+Bishopauthor=F.+Bonelliauthor=O.+Gonzalez-Pazauthor=I.+Marcucciauthor=S.+Harperauthor=F.+Narjesauthor=B.+Paciniauthor=E.+Monteagudoauthor=G.+Migliaccioauthor=M.+Rowleyauthor=R.+Laufer&title=Preclinical+pharmacokinetics+and+metabolism+of+a+potent+non-nucleoside+inhibitor+of+the+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase</span></div><div class="casAuthors">Giuliano, C.; Fiore, F.; Di Marco, A.; Padron Velazquez, J.; Bishop, A.; Bonelli, F.; Gonzalez-paz, O.; Marcucci, I.; Harper, S.; Narjes, F.; Pacini, B.; Monteagudo, E.; Migliaccio, G.; Rowley, M.; Laufer, R.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10/11</span>),
    <span class="NLM_cas:pages">1035-1054</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The disposition of compd. A, a potent inhibitor of the hepatitis C virus (HCV) NS5B polymerase, was characterized in animals in support of its selection for further development.  Compd. A exhibited marked species differences in pharmacokinetics.  Plasma clearance was 44 mL min-1 kg-1 in rats, 9 mL min-1 kg-1 in dogs and 16 mL min-1 kg-1 in rhesus monkeys.  Oral bioavailability was low in rats (10%) but significantly higher in dogs (52%) and monkeys (26%).  Compd. A was eliminated primarily by metab. in rats, with biliary excretion accounting for 30% of its clearance.  Metab. was mainly mediated by cyclohexyl hydroxylation, with N-deethylation and acyl glucuronide formation constituting minor metabolic pathways.  Qual., the same metabolites were identified using in vitro systems from all species studied, including humans.  The low oral bioavailability of compd. A in rats was mostly due to poor intestinal absorption.  This conclusion was borne out by the findings that hepatic extn. in the rat was only 30%, i.p. bioavailability was good, and compd. A was poorly absorbed from the rat isolated intestinal loop, with no detectable intestinal metab.  Compd. A was not an inhibitor of major human cytochrome P 450 enzymes, indicating minimal potential for clin. drug-drug interactions.  The metabolic clearance of compd. A in rat, dog and monkey hepatocytes correlated with the systemic clearance obsd. in these species.  Since compd. A was very stable in human hepatocytes, the results suggest that it will be a low clearance drug in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAvzCrg7n-1LVg90H21EOLACvtfcHk0liF1NpoiLU-xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlGhurjJ&md5=a8b429d163e1f1f935271e31fdb289e6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F00498250500356548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250500356548%26sid%3Dliteratum%253Aachs%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DDi%2BMarco%26aufirst%3DA.%26aulast%3DPadron%2BVelazquez%26aufirst%3DJ.%26aulast%3DBishop%26aufirst%3DA.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DGonzalez-Paz%26aufirst%3DO.%26aulast%3DMarcucci%26aufirst%3DI.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DPacini%26aufirst%3DB.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DLaufer%26aufirst%3DR.%26atitle%3DPreclinical%2520pharmacokinetics%2520and%2520metabolism%2520of%2520a%2520potent%2520non-nucleoside%2520inhibitor%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DXenobiotics%26date%3D2005%26volume%3D35%26spage%3D1035%26epage%3D1054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ontoria, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin Hernando, J. I</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malancona, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attenni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stansfield, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conte, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercolani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Filippo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Identification of thieno[3,2-<i>b</i>]pyrroles as allosteric inhibitors of hepatitis C virus NS5B polymerase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4026</span><span class="NLM_x">–</span> <span class="NLM_lpage">4030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4026-4030&author=J.+M.+Ontoriaauthor=J.+I+Martin+Hernandoauthor=S.+Malanconaauthor=B.+Attenniauthor=I.+Stansfieldauthor=I.+Conteauthor=C.+Ercolaniauthor=J.+Habermannauthor=S.+Ponziauthor=M.+Di+Filippoauthor=U.+Kochauthor=M.+Rowleyauthor=F.+Narjes&title=Identification+of+thieno%5B3%2C2-b%5Dpyrroles+as+allosteric+inhibitors+of+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOntoria%26aufirst%3DJ.%2BM.%26aulast%3DMartin%2BHernando%26aufirst%3DJ.%2BI%26aulast%3DMalancona%26aufirst%3DS.%26aulast%3DAttenni%26aufirst%3DB.%26aulast%3DStansfield%26aufirst%3DI.%26aulast%3DConte%26aufirst%3DI.%26aulast%3DErcolani%26aufirst%3DC.%26aulast%3DHabermann%26aufirst%3DJ.%26aulast%3DPonzi%26aufirst%3DS.%26aulast%3DDi%2BFilippo%26aufirst%3DM.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DIdentification%2520of%2520thieno%255B3%252C2-b%255Dpyrroles%2520as%2520allosteric%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4026%26epage%3D4030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Martin Hernando, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ontoria, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malancona, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attenni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colarusso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gennari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico Ferreira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Optimization of thienopyrrole-based finger-loop inhibitors of the hepatitis C virus NS5B polymerase</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1695</span><span class="NLM_x">–</span> <span class="NLM_lpage">1713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1695-1713&author=J.+I.+Martin+Hernandoauthor=J.+M.+Ontoriaauthor=S.+Malanconaauthor=B.+Attenniauthor=F.+Fioreauthor=F.+Bonelliauthor=U.+Kochauthor=S.+Di+Marcoauthor=S.+Colarussoauthor=S.+Ponziauthor=N.+Gennariauthor=M.+Rico+Ferreiraauthor=R.+Delauthor=J.+Habermannauthor=M.+Rowleyauthor=F.+Narjes&title=Optimization+of+thienopyrrole-based+finger-loop+inhibitors+of+the+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%2BHernando%26aufirst%3DJ.%2BI.%26aulast%3DOntoria%26aufirst%3DJ.%2BM.%26aulast%3DMalancona%26aufirst%3DS.%26aulast%3DAttenni%26aufirst%3DB.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DDi%2BMarco%26aufirst%3DS.%26aulast%3DColarusso%26aufirst%3DS.%26aulast%3DPonzi%26aufirst%3DS.%26aulast%3DGennari%26aufirst%3DN.%26aulast%3DRico%2BFerreira%26aufirst%3DM.%26aulast%3DDel%26aufirst%3DR.%26aulast%3DHabermann%26aufirst%3DJ.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DOptimization%2520of%2520thienopyrrole-based%2520finger-loop%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1695%26epage%3D1713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Habermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capitò, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico Ferreira, M. d. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Discovery of pentacyclic compounds as potent inhibitors of hepatitis C virus NS5B polymerase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=633-638&author=J.+Habermannauthor=E.+Capit%C3%B2author=M.+d.+R.+Rico+Ferreiraauthor=U.+Kochauthor=F.+Narjes&title=Discovery+of+pentacyclic+compounds+as+potent+inhibitors+of+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHabermann%26aufirst%3DJ.%26aulast%3DCapit%25C3%25B2%26aufirst%3DE.%26aulast%3DRico%2BFerreira%26aufirst%3DM.%2Bd.%2BR.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520pentacyclic%2520compounds%2520as%2520potent%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D633%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ponzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico Ferreira, M. del R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Synthesis of indolo[2,1-<i>a</i>][2]benzazepine and indolo[2,1-<i>a</i>][2]benzazocine</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">1395</span><span class="NLM_x">–</span> <span class="NLM_lpage">1400</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=1395-1400&author=S.+Ponziauthor=J.+Habermannauthor=M.+del+R.+Rico+Ferreiraauthor=F.+Narjes&title=Synthesis+of+indolo%5B2%2C1-a%5D%5B2%5Dbenzazepine+and+indolo%5B2%2C1-a%5D%5B2%5Dbenzazocine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPonzi%26aufirst%3DS.%26aulast%3DHabermann%26aufirst%3DJ.%26aulast%3DRico%2BFerreira%26aufirst%3DM.%2Bdel%2BR.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DSynthesis%2520of%2520indolo%255B2%252C1-a%255D%255B2%255Dbenzazepine%2520and%2520indolo%255B2%252C1-a%255D%255B2%255Dbenzazocine%26jtitle%3DSynlett%26date%3D2009%26spage%3D1395%26epage%3D1400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mercer, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinfret, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Addison, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakey, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kneteman, N. M.</span><span> </span><span class="NLM_article-title">Hepatitis C Virus Replication in Mice with Chimeric Human Livers</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=927-933&author=D.+F.+Mercerauthor=D.+E.+Schillerauthor=J.+F.+Elliottauthor=D.+N.+Douglasauthor=C.+Haoauthor=A.+Rinfretauthor=W.+R.+Addisonauthor=K.+P.+Fischerauthor=T.+A.+Churchillauthor=J.+R.+Lakeyauthor=D.+L.+Tyrrellauthor=N.+M.+Kneteman&title=Hepatitis+C+Virus+Replication+in+Mice+with+Chimeric+Human+Livers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMercer%26aufirst%3DD.%2BF.%26aulast%3DSchiller%26aufirst%3DD.%2BE.%26aulast%3DElliott%26aufirst%3DJ.%2BF.%26aulast%3DDouglas%26aufirst%3DD.%2BN.%26aulast%3DHao%26aufirst%3DC.%26aulast%3DRinfret%26aufirst%3DA.%26aulast%3DAddison%26aufirst%3DW.%2BR.%26aulast%3DFischer%26aufirst%3DK.%2BP.%26aulast%3DChurchill%26aufirst%3DT.%2BA.%26aulast%3DLakey%26aufirst%3DJ.%2BR.%26aulast%3DTyrrell%26aufirst%3DD.%2BL.%26aulast%3DKneteman%26aufirst%3DN.%2BM.%26atitle%3DHepatitis%2520C%2520Virus%2520Replication%2520in%2520Mice%2520with%2520Chimeric%2520Human%2520Livers%26jtitle%3DNature%2520Med.%26date%3D2001%26volume%3D7%26spage%3D927%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Meulemann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux-Roels, G.</span><span> </span><span class="NLM_article-title">The human liver-upa-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2008&pages=231-238&author=P.+Meulemannauthor=G.+Leroux-Roels&title=The+human+liver-upa-SCID+mouse%3A+a+model+for+the+evaluation+of+antiviral+compounds+against+HBV+and+HCV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeulemann%26aufirst%3DP.%26aulast%3DLeroux-Roels%26aufirst%3DG.%26atitle%3DThe%2520human%2520liver-upa-SCID%2520mouse%253A%2520a%2520model%2520for%2520the%2520evaluation%2520of%2520antiviral%2520compounds%2520against%2520HBV%2520and%2520HCV%26jtitle%3DAntiviral%2520Res.%26date%3D2008%26volume%3D80%26spage%3D231%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Klunder, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">Arenesulfonate derivatives of homochiral glycidol: versatile chiral building blocks for organic synthesis</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1304</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00267a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADyaL1MXhtlCqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1989&pages=1295-1304&author=J.+M.+Klunderauthor=T.+Onamiauthor=K.+B.+Sharpless&title=Arenesulfonate+derivatives+of+homochiral+glycidol%3A+versatile+chiral+building+blocks+for+organic+synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Arenesulfonate derivatives of homochiral glycidol:  versatile chiral building blocks for organic synthesis</span></div><div class="casAuthors">Klunder, Janice M.; Onami, Tetsuo; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1295-304</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The prepn. of a series of cryst. arenesulfonate derivs. of enantiomerically enriched glycidol is described.  The enhancement of optical purity by recrystn. was particularly successful for two of these derivs., glycidyl tosylate and glycidyl 3-nitrobenzenesulfonate, which were obtained in 97% ee and 99% ee, resp.  Very high regioselectivity was obsd. in the reactions of these compds. with a variety of nucleophiles, including aryl oxides, Et2AlCN, organometallic reagents, and BH3-NaBH4.  The application of this methodol. to the synthesis of homochiral β-adrenergic blocking agents and homochiral terminal epoxides is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqupfXNm6dqrVg90H21EOLACvtfcHk0lhfg4Cs4_a49A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhtlCqurc%253D&md5=a7b12df2ca30fa1b1b3f5fdead5d08f0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo00267a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00267a014%26sid%3Dliteratum%253Aachs%26aulast%3DKlunder%26aufirst%3DJ.%2BM.%26aulast%3DOnami%26aufirst%3DT.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DArenesulfonate%2520derivatives%2520of%2520homochiral%2520glycidol%253A%2520versatile%2520chiral%2520building%2520blocks%2520for%2520organic%2520synthesis%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1989%26volume%3D54%26spage%3D1295%26epage%3D1304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Soli, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manoso, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeShong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favor, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirschmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  III.</span><span> </span><span class="NLM_article-title">Azide and cyanide displacements via hypervalent silicate intermediates</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">3171</span><span class="NLM_x">–</span> <span class="NLM_lpage">3177</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo982302d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1999&pages=3171-3177&author=E.+D.+Soliauthor=A.+S.+Manosoauthor=M.+C.+Pattersonauthor=P.+DeShongauthor=D.+A.+Favorauthor=R.+Hirschmannauthor=A.+B.+Smith&title=Azide+and+cyanide+displacements+via+hypervalent+silicate+intermediates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjo982302d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo982302d%26sid%3Dliteratum%253Aachs%26aulast%3DSoli%26aufirst%3DE.%2BD.%26aulast%3DManoso%26aufirst%3DA.%2BS.%26aulast%3DPatterson%26aufirst%3DM.%2BC.%26aulast%3DDeShong%26aufirst%3DP.%26aulast%3DFavor%26aufirst%3DD.%2BA.%26aulast%3DHirschmann%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DAzide%2520and%2520cyanide%2520displacements%2520via%2520hypervalent%2520silicate%2520intermediates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1999%26volume%3D64%26spage%3D3171%26epage%3D3177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Nishizono, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, A.</span><span> </span><span class="NLM_article-title">Nucleosides and nucleotides. 159. Synthesis of thietane nucleosides via the Pummerer reaction as a key step</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">7569</span><span class="NLM_x">–</span> <span class="NLM_lpage">7572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=7569-7572&author=N.+Nishizonoauthor=N.+Koikeauthor=Y.+Yamagataauthor=S.+Fujiiauthor=A.+Matsuda&title=Nucleosides+and+nucleotides.+159.+Synthesis+of+thietane+nucleosides+via+the+Pummerer+reaction+as+a+key+step"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNishizono%26aufirst%3DN.%26aulast%3DKoike%26aufirst%3DN.%26aulast%3DYamagata%26aufirst%3DY.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DMatsuda%26aufirst%3DA.%26atitle%3DNucleosides%2520and%2520nucleotides.%2520159.%2520Synthesis%2520of%2520thietane%2520nucleosides%2520via%2520the%2520Pummerer%2520reaction%2520as%2520a%2520key%2520step%26jtitle%3DTetrahedron%2520Lett.%26date%3D1996%26volume%3D37%26spage%3D7569%26epage%3D7572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFemina, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span> </span><span class="NLM_article-title">A Genotype 2b NS5B Polymerase with Novel Substitutions Supports Replication of a Chimeric HCV 1b:2b Replicon Containing a Genotype 1b NS3-5A Background</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=24-30&author=D.+J.+Grahamauthor=M.+Stahlhutauthor=O.+Floresauthor=D.+B.+Olsenauthor=D.+J.+Hazudaauthor=R.+L.+LaFeminaauthor=S.+W.+Ludmerer&title=A+Genotype+2b+NS5B+Polymerase+with+Novel+Substitutions+Supports+Replication+of+a+Chimeric+HCV+1b%3A2b+Replicon+Containing+a+Genotype+1b+NS3-5A+Background"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DFlores%26aufirst%3DO.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DLaFemina%26aufirst%3DR.%2BL.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26atitle%3DA%2520Genotype%25202b%2520NS5B%2520Polymerase%2520with%2520Novel%2520Substitutions%2520Supports%2520Replication%2520of%2520a%2520Chimeric%2520HCV%25201b%253A2b%2520Replicon%2520Containing%2520a%2520Genotype%25201b%2520NS3-5A%2520Background%26jtitle%3DAntiviral%2520Res.%26date%3D2006%26volume%3D69%26spage%3D24%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Herlihy, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumpf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patick, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S. T.</span><span> </span><span class="NLM_article-title">Development of Intergenotypic Replicons to Determine the Broad-Spectrum Antiviral Activities of Hepatitis C Virus Polymerase Inhibitors</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3523</span><span class="NLM_x">–</span> <span class="NLM_lpage">3531</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3523-3531&author=K.+J.+Herlihyauthor=J.+P.+Grahamauthor=R.+Kumpfauthor=A.+K.+Patickauthor=R.+Duggalauthor=S.+T.+Shi&title=Development+of+Intergenotypic+Replicons+to+Determine+the+Broad-Spectrum+Antiviral+Activities+of+Hepatitis+C+Virus+Polymerase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHerlihy%26aufirst%3DK.%2BJ.%26aulast%3DGraham%26aufirst%3DJ.%2BP.%26aulast%3DKumpf%26aufirst%3DR.%26aulast%3DPatick%26aufirst%3DA.%2BK.%26aulast%3DDuggal%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DS.%2BT.%26atitle%3DDevelopment%2520of%2520Intergenotypic%2520Replicons%2520to%2520Determine%2520the%2520Broad-Spectrum%2520Antiviral%2520Activities%2520of%2520Hepatitis%2520C%2520Virus%2520Polymerase%2520Inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3523%26epage%3D3531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Rydberg, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartholomew, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbato, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paonessa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carfi, A.</span><span> </span><span class="NLM_article-title">Structural basis for resistance of the genotype 2b hepatitis C virus NS5B polymerase to site A non-nucleoside Inhibitors</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">390</span><span class="NLM_x">, </span> <span class="NLM_fpage">1048</span><span class="NLM_x">–</span> <span class="NLM_lpage">1059</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2009&pages=1048-1059&author=E.+H.+Rydbergauthor=A.+Cellucciauthor=L.+Bartholomewauthor=M.+Mattuauthor=G.+Barbatoauthor=S.+W.+Ludmererauthor=D.+J.+Grahamauthor=S.+Altamuraauthor=G.+Paonessaauthor=R.+De+Francescoauthor=G.+Migliaccioauthor=A.+Carfi&title=Structural+basis+for+resistance+of+the+genotype+2b+hepatitis+C+virus+NS5B+polymerase+to+site+A+non-nucleoside+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRydberg%26aufirst%3DE.%2BH.%26aulast%3DCellucci%26aufirst%3DA.%26aulast%3DBartholomew%26aufirst%3DL.%26aulast%3DMattu%26aufirst%3DM.%26aulast%3DBarbato%26aufirst%3DG.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DPaonessa%26aufirst%3DG.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DCarfi%26aufirst%3DA.%26atitle%3DStructural%2520basis%2520for%2520resistance%2520of%2520the%2520genotype%25202b%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%2520to%2520site%2520A%2520non-nucleoside%2520Inhibitors%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D390%26spage%3D1048%26epage%3D1059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="note"><p class="first last">The atomic coordinates and structure factors have been deposited with the Protein Data Bank (accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xwy">2xwy</a>). Further information about soaking conditions and structure determination is available in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Figures were generated with PyMOL (DeLano Scientific).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span>MacroModel version 7.0; <span class="NLM_publisher-name">Schrodinger Inc.</span>: <span class="NLM_publisher-loc">Portland OR 97201</span>; <a href="http://www.schrodinger.com/Products/macromodel.html" class="extLink">http://www.schrodinger.com/Products/macromodel.html</a>,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MacroModel+version+7.0%3B+Schrodinger+Inc.%3A+Portland+OR+97201%3B+http%3A%2F%2Fwww.schrodinger.com%2FProducts%2Fmacromodel.html%2C+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMacroModel%2520version%25207.0%26pub%3DSchrodinger%2520Inc%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Meuleman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libbrecht, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Hemptinne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevaert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandekerckhove, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roskams, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux-Roels, G.</span><span> </span><span class="NLM_article-title">Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">856</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=847-856&author=P.+Meulemanauthor=L.+Libbrechtauthor=R.+de+Vosauthor=B.+de+Hemptinneauthor=K.+Gevaertauthor=J.+Vandekerckhoveauthor=T.+Roskamsauthor=G.+Leroux-Roels&title=Morphological+and+biochemical+characterization+of+a+human+liver+in+a+uPA-SCID+mouse+chimera"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeuleman%26aufirst%3DP.%26aulast%3DLibbrecht%26aufirst%3DL.%26aulast%3Dde%2BVos%26aufirst%3DR.%26aulast%3Dde%2BHemptinne%26aufirst%3DB.%26aulast%3DGevaert%26aufirst%3DK.%26aulast%3DVandekerckhove%26aufirst%3DJ.%26aulast%3DRoskams%26aufirst%3DT.%26aulast%3DLeroux-Roels%26aufirst%3DG.%26atitle%3DMorphological%2520and%2520biochemical%2520characterization%2520of%2520a%2520human%2520liver%2520in%2520a%2520uPA-SCID%2520mouse%2520chimera%26jtitle%3DHepatology%26date%3D2005%26volume%3D41%26spage%3D847%26epage%3D856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lindenbach, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meuleman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanwolleghem, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syder, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeating, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanford, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstone, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux-Roels, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">3805</span><span class="NLM_x">–</span> <span class="NLM_lpage">3809</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=3805-3809&author=B.+D.+Lindenbachauthor=P.+Meulemanauthor=A.+Plossauthor=T.+Vanwolleghemauthor=A.+J.+Syderauthor=J.+A.+McKeatingauthor=R.+E.+Lanfordauthor=S.+M.+Feinstoneauthor=M.+E.+Majorauthor=G.+Leroux-Roelsauthor=C.+M.+Rice&title=Cell+culture-grown+hepatitis+C+virus+is+infectious+in+vivo+and+can+be+recultured+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindenbach%26aufirst%3DB.%2BD.%26aulast%3DMeuleman%26aufirst%3DP.%26aulast%3DPloss%26aufirst%3DA.%26aulast%3DVanwolleghem%26aufirst%3DT.%26aulast%3DSyder%26aufirst%3DA.%2BJ.%26aulast%3DMcKeating%26aufirst%3DJ.%2BA.%26aulast%3DLanford%26aufirst%3DR.%2BE.%26aulast%3DFeinstone%26aufirst%3DS.%2BM.%26aulast%3DMajor%26aufirst%3DM.%2BE.%26aulast%3DLeroux-Roels%26aufirst%3DG.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DCell%2520culture-grown%2520hepatitis%2520C%2520virus%2520is%2520infectious%2520in%2520vivo%2520and%2520can%2520be%2520recultured%2520in%2520vitro%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D3805%26epage%3D3809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bukh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meuleman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engle, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstone, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satterfield, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Govindarajan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krawczynski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux-Roels, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, R. H.</span><span> </span><span class="NLM_article-title">Challenge pools of hepatitis C virus genotypes 1−6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">201</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">–</span> <span class="NLM_lpage">1389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1086%2F651579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=20353362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlSmtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=201&publication_year=2010&pages=1381-1389&author=J.+Bukhauthor=P.+Meulemanauthor=R.+Tellierauthor=R.+E.+Engleauthor=S.+M.+Feinstoneauthor=G.+Ederauthor=W.+C.+Satterfieldauthor=S.+Govindarajanauthor=K.+Krawczynskiauthor=R.+H.+Millerauthor=G.+Leroux-Roelsauthor=R.+H.+Purcell&title=Challenge+pools+of+hepatitis+C+virus+genotypes+1%E2%88%926+prototype+strains%3A+replication+fitness+and+pathogenicity+in+chimpanzees+and+human+liver-chimeric+mouse+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40bR"><div class="casContent"><span class="casTitleNuber">40b</span><div class="casTitle"><span class="NLM_cas:atitle">Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models</span></div><div class="casAuthors">Bukh, Jens; Meuleman, Philip; Tellier, Raymond; Engle, Ronald E.; Feinstone, Stephen M.; Eder, Gerald; Satterfield, William C.; Govindarajan, Sugantha; Krawczynski, Krzysztof; Miller, Roger H.; Leroux-Roels, Geert; Purcell, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">201</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1381-1389</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Chimpanzees represent the only animal model for studies of the natural history of hepatitis C virus (HCV).  To generate virus stocks of important HCV variants, we infected chimpanzees with HCV strains of genotypes 1-6 and detd. the infectivity titer of acute-phase plasma pools in addnl. animals.  The courses of first- and second-passage infections were similar, with early appearance of viremia, HCV RNA titers of >104.7 IU/mL, and development of acute hepatitis; the chronicity rate was 56%.  The challenge pools had titers of 103-105 chimpanzee infectious doses/mL.  Human liver-chimeric mice developed high-titer infections after inoculation with the challenge viruses of genotypes 1-6.  Inoculation studies with different doses of the genotype 1b pool suggested that a relatively high virus dose is required to consistently infect chimeric mice.  The challenge pools represent a unique resource for studies of HCV mol. virol. and for studies of pathogenesis, protective immunity, and vaccine efficacy in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgwPI9Ftj_hrVg90H21EOLACvtfcHk0lgGOHef9JphJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlSmtLw%253D&md5=81236a78a964efe801dd4648a5832d60</span></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1086%2F651579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F651579%26sid%3Dliteratum%253Aachs%26aulast%3DBukh%26aufirst%3DJ.%26aulast%3DMeuleman%26aufirst%3DP.%26aulast%3DTellier%26aufirst%3DR.%26aulast%3DEngle%26aufirst%3DR.%2BE.%26aulast%3DFeinstone%26aufirst%3DS.%2BM.%26aulast%3DEder%26aufirst%3DG.%26aulast%3DSatterfield%26aufirst%3DW.%2BC.%26aulast%3DGovindarajan%26aufirst%3DS.%26aulast%3DKrawczynski%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DR.%2BH.%26aulast%3DLeroux-Roels%26aufirst%3DG.%26aulast%3DPurcell%26aufirst%3DR.%2BH.%26atitle%3DChallenge%2520pools%2520of%2520hepatitis%2520C%2520virus%2520genotypes%25201%25E2%2588%25926%2520prototype%2520strains%253A%2520replication%2520fitness%2520and%2520pathogenicity%2520in%2520chimpanzees%2520and%2520human%2520liver-chimeric%2520mouse%2520models%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2010%26volume%3D201%26spage%3D1381%26epage%3D1389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kneteman, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aukerman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovelsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, Z.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashash, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kline, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D. L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, D. F.</span><span> </span><span class="NLM_article-title">Anti-HCV therapies in chimeric Scid-Alb/Upa mice parallel outcomes in human clinical application</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1346</span><span class="NLM_x">–</span> <span class="NLM_lpage">1353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2006&pages=1346-1353&author=N.+M.+Knetemanauthor=A.+J.+Weinerauthor=J.+O%E2%80%99Connellauthor=M.+Collettauthor=T.+Gaoauthor=L.+Aukermanauthor=R.+Kovelskyauthor=Z.-J.+Niauthor=A.+Hashashauthor=J.+Klineauthor=B.+Hsiauthor=D.+Schillerauthor=D.+Douglasauthor=D.+L.+J.+Tyrrellauthor=D.+F.+Mercer&title=Anti-HCV+therapies+in+chimeric+Scid-Alb%2FUpa+mice+parallel+outcomes+in+human+clinical+application"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKneteman%26aufirst%3DN.%2BM.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DCollett%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DAukerman%26aufirst%3DL.%26aulast%3DKovelsky%26aufirst%3DR.%26aulast%3DNi%26aufirst%3DZ.-J.%26aulast%3DHashash%26aufirst%3DA.%26aulast%3DKline%26aufirst%3DJ.%26aulast%3DHsi%26aufirst%3DB.%26aulast%3DSchiller%26aufirst%3DD.%26aulast%3DDouglas%26aufirst%3DD.%26aulast%3DTyrrell%26aufirst%3DD.%2BL.%2BJ.%26aulast%3DMercer%26aufirst%3DD.%2BF.%26atitle%3DAnti-HCV%2520therapies%2520in%2520chimeric%2520Scid-Alb%252FUpa%2520mice%2520parallel%2520outcomes%2520in%2520human%2520clinical%2520application%26jtitle%3DHepatology%26date%3D2006%26volume%3D43%26spage%3D1346%26epage%3D1353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit41b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vanwolleghem, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meuleman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libbrecht, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roskams, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux-Roels, G.</span><span> </span><span class="NLM_article-title">Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2007&pages=1144-1155&author=T.+Vanwolleghemauthor=P.+Meulemanauthor=L.+Libbrechtauthor=T.+Roskamsauthor=R.+De+Vosauthor=G.+Leroux-Roels&title=Ultra-rapid+cardiotoxicity+of+the+hepatitis+C+virus+protease+inhibitor+BILN+2061+in+the+urokinase-type+plasminogen+activator+mouse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVanwolleghem%26aufirst%3DT.%26aulast%3DMeuleman%26aufirst%3DP.%26aulast%3DLibbrecht%26aufirst%3DL.%26aulast%3DRoskams%26aufirst%3DT.%26aulast%3DDe%2BVos%26aufirst%3DR.%26aulast%3DLeroux-Roels%26aufirst%3DG.%26atitle%3DUltra-rapid%2520cardiotoxicity%2520of%2520the%2520hepatitis%2520C%2520virus%2520protease%2520inhibitor%2520BILN%25202061%2520in%2520the%2520urokinase-type%2520plasminogen%2520activator%2520mouse%26jtitle%3DGastroenterology%26date%3D2007%26volume%3D133%26spage%3D1144%26epage%3D1155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit41c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kneteman, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, A. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevear, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, D. F.; D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immermann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villano, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collett, M.</span><span> </span><span class="NLM_article-title">HCV796: a selective nonstructural protein 5B polymerase inhibitor with potent anti-Hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with Hepatitis C virus</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=16&amp;doi=10.1021%2Fjm1013105&amp;key=10.1002%2Fhep.22717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=8&amp;doi=10.1021%2Fjm1013105&amp;key=19072827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=32&amp;doi=10.1021%2Fjm1013105&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFOnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=745-752&author=N.+M.+Knetemanauthor=A.+Y.+M.+Howeauthor=T.+Gaoauthor=J.+Lewisauthor=D.+Pevearauthor=G.+Lundauthor=D.+Douglasauthor=D.+F.%3B+D.+Mercerauthor=D.+L.+Tyrrellauthor=F.+Immermannauthor=I.+Chaudharyauthor=J.+Spethauthor=S.+A.+Villanoauthor=J.+O%E2%80%99Connellauthor=M.+Collett&title=HCV796%3A+a+selective+nonstructural+protein+5B+polymerase+inhibitor+with+potent+anti-Hepatitis+C+virus+activity+in+vitro%2C+in+mice+with+chimeric+human+livers%2C+and+in+humans+infected+with+Hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41cR"><div class="casContent"><span class="casTitleNuber">41c</span><div class="casTitle"><span class="NLM_cas:atitle">HCCV796: a selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus</span></div><div class="casAuthors">Kneteman, Norman M.; Howe, Anita Y. M.; Gao, Tiejun; Lewis, Jamie; Pevear, Dan; Lund, Gary; Douglas, Donna; Mercer, David F.; Tyrrell, D. Lorne J.; Immermann, Frederick; Chaudhary, Inder; Speth, John; Villano, Stephen A.; O'Connell, John; Collett, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">745-752</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Anti-hepatitis C virus (HCV) drug development has been challenged by a lack of experience with inhibitors inclusive of in vitro, animal model, and clin. study.  This manuscript outlines activity and correlation across such a spectrum of models and into clin. trials with a novel selective nonstructural protein 5B (NS5B) polymerase inhibitor, HCV796.  Enzyme assays yielded median inhibitory concn. (IC50) values of 0.01 to 0.14 μM for genotype 1, with half maximal effective concn. (EC50s) of 5 nM and 9 nM against genotype 1a and 1b replicons.  In the chimeric mouse model, a 2.02 ± 0.55 log redn. in HCV titer was seen with monotherapy, whereas a suboptimal dose of 30 mg/kg three times per day in combination with interferon demonstrated a 2.44 log redn. (P = 0.001 vs. interferon alone) Clin. outcomes in combination with pegylated interferon and ribavirin have revealed additive efficacy in treatment naive patients.  Abnormal liver function test results were obsd. in 8% of HCV-796 patients treated for over 8 wk, resulting in suspension of further trial activity.  Conclusion: The RNA-dependent RNA polymerase inhibitor HCV796 demonstrated potent anti-HCV activity consistently through enzyme inhibition assays, subgenomic replicon, and chimeric mouse studies.  Strong correlations of outcomes in the mouse model were seen with subsequent clin. trials, including a plateau in dose-related antiviral activity and additive impact from combination therapy with interferon.  These outcomes demonstrate the utility of the range of in vitro and in vivo models now available for anti-HCV drug development and support the potential utility of polymerase inhibitors in future combination therapies for HCV treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7ZCtNeI0RLLVg90H21EOLACvtfcHk0lgGOHef9JphJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFOnu70%253D&md5=0dcebc9c1e93051ad46eae43b352e7cf</span></div><a href="/servlet/linkout?suffix=cit41c&amp;dbid=16384&amp;doi=10.1002%2Fhep.22717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22717%26sid%3Dliteratum%253Aachs%26aulast%3DKneteman%26aufirst%3DN.%2BM.%26aulast%3DHowe%26aufirst%3DA.%2BY.%2BM.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DPevear%26aufirst%3DD.%26aulast%3DLund%26aufirst%3DG.%26aulast%3DDouglas%26aufirst%3DD.%26aulast%3DMercer%26aufirst%3DD.%2BF.%253B%2BD.%26aulast%3DTyrrell%26aufirst%3DD.%2BL.%26aulast%3DImmermann%26aufirst%3DF.%26aulast%3DChaudhary%26aufirst%3DI.%26aulast%3DSpeth%26aufirst%3DJ.%26aulast%3DVillano%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DCollett%26aufirst%3DM.%26atitle%3DHCV796%253A%2520a%2520selective%2520nonstructural%2520protein%25205B%2520polymerase%2520inhibitor%2520with%2520potent%2520anti-Hepatitis%2520C%2520virus%2520activity%2520in%2520vitro%252C%2520in%2520mice%2520with%2520chimeric%2520human%2520livers%252C%2520and%2520in%2520humans%2520infected%2520with%2520Hepatitis%2520C%2520virus%26jtitle%3DHepatology%26date%3D2009%26volume%3D49%26spage%3D745%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit41d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">LaPorte, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draper, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaboury, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussey, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rippin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benetatos, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chunduru, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coburn, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, A. Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collett, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevear, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D. L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kneteman, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, S. M.</span><span> </span><span class="NLM_article-title">The discovery of pyrano[3,4-<i>b</i>]indole-based allosteric inhibitors of HCV NS5B polymerase with in vivo activity</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1508</span><span class="NLM_x">–</span> <span class="NLM_lpage">1515</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1508-1515&author=M.+G.+LaPorteauthor=R.+W.+Jacksonauthor=T.+L.+Draperauthor=J.+A.+Gabouryauthor=K.+Galieauthor=T.+Herbertzauthor=A.+R.+Husseyauthor=S.+R.+Rippinauthor=C.+A.+Benetatosauthor=S.+K.+Chunduruauthor=J.+S.+Christensenauthor=G.+A.+Coburnauthor=C.+J.+Rizzoauthor=G.+Rhodesauthor=J.+O%E2%80%99Connellauthor=A.+Y.+M.+Howeauthor=T.+S.+Mansourauthor=M.+S.+Collettauthor=D.+C.+Pevearauthor=D.+C.+Youngauthor=T.+Gaoauthor=D.+L.+J.+Tyrrellauthor=N.+M.+Knetemanauthor=C.+J.+Burnsauthor=S.+M.+Condon&title=The+discovery+of+pyrano%5B3%2C4-b%5Dindole-based+allosteric+inhibitors+of+HCV+NS5B+polymerase+with+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaPorte%26aufirst%3DM.%2BG.%26aulast%3DJackson%26aufirst%3DR.%2BW.%26aulast%3DDraper%26aufirst%3DT.%2BL.%26aulast%3DGaboury%26aufirst%3DJ.%2BA.%26aulast%3DGalie%26aufirst%3DK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DHussey%26aufirst%3DA.%2BR.%26aulast%3DRippin%26aufirst%3DS.%2BR.%26aulast%3DBenetatos%26aufirst%3DC.%2BA.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DChristensen%26aufirst%3DJ.%2BS.%26aulast%3DCoburn%26aufirst%3DG.%2BA.%26aulast%3DRizzo%26aufirst%3DC.%2BJ.%26aulast%3DRhodes%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DHowe%26aufirst%3DA.%2BY.%2BM.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DCollett%26aufirst%3DM.%2BS.%26aulast%3DPevear%26aufirst%3DD.%2BC.%26aulast%3DYoung%26aufirst%3DD.%2BC.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DTyrrell%26aufirst%3DD.%2BL.%2BJ.%26aulast%3DKneteman%26aufirst%3DN.%2BM.%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26atitle%3DThe%2520discovery%2520of%2520pyrano%255B3%252C4-b%255Dindole-based%2520allosteric%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%2520with%2520in%2520vivo%2520activity%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D1508%26epage%3D1515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit41e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Meuleman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesselgesser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanwolleghem, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desombere, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux-Roels, G.</span><span> </span><span class="NLM_article-title">Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1761</span><span class="NLM_x">–</span> <span class="NLM_lpage">1768</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=1761-1768&author=P.+Meulemanauthor=J.+Hesselgesserauthor=M.+Paulsonauthor=T.+Vanwolleghemauthor=I.+Desombereauthor=H.+Reiserauthor=G.+Leroux-Roels&title=Anti-CD81+antibodies+can+prevent+a+hepatitis+C+virus+infection+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeuleman%26aufirst%3DP.%26aulast%3DHesselgesser%26aufirst%3DJ.%26aulast%3DPaulson%26aufirst%3DM.%26aulast%3DVanwolleghem%26aufirst%3DT.%26aulast%3DDesombere%26aufirst%3DI.%26aulast%3DReiser%26aufirst%3DH.%26aulast%3DLeroux-Roels%26aufirst%3DG.%26atitle%3DAnti-CD81%2520antibodies%2520can%2520prevent%2520a%2520hepatitis%2520C%2520virus%2520infection%2520in%2520vivo%26jtitle%3DHepatology%26date%3D2008%26volume%3D48%26spage%3D1761%26epage%3D1768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Conte, I.; Ercolani, C.; Narjes, F.; Pompei, M.; Rowley, M.; Stansfield, I.</span><span> </span><span class="NLM_article-title">Preparation of tetracyclic indole derivatives as antiviral agents</span>. PCT Int. Appl. WO 2006/046030,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=I.+Conte&author=C.+Ercolani&author=F.+Narjes&author=M.+Pompei&author=M.+Rowley&author=I.+Stansfield&title=Preparation+of+tetracyclic+indole+derivatives+as+antiviral+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DConte%26aufirst%3DI.%26atitle%3DPreparation%2520of%2520tetracyclic%2520indole%2520derivatives%2520as%2520antiviral%2520agents%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">De Francesco, R.; Paonessa, G.; Olsen, D.; Rowley, M.; Crescenzi, B.; Habermann, J.; Narjes, F.; Laufer, R.</span><span> </span><span class="NLM_article-title">Robust antiviral efficacy of a “finger-loop” allosteric inhibitor of the HCV polymerase in HCV infected chimpanzees [abstract 24]</span>. Presented at <span class="NLM_conf-name">Hep DART 2007</span>, <span class="NLM_conf-loc">Lahaina, HI</span>, <span class="NLM_conf-date">December 9−13, 2007</span><span class="NLM_year"></span>; <span class="NLM_year"></span>; <span class="NLM_publisher-loc"></span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=De+Francesco%2C+R.%3B+Paonessa%2C+G.%3B+Olsen%2C+D.%3B+Rowley%2C+M.%3B+Crescenzi%2C+B.%3B+Habermann%2C+J.%3B+Narjes%2C+F.%3B+Laufer%2C+R.+Robust+antiviral+efficacy+of+a+%E2%80%9Cfinger-loop%E2%80%9D+allosteric+inhibitor+of+the+HCV+polymerase+in+HCV+infected+chimpanzees+%5Babstract+24%5D.+Presented+at+Hep+DART+2007%2C+Lahaina%2C+HI%2C+December+9%E2%88%9213%2C+2007%3B+%3B+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26atitle%3DRobust%2520antiviral%2520efficacy%2520of%2520a%2520%25E2%2580%259Cfinger-loop%25E2%2580%259D%2520allosteric%2520inhibitor%2520of%2520the%2520HCV%2520polymerase%2520in%2520HCV%2520infected%2520chimpanzees%2520%255Babstract%252024%255D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit43b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brainard, D. M.; Anderson, M. S.; Petry, A.; Van Dyck, K.; De Lepeleire, I.; Sneddon, K.; Cummings, C. E.; Nachbar, R. B.; Barnard, R. J.; Sun, P.; Panorchan, P.; Sanderson, J. P.; Udezue, E.; Wagner, F.; Iwamoto, M.; Chodakewitz, J.; A.; Wagner, J.</span><span> </span><span class="NLM_article-title">Safety and Antiviral Activity of NS5B Polymerase Inhibitor MK-3281, in Treatment-Naïve Genotype 1A, 1B and 3 HCV-Infected Patients</span>. Presented at the <span class="NLM_conf-name">60th Annual Meeting of the American Association for the Study of Liver Diseasesm</span>, <span class="NLM_conf-loc">Boston, MA</span>, <span class="NLM_conf-date">October 30−November 3, 2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Brainard%2C+D.+M.%3B+Anderson%2C+M.+S.%3B+Petry%2C+A.%3B+Van+Dyck%2C+K.%3B+De+Lepeleire%2C+I.%3B+Sneddon%2C+K.%3B+Cummings%2C+C.+E.%3B+Nachbar%2C+R.+B.%3B+Barnard%2C+R.+J.%3B+Sun%2C+P.%3B+Panorchan%2C+P.%3B+Sanderson%2C+J.+P.%3B+Udezue%2C+E.%3B+Wagner%2C+F.%3B+Iwamoto%2C+M.%3B+Chodakewitz%2C+J.%3B+A.%3B+Wagner%2C+J.+Safety+and+Antiviral+Activity+of+NS5B+Polymerase+Inhibitor+MK-3281%2C+in+Treatment-Na%C3%AFve+Genotype+1A%2C+1B+and+3+HCV-Infected+Patients.+Presented+at+the+60th+Annual+Meeting+of+the+American+Association+for+the+Study+of+Liver+Diseasesm%2C+Boston%2C+MA%2C+October+30%E2%88%92November+3%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBrainard%26aufirst%3DD.%2BM.%26atitle%3DSafety%2520and%2520Antiviral%2520Activity%2520of%2520NS5B%2520Polymerase%2520Inhibitor%2520MK-3281%252C%2520in%2520Treatment-Na%25C3%25AFve%2520Genotype%25201A%252C%25201B%2520and%25203%2520HCV-Infected%2520Patients" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><div class="note"><p class="first last">The enantiomeric excess of alcohol <b>10a</b> (or <b>10b</b>) has not been determined at this stage. A full account of the process development of compound <b>33</b>, which uses this initial sequence but modified reaction conditions, will be available soon.</p></div><span class="NLM_contrib-group">Scott, J. P.; Alam, M.; Bremeyer, N.; Goodyear, A.; Thientu Lam, T.; Wilson, R. D.; Zhou, G.</span><span> </span><span class="NLM_article-title">Mitsunobu Inversion of a Secondary Alcohol with Diphenylphosphoryl Azide. Application to the Enantioselective Multikilogram Synthesis of a HCV Polymerase Inhibitor</span>.  <span class="citation_source-journal">Org. Process Res. Dev.</span><div class="note"><p class="first last">submitted for publication.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+enantiomeric+excess+of+alcohol+10a+%28or+10b%29+has+not+been+determined+at+this+stage.+A+full+account+of+the+process+development+of+compound+33%2C+which+uses+this+initial+sequence+but+modified+reaction+conditions%2C+will+be+available+soon.Scott%2C+J.+P.%3B+Alam%2C+M.%3B+Bremeyer%2C+N.%3B+Goodyear%2C+A.%3B+Thientu+Lam%2C+T.%3B+Wilson%2C+R.+D.%3B+Zhou%2C+G.+Mitsunobu+Inversion+of+a+Secondary+Alcohol+with+Diphenylphosphoryl+Azide.+Application+to+the+Enantioselective+Multikilogram+Synthesis+of+a+HCV+Polymerase+Inhibitor.+Org.+Process+Res.+Dev.submitted+for+publication."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BP.%26atitle%3DMitsunobu%2520Inversion%2520of%2520a%2520Secondary%2520Alcohol%2520with%2520Diphenylphosphoryl%2520Azide.%2520Application%2520to%2520the%2520Enantioselective%2520Multikilogram%2520Synthesis%2520of%2520a%2520HCV%2520Polymerase%2520Inhibitor%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xwy" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xwy','PDB','2xwy'); return false;">PDB: 2xwy</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i34"><a href="/doi/suppl/10.1021/jm1013105">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82112"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures and spectroscopic data for compounds <b>6</b>, <b>8</b>, <b>10b</b>, <b>13</b>, <b>14</b>, <b>16</b>−<b>20</b>, <b>22</b>−<b>28</b>, <b>36</b>, and <b>38</b>; table with purity data and retention times for all tested compounds; enzyme and cell-based assay protocols; soaking experiments and X-ray data collection. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm1013105/suppl_file/jm1013105_si_001.pdf">jm1013105_si_001.pdf (120.14 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm1013105&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-1%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm1013105" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm1013105" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679984cbac223c76","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
